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Abstract 
Dosage compensation is the key regulatory process employed in Drosophila 
melanogaster to equalize the level of gene transcripts between the single X chromosome in 
males (XY) and the two X chromosomes in females (XX).  Dimorphic sex chromosomes 
evolved by the severe degeneration of the Y chromosome, giving rise to an imbalance between 
the heterogametic sex and the homogametic sex.  Vital to the viability of male Drosophila is 
the dosage compensation complex (DCC), a ribonucleoprotein complex that mediates the 
precise two-fold transcription of the single male X chromosome.  The DCC is comprised of 
five proteins: male-specific-lethal proteins (MSL) 1, 2, and 3, male absent-on-the-first (MOF), 
maleless (MLE), and two non-coding RNAs.  The complex specifically co-localizes along the 
male X chromosome in a reproducible manner, resulting in acetylation of lysine 16 of the N-
terminal tail of histone H4.  The exact mechanism of recruitment and spreading of the DCC 
along the male X chromosome remains unclear; recent studies propose a multi-step mechanism 
involving DNA sequence elements, epigenetic marks, and transcription.  Understanding how 
dosage compensation functions provides insight into the interplay between gene regulation and 
chromatin remodelling.  The goal of this project was to better understand how Drosophila 
MSL1, MSL3, and MOF interact and how their interaction modulates MOF’s acetyltransferase 
activity.  Recombinant protein constructs were cloned and over-expressed in a bacterial 
expression system permitting future structure determination by X-ray crystallography.  The 
dMSL1820-1039 construct consisted of the C-terminal domain, reported to be able to interact with 
both dMSL3 and dMOF.  dMSL3186-512 contained the domain required for the interaction with 
dMSL1 and dMOF.  dMOF371-827 was comprised of the catalytic domain, the CCHC zinc 
finger, and the chromodomain, as the N-terminal region does not encode any known domains.  
All three recombinant proteins were successfully cloned, over-expressed, and purified to 
homogeneity.  Recombinant dMOF371-827 was determined to acetylate histones.  Interaction 
studies using GST pull-down assays and size exclusion chromatography determined that 
dMSL1820-1039 and dMOF371-827 did not interact above background levels.  Moreover, size 
exclusion chromatography revealed dMSL3186-512 and dMOF371-827 did not interact nor did the 
three recombinant proteins form a stable complex.                        
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1. Introduction 
The introduction summarizes the literature of Drosophila melanogaster dosage 
compensation and the interplay between dosage compensation, chromatin and nucleosome 
structures, and epigenetics.  Moreover, the review provides insight on how the Drosophila 
melanogaster dosage compensation complex (DCC) functions by reviewing the literature of 
individual members of the DCC, their interactions with one another, and their proposed 
mechanisms of action.  Studying the DCC permits an understanding of the general principles of 
transcription and their relationship to chromosome gene wide regulation.  This literature review 
will provide insight into epigenetic regulation, and how the cross-talk between post-
translational modifications of histone tails leads to an equalization of X-linked gene expression 
between male and female Drosophila melanogaster.      
 
1.1 Dosage compensation  
1.1.2 Dosage compensation in metazoans 
 Worms, flies, and mammals each have evolved a unique mechanism of dosage 
compensation to resolve their unequal expression of sex-linked genes (Table 1.1).  
Disproportionate expression levels of genes encoded on respective sex chromosomes is 
generated in organisms with heterogametic males and homogametic females.  The term dosage 
compensation was first used to describe how heterogametic males and homogametic females 
display identical phenotypes from X chromosomal sex-linked genes (Muller et al. 1931).    
Homo sapiens males, like male Drosophila are heterogametes, posses an X chromosome and a 
Y chromosome.  Female Homo sapiens, like female Drosophila, are the homogametic sex, 
inheriting an X chromosome from both male and female parents (Table 1.1).  In Homo sapiens, 
dosage compensation occurs in female cells, employing a mechanism termed X chromosomal 
inactivation.  Inactivation is a phenomenon where one of the two X chromosomes undergoes 
severe condensation and forms a Barr body.  This Barr body results in a silent  X chromosome 
that equalizes the gene expression between the sexes through prevention of gene expression of 
one of the two X chromosome in females (Lucchesi et al., 2005; Nguyen and Disteche, 2006; 
Wutz and Gribnau, 2007).  The Barr body contains histone proteins that have undergone high 
levels of posttranslational modifications such as methylation and deacetylation, resulting in a 
tightly packed chromosome inaccessible to transcription.  Similar to mammals, dosage 
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compensation in Caenorhabditis elegans takes place in the homogametic sex (Meyer, 2000).  
The homogametic sex is hermaphroditic, possessing two X chromosomes, and the 
heterogametic sex is male, possessing one X chromosome (Table 1.1).  Dosage compensation 
acts on both of the X chromosomes of the hermaphrodite to effectively down regulate the level 
of transcription.  The two-fold reduction in gene expression of both X chromosomes then 
equates to the single male X chromosome.  Dosage compensation acts to balance the level of 
transcription between the sex chromosomes, but the down regulation of the X chromosomes in 
both mammals and worms creates an imbalance at the level of transcription between the X 
chromosomes and the autosomes (Gupta et al., 2006; Meyer, 2000; Nguyen and Disteche, 
2006).   
 
1.1.2 Dosage compensation in Drosophila melanogaster 
In Drosophila the male is the heterogamete possessing a single X sex chromosome and 
a single Y sex chromosome, from the male parent, whereas the homogametic female 
Drosophila possess two X chromosomes, one inherited from each parent (Table 1.1).  In 
Drosophila, the ratio between X chromosomes and autosomes (X:A) dictates the sex-specific 
development (Lucchesi and Manning, 1987).  The observation that RNA accumulated around 
the male X chromosome in Drosophila suggested that dosage compensation operated at the 
level of DNA transcription (Mukherjee and Beermann, 1965).  The male Y chromosome 
appears to play a minimal role in Drosophila, because it requires no compensation mechanism; 
however, this creates additional pressure on an organism because the X chromosome becomes 
the dominant site of regulation.  The DCC enables male Drosophila to express genes encoded 
on their single X chromosome to equivalent levels of the gene products of the two X 
chromosomes in female Drosophila (Lucchesi and Manning, 1987).  Identification of the DCC 
in Drosophila illustrates a novel method for solving the unequal gene expression of sex 
chromosomes compared to other eukaryotes (Lucchesi and Manning, 1987).   
 
1.1.3 Genetic and biochemical basis of the DCC 
Genetic screens enabled researchers to identify key genes involved in dosage 
compensation.   
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Table 1.1: Overview of the different dosage compensation strategies, including the distribution 
of chromosomes from flies to mammals. 
Organism Female Male 
Drosophila хх   ᴀᴀ XY   ᴀᴀ 
Mammalian Xx   ᴀᴀ XY   ᴀᴀ 
C. elegans xx   ᴀᴀ XO   ᴀᴀ 
The sex chromosomes are indicated by an X or a Y and the autosomes are indicated by an A.  
Capitalization and bolding demarks the sex chromosome affected by dosage compensation.  
The 0 represents the absence of a sex chromosome. 
 
 
As dosage compensation occurs in male Drosophila genes specifically involved in the dosage 
compensation process should cause lethality in males but have no effect on the survival of 
female offspring.  Sex specific lethality, the process by which male Drosophila develop to third 
larval instar or the prepupal stage but fail to metamorphose or hatch, is an effective method to 
understand the biochemical or physiological differences between two sexes and their 
developmental biology (Belote and Lucchesi, 1980; Fukunaga et al., 1975).  Mutations 
generated by ethyl methanesulfonate (EMS) treatment, found while researchers were scanning 
the second and third chromosome, facilitated the discovery of male-specific lethal (MSL) 1, 
MSL2, and maleless (MLE) genes.  The identification of these genes led to the characterization 
of the respective proteins encoded at the gene loci.  Homozygous Drosophila males possessing 
a terminal deletion of the third chromosome resulted in male specific lethality, which led to the 
discovery of MSL3 (Gorman et al., 1995).  Scanning the X chromosome using EMS mutations 
led to the identification of male absent on the first (MOF) (Hilfiker et al., 1997).  Moreover, 
two non-coding RNAs were identified; both gene loci were determined to be in the X-
chromosome and termed RNA on the X (roX1 and roX2) (Akhtar et al., 2000; Meller and 
Rattner, 2002; Meller et al., 1997).   
Involvement of non-coding RNA in Drosophila dosage compensation suggests that 
non-coding RNAs play an important role in the two otherwise dissimilar dosage compensation 
processes (Stuckenholz et al., 2003; Wutz and Jaenisch, 2000).  The non-coding RNA involved 
in dosage compensation in Homo sapiens, termed X-inactive specific transcript (Xist) is also 
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encoded in the X chromosomes.  Xist is central to regulating the X chromosomal inactivation 
as the inactive X chromosome is coated with Xist transcript. 
Co-immunoprecipitation experiments combined with immunofluorescence assays 
illustrated that the components affecting dosage compensation formed a ribonucleoprotein 
DCC consisting of MSL1, MSL2, MSL3, MLE, MOF, roX1, and roX2 (Copps et al., 1998; 
Hilfiker et al., 1997; Scott et al., 2000).  Dosage compensation is specific for male Drosophila 
and therefore, assembly of the DCC is only observed in males.  The reason for male specificity 
is because of a master regulatory gene, sex lethal (sxl); the Sxl protein is constitutively 
expressed in female Drosophila and not males (Cline, 1979; Lucchesi and Skripsky, 1981).  
Moreover, a lethal phenotype is observed in female possessing a loss of function Sxl mutant 
and in males actively expressing Sxl.  The Sxl protein is a female specific RNA-binding 
protein and a key member of the hierarchy of genes regulating sexual dimorphism.  The 
primary way in which Sxl prevents dosage compensation in females is by inhibiting expression 
of MSL2 protein through preventing splicing of the MSL2 messenger RNA.  Specific 
inhibition of MSL2 in females by Sxl was verified by the removal of the putative Sxl binding 
sites in the 3’ untranslated region of MSL2 mRNA resulting in MSL2 to be actively expressed 
(Kelley et al., 1995; Lyman et al., 1997).  All of the other components of the DCC are actively 
expressed in both female and male Drosophila suggesting additional roles of the dosage 
compensation components in female Drosophila (Kelley et al., 1995).   
The primary function of the DCC is targeting the acetyltransferase activity of MOF 
towards K16 of the N-terminal tail of histone H4 (H4K16) specifically along the male X 
chromosome (Gu et al., 1998; Hilfiker et al., 1997).  This posttranslational modification results 
in the in hyperacetylation of H4K16 precisely along the male X chromosome.  Covalent 
attachment of acetyl groups onto lysine residues on the N-terminal tails of histones results in a 
neutralization or reduction of the positively charged histone tails leading to a relaxation or 
loosening of the DNA-histone or nucleosome-nucleosome contacts.  Hyperacetylation of 
H4K16 therefore, results in downstream effects enabling expression of X-linked genes to be 
equalized between males and females by a process termed hypertranscription.  For 
supplementary up to date reviews on the DCC, refer to (Gelbart and Kuroda, 2009; Hallacli 
and Akhtar, 2009; Straub and Becker, 2008).   
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1.2 Components of the Drosophila dosage compensation complex  
The following subsections provide a review of each of the dosage compensation 
components: MSL1, MSL2, MSL3, MOF, MLE, and roX RNA (refer 1.2.1 – 1.2.6).   
 
1.2.1 MSL1 
Drosophila melanogaster MSL1 protein is 1039 amino acid residues (Palmer et al., 
1993) (Fig. 1.1A).  The MSL1 protein was found to contain a coiled-coil domain comprised of 
amino acids 120 – 172,  a highly acidic region defined by amino acid residues 368 – 391, and a 
PEST like sequence within amino acid residues 708 – 801 (Scott et al., 2000).  An additional 
protein domain, termed the PEHE domain was identified as a region extending from amino 
acids 865 – 1004, containing four characteristic amino acid residues proline, glutamate, 
histidine, and glutamate (Marin, 2003).  The high sequence similarity between the PEHE 
domain of Homo sapiens and Drosophila indicates an evolutionarily conserved protein domain. 
 
1.2.2 MSL2 
MSL2, a 773 amino acid protein, contains a really interesting new gene (RING) finger 
motif, residues 25 – 81, a cysteine rich (CXC) motif, residues, 525 – 561, and a C-terminal 
proline rich region (Fig. 1.1C).  The RING finger motif is a type of zinc finger containing the 
consensus sequence (C3HC4 zinc finger) (Lyman et al., 1997).  Interestingly, the RING finger 
motif of Drosophila MSL2 has been identified in E3 ubiquitin ligases from yeast to humans 
(Hibbert et al., 2009).  However, a connection between ubiquitination and dosage 
compensation in Drosophila has not been proposed.  The CXC motif is also found in a number 
of other chromatin-associated proteins (Bashaw and Baker, 1995; Fauth et al., 2010; Kelley et 
al., 1995; Zhou et al., 1995).   
 
1.2.3 MSL3 
The MSL3 protein of Drosophila is 512 amino acids in length (Fig. 1.1D).  The major 
domains in the MSL3 protein includes a chromatin organization modifier (Chromo) domain, 
residues 1 – 90, and a MORF4-related gene (MRG) domain comprised of amino acid residues 
186 – 490.   
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Figure 1.1: Schematic drawing of the protein components of the Drosophila melanogaster 
DCC. (A). Major protein domains of the full-length MSL1 protein.  Coiled-coil domain 
comprised of amino acid residues 120 – 170 and the PEHE domain is amino acid residues 865 
– 1004. (B). Regions described within the N-terminus of MSL1 described by Scott et al. 2005.  
The blue arrows indicate expanded region.  (C). Major protein domains of the full-length 
MSL2 protein.  Major protein domains of the full-length MSL2 protein including the RING 
finger motif comprised of amino acid residues 25 – 81, the CXC motif consisting of residues 
525 – 561, and a C-terminal proline rich region. (D). Major protein domains of the full-length 
MSL3 protein.  The chromodomain is comprised of amino acid residues 1 – 90 and the MRG 
domain consists of amino acid residues 186 – 490. (E). Major protein domains of the full-
length MOF protein.  Chromodomain amino acid residues 371 – 443, HAT domain 592 – 778, 
CCHC zinc finger residues 539 - 599, Acetyl-coA binding site. (F). Major protein domains of 
the full-length MLE protein.  The two RNA binding domains are amino acid residues 1 – 69 
and 170 – 240 respectively, the ATPase/helicase domain comprised of 382 – 773 and glycine 
rich region extends from 1193 – 1271. 
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1.2.4 MOF 
MOF is a 827 amino acid protein possessing a chromodomain comprised of residues 
371 – 443, a CCHC zinc finger comprised of residues 539 - 599, and a MOZ, Ybf3/SAS3, 
SAS2, and Tip60 (MYST) histone acetyltransferase (HAT) domain consisting of residues 592 
– 778 (Fig. 1.1E).  Within the MYST HAT domain is the acetyl-coA (Ac-CoA) substrate 
binding site.   
 
1.2.5 MLE 
MLE is a 1293 amino acid protein and a member of the ATP dependent RNA helicase 
(DExH family).  The identified domains of MLE include two RNA binding (RB) motifs RB1 
and (RB2), an ATPase/helicase domain, and a glycine rich region (Fig. 1.1F).                
 
1.2.6 roX RNA  
The roX1 RNA transcript was determined to be approximately 3,700 nucleotides in 
length, whereas the roX2 RNA was only approximately 600 nucleotides (Park et al., 2002; 
Smith et al., 2000).  Poor sequence similarity between roX1 and roX2 and their respective 
homologues from other Drosophila suggests the functional properties of roX RNA work at the 
level of secondary and tertiary structure.  Computational prediction combined with multiple 
sequence alignments against roX genes from other species of Drosophila revealed roX1 and 
roX2 genes contained a male-specific DNase I hypersensitive site (DHS), a stem-loop 
structure, and GUUNUAGG repeats (roX box) (Park et al., 2007; Park et al., 2008; 
Stuckenholz et al., 2003).  Three roX box repeats were found at the 3’ end of roX1 and two 
roX box repeats at the 3’ end of roX2.              
 
1.3 Nucleosome and chromatin structure in Drosophila 
The regulatory mechanisms of gene expression work at the level of individual genes, 
groups of genes or on entire chromosomes.  Fundamental to the regulation of eukaryotic 
genomic DNA is the ability of the cell’s DNA to fit within the nucleus and yet remain 
transcriptionally competent (Bassett et al., 2009).  In the nucleus, individual chromosomes are 
condensed into a 30 nm chromatin fibre (Kumaran et al., 2008).  Chromatin is comprised of 
nucleosome core particles (NCP), consisting of approximately 146 base pairs of duplex 
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genomic DNA wrapped around an octameric complex of histone proteins (H2A:H2B:H3:H4)2 
like beads on a string (Luger et al., 1997).  The organization of chromatin results in a barrier 
for the transcription of genes and plays an integral role in the organism’s maintenance of 
cellular functions and development (Narlikar et al., 2002).  Eukaryotic chromatin exists in 
several compaction states that can be broadly divided into two main types, euchromatin and 
heterochromatin (Kumaran et al., 2008).  Euchromatin is mainly comprised of gene-rich 
regions packaged loosely to facilitate gene transcription, and is transposon poor (Kumaran et 
al., 2008; Vermaak and Malik, 2009).  Heterochromatin is densely packed, transposon rich, 
and gene sparse.  Compaction of heterochromatin provides a means of regulating gene 
expression and segregating chromosomes into functional units.  The 30 nm chromatin fibre was 
further proposed to be in two unique nucleosome packing densities, stating that the 
euchromatic fibre is 6 nucleosomes per 11 nm, whereas heterochromatic fibre is 12 – 15 
nucleosomes per 11 nm (Fig. 1.2) (Bassett et al., 2009).  The relationship between spatial 
requirements of DNA interacting proteins and exposure of unique consensus sequences 
illustrates how nucleosomal packing regulates transcription.  In Drosophila, two of the three 
autosomes, 2L/R and 3L/R are primarily in a euchromatic state with some distinct regions of 
heterochromatin such as the centromeres.  The male Y sex chromosome and chromosome 4 are 
largely in a heterochromatin state.  The X chromosome also has distinct regions of euchromatin 
and heterochromatin (Fig. 1.3).   
In Drosophila, certain cells can permit an increase in their cell volume and elevate their 
gene expression levels by altering their chromosomes’ structure; these highly specialized 
chromosomes are generated by replication of the genomic DNA thousands of times without 
cell division, termed polyploid cells.  Several types of secretory cells of Drosophila adults, 
including salivary glands and several cells in Drosophila larvae, are polyploid cells.  Under 
such conditions the homologous chromosomes align to form polytene chromosomes (Fig 1.4) 
(Zhimulev et al., 2004).  The polytene chromosomes make Drosophila melanogaster an ideal 
organism to study chromosome compaction, gene regulation, epigenetics, and dosage 
compensation.  Furthermore, polytene chromosomes also maintain their organization into 
euchromatin and heterochromatin.  Polytene chromosomes possess an additional arrangement, 
termed bands and interbands.   
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Figure 1.2: Alternative nucleosome packing in proposed 30 nm chromatin fibre. (A). Model 
representation of heterochromatin, a mass to unit ratio of 12 – 15/11 nm. (B). Representation of 
the 30 nm euchromatin fibre with a mass to unit ratio of 6/11 nm.  Figure taken from (Bassett 
et al., 2009). Individual NCP are coloured light blue with either a dark blue center or a 
burgundy center.  Note the compaction of genomic DNA maintains a double helical 
conformation. 
 
 
 
Figure 1.3: Overview of the chromosomes in Drosophila melanogaster.  The autosomes 
include chromosome 2, 3 and 4.  Both chromosome 3 and 4 are comprised of a left and right 
region joined by a centromere.  The sex chromosomes are the X and Y chromosome.  The three 
states of chromatin are illustrated along the individual chromosomes.    
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Figure 1.4: Illustration of the bands and interbands observed by fluorescent DAPI stained 
Drosophila melanogaster polytene chromosome (msg.ucsf.edu/sedat//polytene_chrom.html).  
Bands are stained blue and interbands appear black.  The arrow demarks the chromocenter and 
the individual chromosomes are indicated as X, 2, 3, and 4.  The right and left arm of 
chromosome 2 and 3 are shown by an L or a R.   
 
 
Bands and interbands were discovered by the unique staining patterns of 4', 6-
diamidino-2-phenylindole (DAPI), a fluorescent dye which strongly interacts with the minor 
groove of DNA (Fig. 1.4) (Bayani et. al. 2004).  Drosophila polytene chromosomes also 
contain a chromocenter, defined as a heavily stained region where heterochromatic regions 
surrounding the centromeres align.     
The consistent banding pattern of the polytene chromosomes is evidence that the 
Drosophila interphase chromosomes are in a highly organized arrangement (Zhimulev et al., 
2004).  The decondensation of bands, termed chromatin puffs because of active transcription 
was originally observed  in polytene chromatin, from Drosophila salivary glands  (Semeshin et 
al., 2008).  Both bands and interbands are packaged into nucleosomes, but there are clearly 
significant differences in the higher order packing of the chromatin fibre.  Bands are typically 
compacted regions that are transcriptionally silent.  Interbands appear as more dispersed fibrils 
encoding non-coding regions and housekeeping genes.  The decompaction of interbands has 
been proposed to result in activation of proteins possessing insulator or barrier functions.  
Furthermore, interbands may also interact with nuclear matrix factors, playing a role in nuclear 
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architecture, as regulatory regions within promoter regions for RNA polymerase II, and 
function as a way to divide the chromosome into subdomains.  Lastly, it was determined that a 
band plus an interband does not exist as a distinct cytogenetic unit, rather that both bands and 
interbands act as autonomous units (Semeshin et al., 2008).  From cytological studies of the 
dosage compensation proteins, it has become evident that the DCC localizes to the interband 
regions of the male X chromosome, but not to the bands or the heterochromatic centromeres.  
Hence ascertaining how the DCC functions requires elucidation of the structural details 
governing bands and interbands, and their correlation with nucleosome packing, epigenetic 
markers, and gene transcription.        
   
1.4 Epigenetic markers and states of chromatin 
Regulation of chromosomes into heterochromatin and euchromatin does not stop there; 
there exists epigenetic mechanisms for controlling the information encoded in the DNA of 
chromosomes (Jenuwein and Allis, 2001; Marmorstein and Trievel, 2009; Suganuma and 
Workman, 2008).  The mechanisms of epigenetic actions are regulated through histone 
modifications, histone variants, noncoding RNAs, and nucleosome remodelling.  Each of the 
four histone proteins contains unstructured regions at their respective N- and C-termini termed 
histone tails that are rich in lysine and arginine amino acid residues.  The tails of histone 
proteins are known sites of posttranslational modifications.  Various permutations of histone 
tail modifications are thought to determine a histone code whereby the transcriptional 
competence of a gene is determined by a “bar code” of modifications maintained on the histone 
tails (Jenuwein and Allis, 2001).  Histone modifications, more specifically, are 
posttranslational modification of the N-terminal tails of the histone proteins H3 and H4, and, in 
some cases, H2A and H2B; types of modification include lysine acetylation, lysine or arginine 
N-methylation, ubiquitination, phosphorylation, sumolyation, arginine deimination, ADP-
ribosylation, and lysine deacetylation.  Histone modifications are mainly targeted towards the 
ε-amine group of lysine residues and the θ-amine of arginine residues (Smith and Denu, 2009).  
 Solving the crystal structure of the Xenopus laevis NCP (core histone proteins bound to 
a 147 base-pair DNA fragment, modified from human α-satellite DNA) enabled visualization 
of the potential mechanisms of the histone code (Luger et al., 1997; Luger and Richmond, 
1998) (Fig. 1.5A - C).          
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Figure 1.5: Solved nucleosome core particles from Xenopus laevis, Drosophila melanogaster, 
and Homo sapiens by x-ray crystallography.  (A). NCP from Xenopus laevis (PDB accession 
number: 1KX3, (Davey et al., 2002) including 147 bp double stranded DNA fragment (cyan), 
H2A (orange), H2B (dark blue), H3 (red), and H4 (green).  (B). Side view of NCP from 
Xenopus laevis emphasising the N-terminal tails from each of the histone proteins.  (C). NCP 
from Xenopus laevis emphasising the H4 N-terminal tail including the conserved amino acid 
residues from 16 – 25 (magenta).  (D). NCP from Drosophila melanogaster (PDB accession 
number: 2PYO,(Clapier et al., 2008)). (E). NCP from Homo sapiens (PDB accession number: 
2CV5, (Tsunaka et al., 2005).    
 
 
The histone tails account for approximately 30% of the core histone protein sequence and are 
largely comprised of lysine and arginine residues; consequently, they have a prominent 
positive charge at neutral pH (Luger and Richmond, 1998).  The interaction between histones 
and DNA is mediated in part through hydrogen bonds from positively charged amino acids on 
the histone proteins to the phosphodiester backbone of the DNA double helix.  The N-terminal 
13 
 
tails prefer interaction with the DNA minor groove.  The N-terminal tail of histone H4 is a 
highly conserved region encoding 4 invariant lysine residues at positions 5, 8, 12, and 16 
(Megee et al., 1995).  More specifically, the amino acid residues 16 – 24 of the histone H4 
amino-terminal tail are critical for crystallization of the NCP, where the basic polypeptide of 
the histone H4 N-tail interacted with an acidic region formed by H2A and H2B on the surface 
of the NCP.  Intriguingly, the acidic region of H2A is highly conserved among histone variants 
and is the only highly acidic patch on the surface of the histone octamer (Luger and Richmond, 
1998) (Fig. 1.5).  The importance of the histone H4 tail was stressed in mutagenesis studies in 
Saccharomyces cerevisiae; the absence of the N-terminal tail resulted in a reduced viability and 
genome integrity (Megee et al., 1995).  Solving the NCP structure of Drosophila and Homo 
sapiens revealed a high degree of conservation of the overall tertiary and quaternary structure 
(Fig. 1.5D, E) (Clapier et al., 2008; Tsunaka et al., 2005).  The strict conservation of the NCP 
across evolution was illustrated in the 99% sequence identity of histone H4 amino acid 
sequences (Clapier et al., 2008).  How the DNA is contorted about the NCP results in different 
lengths of genomic DNA per NCP.  This translates into a functional relationship between NCP 
compaction and transcription, because the average lengths of exons are approximately equal to 
the average length of DNA wrapped around a NCP (Schwartz et al., 2009).  Acetylation is 
thought to relax nucleosomes, reduce the number of internucleosomal interactions, by an 
alteration of the electrostatic interactions between the positively-charged histone N-terminal 
tails and the negatively charged phosphodiester backbone of nucleosomal DNA.   Classically, 
acetylation is thought to promote accessibility of the genomic DNA of promoter regions.  
Moreover, acetylation may also function as a sight for the recruitment of specific 
macromolecular complexes involved in chromatin remodelling, cell cycle, splicing, and 
nuclear transport (Choudhary et al., 2009).  With regard to dosage compensation, it has been 
suggested that the acetylation of the H4K16 by MOF likely opens up the chromatin structure 
on the male X chromosome by altering the interaction between the histone H4 N-terminal tail 
and the acidic region of H2A and H2B of the neighbouring nucleosome, thereby facilitating an 
increase in transcription of X chromosomal genes.   
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1.4.1 Overview of histone modifications implicated in dosage compensation 
Regulating the indexing of chromosomes into functional euchromatin or 
heterochromatin subdomains is critical to maintaining distinct types of chromatin.  Within the 
Drosophila genome there are greater than 50 suppressor of position-effect variegation (PEV) 
[Su(var)] loci that encode structural components of chromatin.  All of the Su(var) genes are 
thought to all be involved in defining, regulating, and maintaining heterochromatin (Ebert et 
al., 2006; Ebert et al., 2004).  PEV was originally described in white mottled-4 translocation 
(w[m4]), where an inversion on the X chromosome results in the w[m4] gene to relocate 
adjacent to pericentric heterochromatin, resulting in a red eye colour compared to wild-type 
white eye colour.  Inactivation or altered expression of specific genes by PEV is mediated 
through the rearrangement of gene loci: normally expressed euchromatic gene loci relocate 
either into silent heterochromatin or adjacent centromeric regions (Girton and Johansen, 2008).  
Altered expression is thought to be through histone modifications (H3K9 tri-methylation) and 
the recruitment of heterochromatin related proteins, results in spreading of heterochromatin, 
which overrides the basal expression level.  Moreover, PEV exemplifies how subdomains of 
chromosomes, nucleosome packing, and histone modifications regulate gene expression.  
Polytene squashes of Drosophila carrying PEV mutations revealed differentiation from a 
structured banded morphology into a diffuse banding morphology.  Three of the most 
established Su(var) gene products that affect dosage compensation are the zinc finger protein 
Su(var)3-7, the histone methyltransferase (HMTase) Su(var)3-9, and the chromodomain 
protein Su(var)2-5 encoding heterochromatin protein 1 (HP1).  Importantly, disruption of the 
modifiers of variegation also alters the morphology of the male polytene chromosome and 
dosage compensation of the male X chromosome (Spierer et al., 2005).   
In Drosophila, there are five HP1 protein isoforms (Vermaak and Malik, 2009).  The 
defined protein domains of HP1 consist of a chromodomain, required for binding H3K9Me2, a 
chromo shadow domain, involved in homodimerization and protein-protein interactions, and a 
hinge domain, involved in mediating localization and interaction with genomic DNA.  It has 
been documented that HP1 interacts with numerous proteins in connection with transcription, 
DNA replication, DNA repair, nuclear organization, and telomere maintenance (Vermaak and 
Malik, 2009).  For instance, loss of Su(var)3-7 or HP1 results in specific male lethality.  The 
connection between HP1 and the DCC likely has to do with the maintenance of 
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heterochromatin boundaries on the X chromosome as defined by the presence of repressive 
methylation markers on H3K9 and the phosphorylation of H3S10 by kinase Jil-1 (see below) 
(Spierer et al., 2005).       
Jil-1 encoded in the Su(var)3-1 locus is a chromosomal histone H3 protein tandem 
kinase.  From immunofluorescence colocalization experiments, it has become evident that both 
Jil-1 and the DCC are enriched at the interbands along the male X polytene chromosome (Ebert 
et al., 2004; Jin et al., 2000).  Notable pull-down assays proved that the kinase domains of Jil-1 
interacts with MSL1 (Jin et al., 2000).  In Drosophila homozygous for Jil-1 mutated alleles, the 
euchromatin bands are absent and all of their chromosome arms are drastically condensed.  
Ectopic expression of Jil-1 can rescue the null Jil-1 phenotype, resulting in complete 
restoration of chromatin to the appearance of wild-type chromatin (Wang et al., 2001).  In the 
case of Jil-1 null hypomorphic alleles, the reduced levels of H3S10 phosphorylation permitted 
dimethylation of H3K9 by Su(var)3-9 and allowed a subsequent spread of HP1 to ectopic 
locations along all chromosomes, including the highest levels along the male X chromosome 
(Zhang et al., 2006b).  Therefore, the proposed model of Jil-1 kinase activity is that it functions 
in the maintenance of the euchromatin, and establishment of chromatin structure.  Furthermore, 
phosphorylation of H3S10 was found to be critical in transcription elongation by release of 
RNA Polymerase II from promoter-proximal pausing complicating the issue of the DCC and 
Jil-1 crosstalk (Ivaldi et al., 2007).  This reflects the ability of both the DCC and Jil-1 to help to 
regulate the compaction state and transcriptional competence of the X-chromosome.   
ATPase dependent nucleosome remodelling complexes are thought to affect dosage 
compensation by affecting the structure and spacing of nucleosomes.  The hyperacetylation of 
H4K16 along the male X chromosome has been found to antagonize ISWI function (Corona et 
al., 2002).  ISWI is a member of the SWI2/SNF2 family of nucleosome remodelling ATPase 
complexes, which are thought to promote chromatin folding.  The relationship between dosage 
compensation and other nucleosome modifying complexes is in the maintenance of higher-
order chromatin structure, in crosstalk between histone modifications, and in the subdivision of 
chromosomes.  Particular to the function of the DCC is the intricate balance of the histone tail 
modifications along the male X chromosome.    
Encoding epigenetic information in higher eukaryotes is in part carried out by DNA 
methylation (Mandrioli and Borsatti, 2006).  Predominantly DNA methylation occurs on the 
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CpG dinucleotide, which is thought to mediate chromatin silencing by recruitment of methyl-
CpG binding proteins.  However, the occurrence of DNA methylation in Drosophila is only 
beginning to be acknowledged, subsequently how it affects dosage compensation is not yet 
known. 
 
1.4.2 Histone acetyltransferase: mechanism and recognition 
 One of the most abundant histone posttranslational modifications (epigenetic marker) is 
the reversible acetylation of lysine residues on histone N-terminal tails.  The specific 
acetylation of H4K16 along the Drosophila male X chromosome by MOF requires an 
appreciation of histone acetylation.  The exposure of genomic DNA for replication or 
transcription depends on local nucleosome organization.  It is understood that acetylation of 
histone tails by HATs induces micro- and macro-specific gene regulations.  The targeting of 
specific lysine residues by HAT enzymes within the N-terminal tails of the histone proteins is 
poorly understood.  Collectively it has been observed that some HATs precisely target 
promoters to mediate activation or repression of specific genes, whereas other HATs act 
globally on large domains of chromatin, including both coding regions and non-promoter 
regions (Dekker and Haisma, 2009; Marmorstein and Trievel, 2009).  The involvement of 
HATs in developmental defects and cancer has inspired recent attempts to understand the 
targeting mechanism of HATs and the cascade that results from the acetylation of the lysine 
residues of the N-terminal tails.   
The majority of HAT enzymes participate in large multiprotein complexes 
(Marmorstein and Trievel, 2009).  HAT enzymes do not always target histone proteins; for 
instance p300/CBP also acetylates transcription factors and non-transcription factors (Bannister 
and Kouzarides, 1996; Kalkhoven, 2004; Marmorstein and Trievel, 2009).  Moreover, the 
human homologue of MOF, hMOF, is known to acetylate p53 (Li et al., 2009).  The poor 
sequence conservation between different HAT families and the different catalytic mechanisms 
attests to the diversity HATs (Marmorstein and Trievel, 2009).        
The DCC component MOF belongs to the MYST family of histone N-acetyltransferase 
enzymes.  The MYST family of HATs include human HIV-1 Tat interactive protein (Tip60), 
human monocyte leukemia zinc finger protein (MOZ), yeast something about silencing 
proteins (SAS2 and SAS3), yeast essential SAS2-related acetyltransferase (Esa1), human 
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HBO1, mouse Querkopf, and fly MOF (Table 1.2) (Thomas and Voss, 2007).  The fact that 
MOF, a key member of the DCC and dosage compensation in male Drosophila, remains 
expressed in female Drosophila implies additional roles, such as acetylation of other proteins 
and/or histone proteins.  In Drosophila females, H4K16 acetylation occurs in the 5’ promoter 
regions of genes, which is atypical in relation to what occurs in males where acetylation occurs 
in the coding 3’ region of genes (Kind et al., 2008; Prestel et al., 2010).  Superposition of the 
solved protein structures of hMOZ, hMOF, Tip60, and Esa1 illustrates the high degree of 
conservation of the tertiary structure and the active site in the MYST family of HATs (Fig. 
1.6A, B).  A MOF construct, comprised only of amino acid residues 518 to 827, maintained its 
ability to acetylate histones and specificity for histone H4 (Smith et al., 2000).  Recombinant 
MOF with a G691E mutation in the acetyl-Co binding site, possessed a 10 fold decrease in 
HAT activity towards histone substrates compared to recombinant full-length wild type MOF 
(Fig. 1.6C, D) (Akhtar and Becker, 2000; Hilfiker et al., 1997).  Also, the recombinant full-
length MOF was shown to preferentially monoacetylate H4K16 on both free and nucleosomal 
histones; these results were corroborated by the inability of the G691E mutant to acetylate 
histones.  Expression of G691E MOF, containing an inactive HAT domain, greatly reduced the 
level of DCC assembly on the X chromosome in females (Gu et al., 2000).  Therefore, MOF 
has been determined to be the sole acetyltransferase within the DCC.   
 
 
Table 1.2: Summary of the MYST HAT family in metazoans.  
            HAT Organism 
MYST family  
Sas2 
Sas3 
Esa1 
MOF 
HBO1 
MOZ 
Tip60 
Yeast 
Yeast 
Yeast 
Fruit fly 
Human 
Human 
Human 
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Figure 1.6: Solved protein structures of MYST family HATs.  (A). Superposition of Esa1 
(magenta) (PBD accession id: 1MJA), Tip60 (green) (PBD accession id: 2OU2), Homo sapiens 
MOZ (orange) (PBD accession id: 2RC4), and Homo sapiens MOF (cyan) (PBD accession id: 
2PQ8) interacting with acetyl-coA, and indicating the conserved zinc finger.  (B). Ribbon 
representation of Homo sapiens MOF illustrating the secondary structure, the CCHC zinc 
finger, and Acetyl-CoA.  (C). Ribbon representation of Homo sapiens MOF showing the 
G691E mutation (red), and the Y572G, L578G and Y580G mutations within the zinc finger 
(blue).  (D). Surface accessibility of the G691E mutation.  E. Surface accessibility of the 
Y572G, L578G, and Y580G mutations (Akhtar and Becker, 2000; Akhtar and Becker, 2001).   
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Insight into the how MOF catalyzes the acetylation of H4K16 comes largely from the 
proposed mechanism for Esa1 (Marmorstein and Roth, 2001; Marmorstein and Trievel, 2009; 
Yan et al., 2002).  In the reaction mechanism, the first step is deprotonation of the sulphydryl 
group of C304 by E338 (Yan et al., 2002).  This enables a nucleophilic attack by C304 on the 
thioester of Ac-CoA generating an acetyl-cysteine enzyme intermediate.  The acetyl moiety is 
then transferred to the lysine residue of the histone N-terminal tail by a nucleophilic 
displacement reaction involving the deprotonated ε-amino group of the lysine substrate.  
Moreover, both the cysteine and the glutamate residues are conserved all of the members of the 
MYST family suggesting conservation of the catalytic mechanism (Marmorstein and Trievel, 
2009).     
One study has hypothesized that the specific covalent modification of the histone tails 
generates high affinity docking surfaces for proteins to interact with chromatin (Nielsen et al., 
2002).  MOF and MSL3 each contained unique chromodomains (Fig. 1.1D, E).  
Chromodomains are known to be a common protein domain found in chromosome 
modifying/interacting proteins; the chromodomain was originally identified in Drosophila 
modifiers of variegation, HP1 and polycomb (PC) protein (Paro and Hogness, 1991).  The 
chromodomains of MOF and MSL3 have been described as a chromo-barrel domain as they 
are both thought to be unique compared to the chromodomains of HP1 and PC (Bertram and 
Pereira-Smith, 2001; Nielsen et al., 2005).  The chromodomain of HP1 consists of a three-
stranded β-sheet whereas the chromo-barrel domain of MSL3 and MOF are comprised of a 
four-stranded β-sheet (Nielsen et al., 2005).  However, the functions of chromodomains are 
typically grouped in with the canonical chromodomain of HP1 and PC proteins; the 
chromodomains from both proteins are known to bind methylated N-terminal tails of histone 
proteins through a conserved aromatic pocket.  The canonical chromodomain interacting with a 
histone tail via an induced-fit mechanism consists of a three-stranded anti-parallel β-sheet and 
an α-helix packed against the β-strand of the histone H3 tail (Jacobs and Khorasanizadeh, 
2002).  Chromodomains differentiate the different methylated lysine residues by unique 
recognition grooves; for example, for K9 the recognition motif is QTARK9, whereas for K27 
the motif is KAARK27 (Fischle et al., 2003; Nielsen et al., 2002).  In the Drosophila HP1 
structure a three walled cage generates the methyl-amino binding site, which consists of Y24, 
W45, and Y48; mutation of the three aromatic residues drastically reduced the binding affinity 
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of the H3K9Me3 peptide (Jacobs and Khorasanizadeh, 2002).  The Homo sapiens 
chromodomain of MORF-related gene on chromosome 15 (MRG15) was solved revealing that 
the chromodomain is also composed of a β-barrel (four-stranded β-sheet) and a α-helix (Zhang 
et al., 2006a).  MRG15 a paralogue of MSL3, was found also to possess a methyl-lysine 
binding cage.  Preliminary data also suggests the MRG15 binds to H3K36Me3 peptides.  In 
vitro binding assays with GST-MRG15 determined MRG15 specifically interacts with 
H3K36Me2 in the presence of other di-methyled lysine residues.  Moreover, the chromodomain 
of MRG15 was found to align with the chromodomain of HP1 (Fig. 1.7A, B).  Alignment of 
the chromodomain of HP1 and MRG15 confirmed that both proteins shared the same three 
stranded β-sheet (β-barrel) and a short α-helix, and the ability to bind tri-methylated lysine.  
Moreover, within the β-barrel of MSL3 there is a hydrophobic pocket generated by Y26, Y46, 
and Y49, which is thought to enable interaction with methylated histone N-terminal tails 
(Nielsen et al., 2005).  The presence of an aromatic pocket analogous to the methyl binding 
pocket of MRG15, HP1 and PC suggested the chromodomain of MSL3 may also bind to 
methylated histone tails.  Furthermore, the solved chromodomain of Drosophila MOF revealed 
that the chromodomain was again comprised of a β-barrel and a short α-helix, but lacked the 
aromatic pocket (Nielsen et al., 2005).  Interestingly, it is possible to super-impose the 
structures of the chromodomain of MOF and the chromodomain of HP1 suggesting structural 
similarities (Fig. 1.7C, D).   
 
1.5 Function of the DCC 
1.5.1 Protein interactions and assembly of the DCC 
Biochemical analysis coupled with immunofluorescence studies has enabled great 
insight into the function and mechanism of the DCC.  The step by step assembly of the DCC is 
not completely understood; however, the initial step requires interaction between MSL1 and 
MSL2, which enables their binding to the X chromosome (Scott et al., 2000).  Yeast two-
hybrid assays determined that MSL1 and MSL2 interact via amphipathic coiled coil α-helical 
regions, amino acid residues 85 – 186 of MSL1 and amino acids 39 – 82 of MSL2 (Fig. 1.8) 
(Copps et al., 1998).  The amphipathic coiled coil α-helical region of MSL1 includes the apolar 
region and the coiled-coil domain, and of MSL2 the RING finger (Fig. 1.1A, B, C) (Li et al., 
2005).  In terms of chromatin association MSL1 and MSL2 possesses overlapping binding 
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patterns, suggesting both proteins target and tether the core complex to the male X 
chromosome (Lyman et al., 1997).   
 
 
 
Figure 1.7: Solved structures of the chromodomains of MRG15, MOF, and HP1.  (A). 
Structural superposition of chromodomains of MRG15 (magenta) (PBD accession id: 2F5K) 
and HP1 (green) (PBD accession id: 1KNE) and the interaction with trimethylated lysine 
peptide (H3K9Me3) (red).  (B). Structural superposition of the chromodomain of MRG15 
against HP1 showing the methyl lysine binding site of HP1 comprised of three aromatic amino 
acids Y24, W45, and Y48 of HP1 (orange) interacting with H3K9Me3 (red).  (C). Structural 
superposition of the chromodomains of MOF (cyan) (PBD accession id: 2BUD) and HP1 
(green), and the H3K9Me3 (red).  (D). Structural superposition of the chromodomain of MOF 
against HP1 showing the methyl lysine binding site of HP1 comprised of three aromatic amino 
acids Y24, W45, and Y48 of HP1 (orange) interacting with H3K9Me3 (red).     
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Figure 1.8: Illustration of the protein-protein interactions between the individual proteins of 
the DCC.  See text for further detail, section 1.5.1. 
  
 
The C-terminus of MSL1 consisting of the PEHE domain has been shown to interact 
via a pull-down assay with both MOF and MSL3 with Drosophila cell extracts (Fig. 1.8) (Scott 
et al., 2000).  Further studies found that the MRG domain of MSL3, residues 186 – 490, 
interacted with MSL1, residues 973 – 1039 (Morales et al., 2005; Morales et al., 2004).  Also, 
amino acid residues 766 – 939 of MSL1 were found to be required for the interaction with 
MOF.  Protein interaction between MSL1 and MOF was found to be dependent on the CCHC 
zinc finger domain of MOF, but the exact amino acid residues of MOF required for this 
interaction remains unknown (Morales et al., 2004).  The interaction between MSL3 and MOF 
in Drosophila is dependent on prior interaction with MSL1 as neither MSL3 nor MOF can 
directly interact with one another (Buscaino et al., 2003; Morales et al., 2004).      
The incorporation of roX RNA into the DCC by MLE has remained poorly understood.  
Studies have indicated that roX RNA mediates the association of MLE with the DCC and, in 
reciprocal fashion MLE incorporates roX RNA into the DCC (Lee et al., 1997).  Another study 
proposed that MSL2 played a role in the transcription of roX RNA (Rattner and Meller, 2004).  
Studies with mutant MLE have shown the absence of MSL3 and MOF from the male X 
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chromosome indicating MLE also plays a role incorporating MOF and MSL3 into the DCC 
(Gorman et al., 1995; Gu et al., 1998).  In a reciprocal fashion the integration of MLE with the 
DCC has also been linked to MSL3. As observed in male Drosophila lacking MSL3, MLE no 
longer associated with the X chromosome (Gorman et al., 1993).  Moreover, MSL3 has been 
shown to be involved in the correct localization of MOF, as the elimination of MSL3 by RNAi 
knockdown resulted in absence of MOF along the male X chromosome (Buscaino et al., 2003). 
   
1.5.2 The DCC requires multiple protein interactions for proper activity 
Direct interaction between MSL1, MSL3, and MOF has been shown to promote 
activation of MOF’s nucleosomal HAT activity and increase substrate specificity towards 
histone H4 (Morales et al., 2004).  Moreover, the inclusion of MSL1 or MSL3 with MOF did 
not result in any positive changes in MOF’s HAT activity.  Although H4K16 is the key target 
for the MOF’s HAT activity, both MSL1 and MSL3 can be acetylated by MOF in vitro 
(Morales et al., 2004).  As MSL3 and MOF cannot directly interact in Drosophila it is thought 
that the MSL1 scaffold brings MSL3 and MOF into direct contact, which could be expected to 
result in a conformational change of MOF that induces a more concise binding of substrate and 
enhanced activity of the acetyltransferase.  A relation, therefore, must exist between the histone 
acetyltransferase activity of MOF and the other proteins of the DCC.  Studies on Tip60, a 
member of the MYST HAT family, established a relationship between HAT activity and 
histone recognition by the Tip60 chromodomain (Sun et al., 2009).  The chromodomain of 
Tip60 was found to interact directly with histone H3K9Me3 and this increased HAT activity 
towards Tip60 substrate.  Therefore, the chromodomain must be able to interact with a precise 
target, H3K9Me3, which acts as an allosteric regulator of Tip60 catalytic activity instead of a 
binding motif for the recruitment of Tip60.  The example of Tip60 supports a role of MOFs 
chromodomain in dosage compensation by affecting the activity of HAT towards H4K16, and 
the possibility that the chromodomains of MOF and MSL3 may interact with methylated 
histone tails. 
The function of the MRG domain of MSL3 is thought to be involved not only in the 
integration of MSL3 into the DCC but also in the regulation of the HAT activity of MOF 
towards H4K16.  Protein interaction studies between MSL3 and MSL1, both expressed using 
baculovirus, showed that the MRG domain was required (Morales et al., 2005).  Studies on 
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MSL3 without the MRG domain, by immunostaining and RNA fluorescence in situ 
hybridization (FISH), revealed that the MRG domain enabled MSL3 to specifically target the 
male X chromosome (Buscaino et al., 2006).  In the absence of MSL3, MOF’s HAT activity 
was determined to be significantly lowered and not specific to H4K16.  Studies with MSL3 
possessing only the MRG domain, or lacking the chromodomain revealed that acetylation of 
K16 on H4 was similar to wild-type levels, indicating that the MRG domain and not the 
chromodomain was required for proper regulation of MOF’s HAT activity (Morales et al., 
2005).  The crystal structure of the MRG domain of MRG15 from Homo sapiens has been 
solved, which revealed a domain comprised of eight alpha helices (α1, α2, α3, α4, α5, α6, α7, 
and α8) (Fig. 1.9) (Bowman et al., 2006).  Moreover, the core of the domain consists of two 
orthogonal helix hairpins formed by two sets of two antiparallel helices (α2 & α3 and α5 & α6 
- 8).  The α6 - 8 helix of MRG domain contains a conserved hydrophobic patch thought to 
participate in protein-protein interaction.  The sequence identity between the MRG domain of 
Homo sapiens MRG15 and the MRG domain of MSL3 is 25 % it is likely that the MSL3 MRG 
domain has a similar arrangement of helices (secondary structure) in its tertiary structure (Fig. 
1.9).   
 
   
Figure 1.9: Structure of the MRG domain of MRG15 from Homo sapiens (PBD accession id: 
2F5J).  The structure contains eight unique α-helices (α1, α2, α3, α4, α5, α6, α7, and α8), and 
two orthogonal helix hairpins formed by two sets of two antiparallel helices (α2 and α3 and α5 
and α6 -8).  The helices are respectively coloured: α1 (red), α2 (blue), α3 (yellow), α4 
(magenta), α5 (cyan), and α6 - 8 (orange).     
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Moreover, sequence alignments between the MRG domains of MRG15 to that of MSL3 
revealed that helices α1, α5, α6 -7 are well conserved, α2 and α3 are moderately conserved, and 
α4 and α8 are not conserved (refer to section 3.4).    
 
1.5.3 Localization of the DCC along the male X chromosome 
The process of how the DCC specifically mediates its targeting of actively transcribed 
genes along the male X chromosome remains largely unknown.  Three hypotheses have been 
proposed for how the DCC localizes to the X chromosome: chromatin entry site (CES), 
multiple-binding-sites, and transcription activation.  The CES theory proposes that the 150 
highly reproducible CESs enables recruitment of the DCC to the male X chromosome 
(Larschan et al., 2007; Legube et al., 2006).  A CES retains MSL1 and MSL2 binding even in 
the absence of MSL3, MOF, and MLE.  The CES may regulate recruitment, as the DCC was 
observed to associate with various CESs when inserted into autosomes (Kageyama et al., 2001; 
Kelley et al., 1999; Larschan et al., 2007; Park et al., 2003).  The multiple-binding-sites model 
proposes that there are many binding sites with a wide range of binding affinities all along the 
male X chromosome.  The observation that numerous sites along the male X chromosome 
retain a high affinity for MSL1, MSL2, or roX RNA when one of the other proteins of the DCC 
was mutated led to the proposition of an endogenous affinity spectrum along the X 
chromosome (Demakova et al., 2003).  Also, in studies where the level of MSL2 was varied, a 
unique distribution pattern along the X chromosome was observed, indicating a hierarchy of 
targeting sites.  The transcription activation model relies on active transcription of genes on the 
X chromosome.  The model proposes that the act of transcription itself signals the recruitment 
of the DCC along the male X chromosome.  The transcription activation model is supported by 
the observation that the MSL proteins bind to a transgene when they are inserted into a 
interband, a region of active transcription, along the X chromosome (Legube et al., 2006).  
Moreover, it was shown that genes on the X chromosome actively being transcribed, in a 
number of cell lines, were enriched with H4K16Ac at the 5’ end of the respective gene loci 
(Gelbart et al., 2009).  In addition, colocalization of the DCC and H4K16Ac was observed at 
the 3’ and middle regions of active genes.  In conclusion, the distribution of the DCC cannot be 
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explained simply by a single principle, and is explained more accurately by all three models in 
a multimodal mechanism (Straub et al., 2008).     
 
1.5.4 Localization of the DCC requires particular protein domains 
A supplementary model of DCC assembly is described as “cotranscriptional assembly” 
at the roX1 and roX2 loci; the individual protein subunits of the DCC recognize the non-coding 
RNA transcript as its actively being transcribed by RNA polymerase II, functioning as a 
beacon tethering the protein subunits and driving assembly of the complex (Kelley et al., 
2008).  An important note is that both roX loci have been categorized as a CES.  The properties 
of the two RB domains of MLE were recently examined in a study researching the recombinant 
MLE proteins purified from insect cells; the study found that the RB2 domain is dominant for 
interaction with roX RNA and its subsequent integration into the DCC (Izzo et al., 2008).  
Removal of the RB2 domain was shown to result in a MLE protein that could not strongly 
interact with RNA; even though the glycine rich region was determined to aid in RNA binding.  
The RB1 domain was found to be involved in targeting the MLE to the X chromosome and not 
for interacting with RNA.  Interestingly, MLE lacking the RB1 domain and the glycine rich 
region was determined to possess a heightened helicase activity.  A GKT to GET mutation of 
the ATPase site A within the ATPase/helicase domain, identified as MLE
GET
, resulted in a 
recombinant protein that no longer retained NTP hydrolysis activity and effectively prevented 
the helicase activity on both RNA and DNA (Lee et al., 1997).  The MLE
GET
 mutant not only 
maintained co-localization with MSL1 on the X chromosome, but it also led to significant 
redistribution towards autosomes.  Furthermore, immunofluorescent staining of cells 
expressing the MLE
GET
 mutant revealed that MSL1, MSL3, and MLE mostly colocalized to the 
CESs along the X chromosome; however, roX1 RNA transcripts were also found throughout 
the nucleus, indicating an improper incorporation of roX1 RNA into the DCC (Gu et al., 2000).  
Mutation of the DEAD box within the helicase domain from DEIH to DQIH revealed a MLE 
protein, termed MLE
DQIH
, which had a high variability in X chromosome binding, and a 
significant inconsistency of the distribution of MSL1 along the male X chromosome (Richter et 
al., 1996).  The MLE
GET
 mutant and the MLE
DQIH
 mutant collectively revealed the importance 
of the ATPase/helicase domain for proper dosage compensation.   
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Explanation of how the DCC is targeted to the male X chromosome is further 
complicated by the ambiguity of DNA recognition sequences.  The absence of any obvious 
DNA sequences encoding a DCC binding site may be the result of degenerate DNA elements, 
which were therefore, lost over time (Gilfillan et al., 2006).  Insight into how MSL1 regulates 
DCC assembly along the male X chromosome was observed by the deletion of amino acid 
residues 1 – 84, which resulted in an MSL1 protein that no longer bound to the male X 
chromosome (Fig. 1.1B) (Scott et al., 2000).  Further deletion studies in transgenic flies 
showed that the removal of amino acid residues 1 – 26 resulted in an MSL1 protein which only 
interacted with the CESs (Li et al., 2005).  Moreover, point mutation of three conserved basic 
amino acids, K3, R4, and K6, all mutated to alanine resulted in a MSL1 protein which was 
only found to bind to five of the CESs.  Mutation of two conserved aromatic acids within the 
basic region, F5A and W7A, produced a protein that lost specificity for the X chromosome, 
and bound to significantly more autosomal sites.  Therefore, it was determined that, amino 
acids 1 – 84 were required to interact with the X chromosome, the three conserved basic 
residues modify CES binding, and the two conserved aromatic residues implicitly distinguish 
the X chromosome from autosomes.  In summary, the N-terminal domain of MSL1 is the 
region required for interaction with the X chromosome and specific regions within N-terminus 
function in a cooperative mechanism to identify and properly bind to specific sites along the X 
chromosome.   
MSL2 cooperates with MSL1 to stably associate with the male X chromosome as 
deletion of the amino acid residues 19 – 140, including the RING finger, inhibited MSL2 and 
MSL1 from binding to the X chromosome  (Kelley et al., 1997; Lyman et al., 1997; Zhou et 
al., 1995).  Therefore, the RING finger must be important in the interaction between MSL1 and 
MSL2 and interaction with the X chromosome.  The CXC motif is implicated in affecting the 
association with genomic DNA as recombinant MSL2 lacking the CXC motif had a drastic 
reduction in its affinity for dsDNA (Fauth et al., 2010).   
MSL3 was also shown to interact with both free and nucleosomal DNA, which were 
immobilized on paramagnetic beads, suggesting MSL3 may also be important in targeting the 
DCC to the male X chromosome (Morales et al., 2004).  In vitro nucleic acid binding 
experiments addressing RNA or DNA interaction, where a competitor was included, illustrated 
MSL3 preferentially interacts with RNA over DNA (Akhtar et al., 2000; Morales et al., 2005).  
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Experiments with recombinant MSL3, comprised of residues 1 – 259 including the 
chromodomain and part of the MRG domain, was found to interact with RNA, interestingly 
with a binding affinity greater than full-length MSL3 (Morales et al., 2005).  Moreover, it was 
determined that residues 1 – 140 of MSL3 containing the chromodomain could not interact 
with RNA (Morales et al., 2005).  However two subsequent studies, using EMSAs, 
demonstrated the ability of MSL3 to interact with DNA and unmodified recombinant 
nucleosomes and required the presence of the chromodomain (Buscaino et al., 2006; Sural et 
al., 2008).  Findings from our lab demonstrated recombinant MSL3 comprised only of amino 
acid residues 1 – 90 strongly interacted with nucleic acid (personal communication with Dr. 
Moore).     
 
1.5.5 Distribution of the DCC along the male X chromosome   
The distribution patterns of the DCC along the X chromosome have also been studied 
with chromatin immunoprecipitations hybridized to DNA microarrays of Drosophila polytene 
chromosomes (ChIP-chip) (Alekseyenko et al., 2006; Gilfillan et al., 2006; Legube et al., 
2006).  The distribution of MSL3 along the male X chromosome from embryonic SL2 cells, 
larval wing imaginal disc cells, and late embryos were examined (Alekseyenko et al., 2006).  
The distribution of MSL1 along the X chromosome of embryos was analyzed (Gilfillan et al., 
2006).  Lastly, the distribution pattern of both MSL1 and MSL3 on the both the male and 
female X chromosomes from 16 hrs embryos, 4 – 6 hrs early embryos, and salivary glands 
from third instar larvae was investigated (Legube et al., 2006). 
The DCC has been identified to interact selectively in a discontinuous pattern with 
greater than half of the genes, between 600 – 900 of the 1389 known genes, encoded in the X-
chromosome (Alekseyenko et al., 2006; Gilfillan et al., 2006).  Discrepancy in determining the 
precise number of genes along the X chromosome that the DCC interact with is rooted in the 
experimental procedure including cell type, developmental stage, and the protein of the DCC 
that is tested MSL1 versus MSL3.  The types of gene product, whether lethal or non-lethal, 
bound by the DCC (MSL1 or MSL3 ) was not indicative of DCC association (Legube et al., 
2006).  Contrarily, it was shown that MSL1 interacts with more genes encoding lethal proteins 
than non-lethal genes (Gilfillan et al., 2006).   
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MSL1 ChIP hybridization to custom microarrays revealed an almost complete bias of 
MSL1 binding to exons; moreover, within exons MSL1 bound to coding regions rather than of 
the 5’ or 3’ untranslated regions (Gilfillan et al., 2006).  Within the coding regions of exons 
MSL1 displayed a clear preference for the 3’ end.  ChIP-chip assays with a modified MSL3 
tagged protein showed that 90% of the DCC binding clusters were within expressed genes with 
a preference for the middle and the 3`end of the genes (Alekseyenko et al., 2006).  Analysis of 
ChIP-chip studies investigating colocalization of MSL1 and MSL3 found that 94 % of the 
binding sites were the same (Legube et al., 2006).  Localization of MSL1 and MSL3 to the 3’ 
end of genes led to the proposition that the DCC’s mechanism of action takes part in 
transcription elongation or termination; in a similar way as transcriptional elongation factors.  
Recent publications on exon-intron structure argues that the average length of exons in 
eukaryotes coincides with the average 147 nucleotides wrapped around the histone octamers 
(Schwartz et al., 2009).  Moreover, in Drosophila it was observed that exons contain a higher 
GC content compared to flanking introns.  The significance of the GC content is due to the 
correlation between nucleosome occupancy and exons.  Because exons are associated with the 
NCP it was reasoned they may possess specific modifications of histones to mark the exons; it 
was determined that histone H3K36 tri-methylation (H3K36Me3) was the most prominent 
modification, but also mono-methylated H4K20, H3K79, and H2BK5 was observed.  In 
Saccharomyces cerevisiae and in Drosophila H3K36Me3 was found to be enriched at the 3’ 
end of exons (Bell et al., 2008).  Moreover, the H3K36Me3 modification in Homo sapiens, C. 
elegans, and again in Drosophila melanogaster was consistently observed to at the 3’ end of 
exons (Kolasinska-Zwierz et al., 2009; Schwartz et al., 2009).  H3K36Me3 is a reported mark 
of transcription elongation.  The association of MSL1 and MSL3 to the 3’ end of exons led to 
the postulation that elevated gene expression of the male X chromosome by the DCC may not 
be involved in the initiation of transcription, but instead the promotion elongation and 
termination of transcription.  Acetylation of H4K16 along the male X chromosome is also 
found at the 3’ end of exons (Alekseyenko et al., 2006; Gilfillan et al., 2006; Kind et al., 
2008).   
A possible link between active transcription and the DCC was investigated through 
examining if MSL1 and RNA polymerase II colocalize along the male X chromosome.  RNA 
polymerase II was observed to interact with approximately 65 % of the genes of the X-
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chromosome, and with 87 % of the genes bound by MSL1.  However, the binding profiles 
were rarely similar, indicating that transcription alone is inadequate for the recruitment of the 
DCC (Alekseyenko et al., 2006).  Experiments with DNA microarrays found that 87 % of 
genes bound by the DCC were actively transcribed; furthermore, 50 % of actively transcribed 
genes were also bound with the MSL3-tagged protein, whereas only 8 % were unbound.  The 
effect of the DCC bound to genes actively being transcribed were studied through MSL2 RNAi 
knockdown.  Analysis of the microarrays found that genes associated with the DCC displayed 
a significant decrease in gene expression after treatment, whereas the expression levels of 
genes not associated with the DCC were less affected.  A weak correlation was determined 
between active transcription and MSL1 as only 15 % of the actively expressed genes encoded 
in the X-chromosome were bound by MSL1 in larvae salivary glands of 4 – 6 hour embryos 
when comparing ChIP-chip data and the expression data from the Yale Drosophila lifetime 
course (Legube et al., 2006).  These findings indicated that expression does not necessarily 
lead to MSL1 binding. The decreased requirement of the DCC may instead be due to the 
maternal stockpiles of mRNA, which are critically involved in the early stages of 
embryogenesis (Kugler and Lasko, 2009).  Polytene chromosomes from salivary glands were 
immunostained for MSL1, RNA polymerase II, and two elongation factors and no apparent 
association between active transcription and MSL1 binding was observed (Legube et al., 
2006).  Therefore, in DCC binding and recruitment transcription is important but not essential.     
Expression patterns among different cell types of Drosophila and the respective DCC 
bindings were studied; it was determined that approximately 600 genes were commonly bound 
by the DCC in embryonic cells, larval wing derived cells, and transgenic embryos, ranging 
between 12 and 17 hours (Alekseyenko et al., 2006).  Therefore, common DCC binding sites 
exist in different cell types.  In addition to DCC binding patterns between different cell types 
the DCC binding patterns between different developmental stages were studied.  Interestingly, 
the number of genes targeted by MSL1 between early embryogenesis and later developmental 
stages increased, indicating that the DCC played a greater and greater role as Drosophila 
progress through the developmental stages (Legube et al., 2006).  Moreover, association of a 
specific gene and the DCC appears to be an inherent property; in other words, the specific 
MSL1 binding patterns seen in previous developmental stages remain in subsequent stages.  
Research showed 40 % of the MSL1 binding sites in the late embryonic stage, are also bound 
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sites in the early larvae stage.  Interestingly, 40 % of the DCC targeted sites in late larval stage 
X chromosome comprised 83 % sites targeted along the X chromosome of the early larval 
stage.  In this sense, sequences may have evolved along commonly expressed genes; however, 
identification of 14 genes which were clearly bound in certain cell types were not bound by the 
DCC in other cell types.  These results indicate that sequence alone is not an absolute in DCC 
binding and recruitment (Legube et al., 2006).   
In order to investigate the reported CESs the binding pattern of MSL2, from embryos 
possessing mutated MSL3, was studied with ChIP-chip  (Alekseyenko et al., 2008).  Moreover, 
the MSL1 and MSL2 distribution along the X chromosome from SL2 cells possessing reduced 
MSL3, MLE and MOF by RNA interference was examined with ChIP-chip (Straub et al., 
2008).  High resolution ChIP-chip studies significantly increased the number of reported CESs 
(35 – 45 sites based on cytological studies of polytene chromosome squashes) along the male 
X chromosome; studies using SL2 cells identified 131 CESs, and studies using male embryos 
identified 150 CESs (Alekseyenko et al., 2008; Straub et al., 2008).  Current research argues a 
CES is defined as a site targeted by MSL1-MSL2 in the absence of MSL3, MOF, or MLE 
(Alekseyenko et al., 2008; Demakova et al., 2003; Gelbart et al., 2009; Straub et al., 2008).  
The average size of the 150 CES were determined to be 1.5 kb in length.  Of the 150 CES, 135 
overlapped with the position of known genes (Alekseyenko et al., 2008).  These studies lead to 
the identification of CES to be enriched with GA and CA dinucleotides, termed a MSL 
recognition element (MRE).  When the GA or CA dinucleotide motif or a MRE was expanded 
to 10 nucleotides, only 40 % of the CES contained the DNA sequence motif.  Therefore, a 
large percentage of the recruitment of the DCC may be sequence independent (Gelbart and 
Kuroda, 2009; Straub and Becker, 2008).  Surprisingly, when the MRE was inserted into an 
autosome, a novel DCC binding site independent of MSL3 was produced.  The clustering of 
weak targeting elements can function collectively to produce a strong binding site in 
Drosophila (Straub et al., 2008).  Interestingly, within all of the 150 CESs the MRE region was 
depleted of histone H3 proteins; suggesting that the absence of nucleosomes is fundamental to 
a CES; it is thought that this would enable quick and easy recruitment and assembly of the 
DCC (Alekseyenko et al., 2008).   
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1.5.6 Interplay between H3K36Me3 and the DCC 
H3K36Me3 is a chromatin modification that correlates with the recent transcriptional 
elongation of a gene.  Control of transcription was originally thought to be essentially only 
regulated by the recruitment of RNA polymerase pre-initiation complexes; however, a novel 
method has emerged to affect transcription by means of protein complexes that modify 
chromatin conformation.  Since H3K36Me3 is enriched at the 3’ end of genes actively being 
transcribed in yeast, it may be a possible chromatin modification, which has the ability to 
recruit the DCC in Drosophila (Larschan et al., 2007).  Huntingtin interacting protein B 
(Hypb) or Set2 was determined to be an essential HMTase because knockout resulted in 
lethality in both male and female Drosophila.  Hypb has been identified to catalyze the 
H3K36Me3 chromatin modification along the male X chromosome (Bell et al., 2008; Larschan 
et al., 2007).  A significant reduction of the posttranslational modification H4K16Ac and 
H3K36Me3 along the male X chromosome was observed when Hypb was severely reduced by 
RNAi interfence, this suggests the DCC is affected by Hypb activity.  With ChIP-chip profiling 
experiments it was determined that MSL3 and H3K36Me3 colocalized at 93 % of the DCC 
binding sites, and at 83 % of the binding sites, MSL3 and H3K4Me2 colocalized (Larschan et 
al., 2007).  A homologue of Drosophila MSL3 the Esa1p-associated factor-3 protein (Eaf3p), 
part of the Rpd3(S) histone deacetylase complex, of Saccharomyces cerevisiae has been found 
to be functionally linked with H3K36Me3.  The chromodomain of Eaf3p was determined to 
bind H3K36Me3, which then recruits the histone deacetylase Rpd3(S) complex.  It is thought 
that the Rdp3(S) complex removes transcription-coupled hyperacetylation and in doing so it 
inhibits unwanted RNA polymerase II initiation.  Therefore, the colocalization of the DCC and 
the histone modification, H3K36Me3 both appear to be part of the process though which DCC 
recognizes actively transcribed genes.   
The role of the MSL3 chromodomain and its ability to interact with methylated histone 
tails, specifically nucleosomes with H3K36Me3 was investigated (Sural et al., 2008).  It was 
determined that full length wild-type MSL3 had a higher affinity for H3K36Me3 modified 
nucleosomes compared to unmodified nucleosomes.  The MRG domain of MSL3 was shown 
again not to interact with nucleosomes and MSL3 lacking the chromodomain was determined 
to not interact with both modified and un-modified nucleosomes.  Interestingly, studies on the 
DCC binding pattern where MSL3 lacked its chromodomain, or possessed the SYD62A 
33 
 
mutation within the chromodomain it was demonstrated that the DCC only interacted with the 
CESs, supporting the importance of the chromodomain of MSL3 in interaction with other 
regions along the male X chromosome (Buscaino et al., 2006; Sural et al., 2008).  However, 
our lab examined recombinant MSL3 expressed in E. coli and found it did not interact 
appreciably with H3K36Me3 (personal communication with Dr. Moore).   
 
1.5.7 Spreading of the DCC along the X chromosome 
Within the mechanisms proposed for proper dosage compensation is first the 
recruitment of the DCC to male X chromosome and subsequent bi-directional but non-
continuous spreading of the DCC to the regions along the male X chromosome.  Bi-directional 
spreading of the DCC from a known entry site was first observed when the roX loci were 
inserted into an autosome (Kelley et al., 1999).      
 
 
Figure 1.10: Proposed mechanism of how the DCC is recruited to and subsequently spreads 
along the male X chromosome.  The DCC members specifically associate along the male X 
chromosome assembling at the CESs.  The assembled DCC acetylates H4K16 at the CESs, and 
then spreads to neighbouring exons along the X chromosome targeted by H3K36Me3.  See text 
for further details, sections 1.5.5 – 1.5.7.  
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The roX loci are known to contain DNase I hypersensitive CESs for the DCC, and both roX1 
and roX2 are found on the X chromosome, suggests their importance in both recruitment and 
spread of the DCC along the X chromosome.  Moreover, bi-directional spreading aids in 
explaining how the observed wide spread distribution of DCC is obtained along the male X 
chromosome in accordance with the CES model and the multiple-binding-sites model (Kelley 
et al., 1999; Oh et al., 2003; Park et al., 2002).  Furthermore, the involvement of DNA 
sequence elements in spreading of the DCC was observed when a candidate CES possessing a 
MRE motif was inserted at an ectopic autosomal site, which resulted in recruitment and 
subsequent bi-directional spreading of the DCC from the autosomal site (Alekseyenko et al., 
2008).  Interestingly, the rate of spreading appeared to be correlated to the rate of transcription 
of the roX RNA; as elevated levels of transcription inhibited local spreading and localization of 
the DCC at other sites on the X chromosome suggesting active transcription at other sites may 
prevent spreading along the male X chromosome (Kelley et al., 2008).  However, active 
transcription of other genes on the X chromosome, enriched with the chromatin modification 
H3K36Me3 at the 3’ end, may aid in targeting the DCC to those genes along the X 
chromosome.  A recent study proposed a mechanism to explain how the DCC spreads along 
the X chromosome (Fig. 1.10) (Sural et al., 2008).  The initial step is the assembly of the DCC 
at the CES, which coincides with the CES model.  The adjacent regions of the CESs contain 
H3K36Me3 which then recruits the DCC away from the CESs.  The vacated CES then enables 
assembly of another DCC.  This continuous assembly and spreading results in the enrichment 
of H4K16Ac along the male X chromosome resulting in the two-fold transcriptional elevation 
of the genes encoded in the X chromosome. 
 
1.6 Homologues of Drosophila dosage compensation proteins   
Comparative genomics has identified a number of DCC orthologues in vertebrate 
species, suggesting that the DCC protein sequences have been conserved through evolution 
(Marin, 2003).  All of the proteins involved in the DCC have homologues in Homo sapiens 
(Taipale and Akhtar, 2005).  The known protein domains within the individual proteins of the 
Drosophila DCC except MLE were all found within their respective Homo sapiens homologue 
(Mendjan et al., 2006).  Experiments using co-immunoprecipitation identified a HAT complex 
consisting of hMSL1, hMSL2, hMSL3, and hMOF (Smith et al., 2005).  The complex was 
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confirmed by use of co-immunoprecipitation and tandem affinity purification, determining that 
targeting any of the four proteins resulted in co-purification of the remaining three members.  
Moreover, in vitro pull-downs determined hMOF and hMSL3 stably associated with one 
another, suggesting a direct interaction (Taipale et al., 2005).  Immunoprecipitations 
consistently revealed two hMSL3 isoforms; surprisingly the shorter splice isoform was 
determined to not possess the chromodomain.  Since the Homo sapiens complex acetylates the 
identical target of Drosophila MOF, H4K16, it is possible that the DCC is also highly 
conserved through evolution (Smith et al., 2005).   
Paralogues of Drosophila MSL3 have been identified with chromatin remodelling 
complexes, analogous to the Drosophila DCC all of these complexes also contain a MYST 
family HAT (Buscaino et al., 2006).  Eaf3p, the MRG15 orthologue in budding yeast, is part of 
the NuA4 complex containing the MYST HAT protein Esa1.  In addition, MRG15 associates 
with the Tip60 complex in Homo sapiens, which includes the MYST HAT protein Tip60. 
The acetylation activity of hMOF akin to dMOF has been shown to be specific H4K16 
(Taipale et al., 2005).  hMOF has been identified in additional complexes including the mixed 
lineage in leukemia 1 (MLL1) complex and the non-specific lethal (NSL) complex (Cai et al., 
2009).  Other MYST HAT members found in humans include: HBO, INO, MOZ, MORF, and 
Tip60 (Voss and Thomas, 2009).  RNAi knockdown of hMOF in HeLa cells caused a decrease 
in acetylation of H4K16 and the cells to arrest their cell cycle at the G(2)/M phase; therefore it 
may have a direct role in regulating cell cycle checkpoints (Gupta et al., 2005; Smith et al., 
2005; Taipale et al., 2005).   
A stable interaction between hMOF and MLL1 has been mapped to the zinc finger of 
MOF and the C-terminal region of MLL1 (Dou et al., 2005).  The complex maintains MLL 
driven histone methyltransferase activity for H3K4 and MOF and mediates histone 
acetyltransferase activity for H4K16.  Interestingly, the complex in vitro was shown to enable 
optimal activation of transcription on a chromatin template.  hMOF and MLL1 complex were 
determined to associate with the ATM, a protein involved in DNA repair (Gupta et al., 2005).   
Affinity purification, coupled with mass spectrometric analysis, identified an 
enzymatically active NSL complex purified from human HeLa cells (Mendjan et al., 2006).  
The interactions between hNSL1 (coiled coil, PEHE domains), hNSL2 (two C/H-rich 
domains), hNSL3 (seven WD40 repeats) and hMOF were confirmed.  Furthermore, the NSL 
36 
 
complex was isolated from Drosophila embryos and Schneider cells, indicating an 
evolutionarily conserved complex from flies to humans.  The NSL complex was found to be 
comprised of 9 subunits, including WD repeat domain 5 (WDR5), host cell factor 1 (HCF1), 
and MCRS1 (Cai et al., 2009).  The hMOF that associated with NSL complex was determined 
to acetylate not just H4K16 but also K5 and K8 on H4.  The MCRS1 protein has been 
previously found in the humans INO chromatin remodelling complex.   
hMLE orthologues have been linked to diverse roles in other eukaryotes.  hMLE has 
been identified as a nuclear DNA helicase II or RNA helicase A (Lee and Hurwitz, 1993).  
Studies on MLE orthologues RNA helicase A of Homo sapiens and nuclear DNA helicase II of 
Bos taurus have led researchers to postulate on the function of MLE.  Sequence alignments 
between MLE and RNA helicase A showed a 50% identity and alignment of MLE with RNA 
helicase II a 85% similarity (Lee et al., 1997; Lee and Hurwitz, 1993; Richter et al., 1996).  
Evidence has shown hMLE to be involved in multiple features of cellular and viral DNA and 
RNA metabolism (Aratani et al., 2008).  Moreover, it has also been shown to recruit the RNA 
polymerase II complex to promoters, activate transcription through interaction with cis-acting 
transcription factors and their promoters, and mediate transactivations through interaction with 
specific nuclear receptors.   
 
1.7 Thesis Objectives and Hypothesis 
The key function of the DCC is to specifically target the acetylation activity of MOF to 
the H4K16 along the male X chromosome (Gu et al., 1998; Hilfiker et al., 1997; Smith et al., 
2000).  Therefore, modulating activity and specificity of MOF’s acetylation activity is pivotal 
for survival of male Drosophila.  The C-terminus of MSL1, consisting of the PEHE domain, 
co-immunoprecipitates both MOF and MSL3 from Drosophila cell lysates (Scott et al., 2000).  
The MRG domain of Drosophila MSL3 comprised of amino acid residues 185 – 490, or 141 – 
490 was found to interact with residues 973 – 1039 of MSL1 (Morales et al., 2005).  
Furthermore, amino acid residues 766 – 939 of MSL1 were determined to interact with MOF 
(Morales et al., 2004).  The CCHC zinc finger and the MYST HAT domain are both required 
to interact with MSL1; however, the exact amino acid residues of MOF which interact with 
MSL1 remain unknown.  Moreover, MSL3 and MOF do not directly interact, but are thought 
to interact once both are bound to MSL1 (Buscaino et al., 2003; Morales et al., 2004). 
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The purpose of this project was to gain a better understanding of the protein interactions 
between MSL1, MSL3, and MOF.  Utilization of recombinant proteins and in vitro protein 
interaction studies enabled investigation of the protein complex.  The project pursues four main 
objectives.  To start we will need to construct a MSL1 C-terminal domain that can be over-
expressed and purified to homogeneity.  Also, to study the interactions of the human MSL1 
components, it is necessary to generate a Homo sapiens MSL1 C-terminal construct that can be 
over-expressed and purified.  Studying the interactions of the DCC components will also 
require the purification of two other proteins of the DCC: the MRG domain of MSL3 and the 
catalytic domain of MOF (chromodomain and MYST HAT domain).  Characterizing protein 
interactions first requires ascertaining the stability and purity of the recombinant proteins by 
biochemical analyses including: characterization of the protein’s structure using calibrated size 
exclusion chromatography, Far-UV spectrophotometry, and other techniques.  It was hoped we 
could demonstrate interaction between the three DCC components using various combinations 
of the purified recombinant domains.  Protein-protein interaction studies will be carried out 
with GST pull-downs and size exclusion chromatography.   An important part of this work will 
be to obtain structures for the C-terminal domain of MSL1 and the MRG domain of MSL3 or 
any of the relevant complexes with MOF.  Crystallization trials will be carried out on the 
recombinant proteins, and if possible co-crystallization trials of the complex for future 
structure determination by X-ray crystallography.  Accomplishment of these goals will allow 
progress toward comprehending dosage compensation, and will also facilitate future structural 
studies.   
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2. Materials and Methods 
2.1 Cloning of Drosophila Melanogaster MSL1, MSL3, and MOF  
 
Table 2.1: List of the PCR primers for the relevant Drosophila MSL1, MSL3, and MOF gene 
fragments cloned in this work.   
Recombinant 
Protein 
Primer Sequence Restriction 
Endonuclease 
dMSL1  
(820 – 1039) 
(AJW009) 5’-GACCTGAGATCTTCGGGAAAACTGCAGTCCAGAT-3’ 
(KK012) 5’-GACGAGGAATTCCTAACGATTCTTCTGGCGCTT-3’ 
BglII 
EcoRI 
dMSL1  
(754 – 1039) 
(KK011) 5’-GCCGAGAGATCTGGCTCAACGCCACAGCATGCG-3’  
(KK012) 3’-CTCGTCGAATTCCTAACGATTCTTCTGGCGCTTGCG-5’ 
BglII 
EcoRI 
dMSL1  
(712 – 1039) 
(KK010) 5’-GCCGAGAGATCTTCACAGGTTACGCTAAGAAAATAAGAGAG-3’ 
(KK012) 3’-CTCGTCGAATTCCTAACGATTCTTCTGGCGCTTGCG-5’   
BglII 
EcoRI 
dMSL1  
(688 – 1039) 
(KK009) 5’-GCCGAGAGATCTCAGAGCCCAGATCAAGAAATAGATGTG-3’  
(KK012) 3’-CTCGTCGAATTCCTAACGATTCTTCTGGCGCTTGCG-5’  
BglII 
EcoRI 
dMOF  
(370 – 827) 
(SAM040) 5’-GACCTGGGATCCCAAAAGATCGATATAAGCGAAAATCCC-3’ 
 
(SAM043) 5’-GACGAGGAATTCCTAGCCGGAATTTCCCGGAGCTCT-3’ 
BamHI 
EcoRI 
dMSL3 
 (185 – 512) 
(BJM007) 5’-GACCTGGGATCCAATGATGTATCGGTCTATAATCATGTG -3’ 
(BJM004) 5’-GACGAGGAATTCCTAAGCAGCAATACCATCCAGGGA -3’ 
BamHI 
EcoRI 
Note that in the synthetic oligonucleotides the clamps are underlined, the endonuclease 
restriction sites are italicized, and the complementary sequences are depicted in boldface.   
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2.2 Cloning of Homo sapiens MSL1  
 
Table 2.2: List of the PCR primers for the relevant Homo sapiens MSL1 gene fragments 
cloned in this work.   
Recombinant 
Protein 
Primer Sequence Restriction 
Endonuclease 
hMSL1 (404 – 614) (KK005) 5’- GCCGAGGGATCCATGGAAAGGCGGATGCAGCTGG-3  
(KK008) 5’- GAGGCCGTCGACCTATTTCCTACACGTCGGTGAGG– 3’ 
BamHI 
SalI 
hMSL1 (364 – 614) (KK006) 5’- GCCGAGGGATCCGAGGAACCCTGTGGTTCC – 3’  
(KK008) 5’- GAGGCCGTCGACCTATTTCCTACACGTCGGTGAGG– 3’ 
BamHI 
SalI 
hMSL1 (262 – 614) (KK007) 5’- GCCGAGGGATCCGGACCCAGCACCCATCCCAAG– 3’  
(KK008) 5’- GAGGCCGTCGACCTATTTCCTACACGTCGGTGAGG– 3’ 
BamHI 
SalI 
hMSL1 (465 – 614)   (AJW017) 5’-GCCGAGGGATCCAGTGTTGCAGGAGAAACTTCAGTC-3’ 
(KK008) 5’- GAGGCCGTCGACCTATTTCCTACACGTCGGTGAGG– 3’      
BamHI 
SalI 
Note that in the synthetic oligonucleotides the clamps are underlined, the endonuclease 
restriction sites are italicized and the complementary sequences are depicted in boldface.   
 
 
2.3 Cloning Procedure   
 Constructs were individually designed by first searching for homologues and then 
aligning the protein sequences to identify the conserved regions in the protein sequences.  
Protein homologues were found through the use of the Basic Local Alignment Search Tool 
(BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi).  Multiple alignments of the relevant protein 
sequences were generated using EMBL-EBI ClustalW2 (Larkin et al., 2007) 
(http://www.ebi.ac.uk/Tools/clustalw/index.html), and adjustments were done manually when 
necessary.  The appropriate gene nucleotide sequences were then used to design the 
corresponding primers.  ExPASy Prot Param (John M. Walker (ed): The Proteomics Protocols 
Handbook, Humana Press (2005) http://www.expasy.ch/tools/protparam.html) was used to 
predict the recombinant protein molecular mass, isoelectric point, and extinction coefficient for 
each construct.     
 Four unique constructs of MSL1, encompassing the C-terminal domain, from both 
Drosophila melanogaster and Homo sapiens were designed (Table 2.1 & 2.2).  A MSL3 
construct and a MOF construct from Drosophila melanogaster were also designed (Table 2.1).  
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All constructs were designed to be inserted into the multiple cloning sites (MCS) of pGEX-6P-
3 downstream of the glutathione S-transferase gene and the PreScission protease cleavage site 
(Fig. 2.1).  
 
2.3.1 Overview of pGEX-6P-3 vector 
 The utilization of the pGEX-6P-3 expression vector (GE Life Science) enabled the 
cloning of a variety of protein constructs, transformation of E. coli, and selection of 
transformants by the appropriate antibiotic (ampicillin).  Insertion of a gene fragment of 
interest into the MCS of the vector enables expression of an in-frame GST-fusion protein.  The 
recombinant GST tag, composed of 228 amino acids, contains a PreScission protease cleavage 
site at the 3’ end of GST DNA, upstream of the MCS.  PreScission protease is a recombinant 
fusion protein comprised of GST and human rhinovirus (HRV) type 14 3C protease.  The 
protease is specific for the core amino acid sequence Leu-Phe-Gln/Gly-Pro and cleaves 
between the Gln and the Gly residue, which has been engineered into the pGEX-6P-3 MCS.  
The GST tag permitted purification of the recombinant protein by means of Glutathione 
Sepharose (GS) affinity chromatography.  
   
 
 
Figure 2.1: Illustration of the pGEX-6P-3 vector.  The MCS, the GST gene, the Amp 
restistance gene, the lac I gene, the pBR322 ori, and the endonuclease restriction sites are all 
shown.  The figure was adapted from the Recombinant Protein Handbook (Amersham 
Biosciences).   
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2.3.2 DNA amplification by Polymerase Chain Reaction 
 Each gene fragment of interest was generated by DNA polymerase chain reaction 
(PCR).  All of the PCRs were done using 2 ng of cDNA template diluted into 50 uL of 1X PCR 
reaction mixture.  The 1X PCR reaction mixture contained 1X PCR reaction buffer (200 mM 
Tris-HCl [pH 8.8 at 25 °C], 100 mM (NH4)2SO4, 100 mM KCl, 1 % [v/v] Triton X-100, 1 
mg/mL BSA, 1.5 mM MgSO4), 0.5 μM 5’ forward primer, 0.5 μM 3’ reverse primer, 200 μM 
dNTPs, 1 μL (5 U) Pyrococcus furiosus (Pfu) DNA polymerase (Fermentas), and H2O, for a 
total volume of 100 μL.  Amplifications by PCR were carried out using a MyCyclerTM Thermal 
Cycler (Bio-Rad) for 30 – 35 cycles.  All primers were purchased from Sigma Genosys and are 
listed in Tables 2.1 and 2.2.  A representative PCR amplification program is illustrated in 
Figure 2.2.  Note that adjustments were made to facilitate the melting temperature of the 
primers and the nature and length of the template cDNA.     
 
 
 
 
Figure 2.2: Typical PCR amplification program.  The program consists of three stages and 30 
cycles.  Stage 1 is an extended 2 min denaturation step.  Stage 2 is made up of the 30 cycles 
where each cycle includes a 30 s denaturation step, a 45 s annealing step, followed by a 3.5 
min. elongation step.  Stage 3 holds the reaction mixture at 4 °C indefinitely.    
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2.3.3 Ethanol Precipitation of PCR DNA 
 Following PCR, the reaction mixture was purified by ethanol precipitation which was 
performed by adding 10 % v/v 3 M sodium acetate (pH 5 at 25 °C) to the PCR mixture, 
followed by a wash of 3X v/v of the PCR mixture with 95% ethanol.   The resultant solution 
was stored at -20 ° C for 10 min, and then pelleted via centrifugation at 17,418 x g (rmax 13,000 
rpm) for 10 min at 4 °C.  The subsequent supernatant was discarded and the pellet was then 
washed with 2X 70 % ethanol.  The remaining liquid within the pellet was removed by rotary-
evaporation and then the pellet was dissolved in 20 μL TE buffer (10 mM Tris-HCl, [pH 7.5 at 
25 °C] and 1 mM EDTA).  
    
2.3.4 Agarose gel electrophoresis  
 Agarose gel electrophoresis was the method employed for further purifying the PCR 
product DNA and estimating the size, quantity, and purity of the desired PCR product, or 
vector DNA.  The agarose matrix was always 1 % agarose (w/v) in 1X TAE solution (40 mM 
Tris-acetate [pH 8.0 at 25 °C] and 1 mM EDTA).  1X TAE solution was diluted from a 50X 
stock solution.  To dissolve the agarose the mixture was heated for 2 min in a microwave, after 
which the solution was cooled and 0.5 μg/mL ethidium bromide was added.  The solution was 
poured into an Easycast
TM
 Horizontal Electrophoresis (Owl Separation Systems) gel casting 
tray containing a 10 well comb.  The gel was set for 30 min, the comb was removed, and the 
gel was placed into the electrophoresis apparatus, and submersed in 1X TAE buffer.  DNA 
samples, ranging between 5 – 100 ng, were combined with DNA loading buffer (0.04% [w/v] 
bromophenol blue and 5% [v/v] glycerol) to a final concentration of 1X.  DNA samples were 
loaded into the agarose gel wells and resolved at 100 V for 30 – 45 min.  Visualization of 
double stranded DNA was by means of ethidium bromide, which intercalates the nucleic acid 
and fluoresces under ultra-violet light, 365 nm.  Photographs of the resultant agarose gels were 
taken with a Gel Logic 200 Scientific Imaging Systems (Eastman Kodak Company) and 
analysed with Kodak Molecular Imaging Software.  
      
 2.3.5 DNA analysis: restriction digestion and DNA purification 
 The cloned insert of interest was analysed by an agarose gel ran with a FastRuler
TM
 
DNA ladder (Fermentas) of known size and concentrations.  All of the Drosophila MSL1 
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constructs were inserted into the MCS of pGEX-6P-3 by means of the BamHI/EcoRI 
restriction endonuclease sites.  However, as the Drosophila MSL1 fragments intended to be 
amplified possessed an internal BamHI site, the insert primers contained BglII and EcoRI 
restrictions sites to generate complementary ends.  In this way, BamHI digested vector can be 
ligated to BglII sticky ends on the PCR product.  The Homo sapiens MSL1 constructs and the 
pGEX-6P-3 vectors were all digested with BamHI/SalI.  The Drosophila MSL3 construct and 
the pGEX-6P-3 vector were both digested with BamHI/EcoRI.  All restriction endonucleases 
were purchased from Fermentas or New England Biolabs.  Digestions were done at 37 °C for a 
minimum of 4 hours.  Agarose gel electrophoresis permitted qualification of the restriction 
endonucleases digestions.  The DNA fragments (vector and insert) were further purified prior 
to DNA ligation by employing the Qiagen Gel Extraction Kit, following the manual provided.  
The DNA was stored in 50 μL of TE buffer. 
 
2.3.6 DNA ligation 
 Ligation reactions enable the generation of a recombinant pGEX-6P-3 vector 
containing an in-frame fusion of the gene fragment of interest.  Ligations were carried out 
using minimal volumes, consisting of 1 μL insert (at a 4:1 insert: vector molar ratio), 2 μL 
vector, 1 μL T4 DNA ligase, 2 μL 5X reaction buffer, and H2O to a final volume of 10 μL.  
The ligation mixture was incubated at 4 
o
C for 8 hrs using the MyCycler
TM
 Thermal Cycler 
(Bio-Rad).  The correct insert to vector molar ratio that resulted in a suitable number of single 
colonies resulting from transformation of competent E. coli cells was determined empirically 
for each insert.   
 
2.3.7 Competent Cell preparation 
 Competent XL-1, Rosetta 2, and BL-21 DE3 (BL-21) E. coli cells were prepared in 
the lab using the following procedure.  Cells were first plated onto Luria-Bertani (LB) broth 
agar plates containing the appropriate antibiotics (if required) and incubated for 14 - 16 hours 
at 37 °C.  Following incubation, a single colony was picked and then inoculated in a 5 mL LB 
broth, possessing the appropriate antibiotic, and incubated for 14 - 16 hours at 37 °C and 300 
rpm.  The culture was diluted 1 in a 100 with fresh LB broth, which possessed the appropriate 
antibiotic.  The diluted culture was grown at 37 °C and 300 rpm to an optical density (OD600 
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nm) of 0.4 to 0.6.  Cells were harvested through the use of a Beckman-Coulter Centrifuge; 
centrifugation was done for 5 minutes at 2,688 x g (rmax 4,000 rpm) and 4 °C.  The cell pellet 
was resuspended into ice cold 0.1 M MgCl2 in a 1 to 5 v/v ratio of the original cell volume 
(100 mL), and incubated on ice for 1 hour.  Cells were harvested by centrifugation for 5 
minutes at 2,688 x g (rmax 4,000 rpm) and 4 °C.  The cell pellet was resuspended in 0.1 M 
CaCl2 plus 14 % glycerol, with a 1 to 50 v/v ratio of the original cell volume (100 mL), and 
incubated on ice for 1 hour.  The cell solution was aliquoted and flash frozen with liquid N2 
and stored at - 80 °C.  The transformation efficiency of the competent cells was determined by 
transformation of 1 μg of vector DNA resulting in either 1 x 106 cell/μg DNA for XL-1 cells, 
or 1 x 10
4
 cell/μg DNA for BL-21, and Rosetta 2 cells, each resulting in 10 – 25 individual 
colonies.      
 
2.3.8 Transformation of Escherichia coli cell lines 
 The entire ligation reaction mixture was mixed with 50 – 100 μL of competent E. coli 
XL-1 cells (stored at -80 °C).  The mixture was thoroughly mixed, cold-shocked by incubating 
the mixture at 4 °C for 45 min, and then plated onto pre-warmed LB plates containing 
ampicillin (100 μg/mL), and incubated for 14 hrs at 37 °C.   
 For protein expression, competent E. coli Rosetta 2 or BL-21 cells were transformed 
with the purified recombinant plasmid.  Approximately 20 – 50 ng of plasmid DNA was 
combined with 50 – 100 μL competent cells and cold-shocked for 45 min.  The solution was 
plated onto pre-warmed LB plates containing the appropriate antibiotic(s) and incubated at 37 
°C for 14 hrs.     
 
2.3.9 Recombinant screening 
 Colony PCR was utilized to screen single colonies grown on LB plate, containing 
appropriate antibiotic(s), for the presence of the correct insert.  The initial strenuous denaturing 
condition (95 °C) of PCR results in the cell to lyse and release of plasmid DNA into the PCR 
mixture.  The PCR mixture contained forward and reverse primers flanking the insert of 
interest, and a robust Thermus aquaticus (Taq) polymerase that enabled the specific 
amplification of the insert of interest.  A single colony was inoculated into the PCR reaction 
mixture, instead of template DNA, and the PCR protocol was followed as shown in Figure 2.2.  
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Analysis of the PCR reaction was done by agarose gel electrophoresis (refer to section 2.3.4).  
The strategy involved a forward primer from either the 3’ end of GST gene or the 5’ forward 
primer used to amplify the gene fragment of interest.  The reverse primer used was the 3’ 
reverse primer for the insert of interest.        
 
2.3.10 Plasmid preparations and DNA sequencing 
 Plasmids preparations were carried out using the QIAprep® Spin Miniprep Kit 
following the instruction manual provided.  For larger plasmid preps the QIAGEN® Plasmid 
Maxi Kit was utilized.  Following individual plasmid preps, restriction digestion and DNA 
sequencing were used to confirm the presence of the correct gene fragment of interest.  The 
oligonucleotides used for the sequencing reactions either annealed to the DNA sequence of 
interest or to the vector DNA flanking the MCS (refer to Table 2.1 and 2.2).  Sequencing was 
done at the National Research Council (NRC) of Canada Plant Biotechnology Institute DNA 
sequencing facility.  Experimental conditions were based upon request of the NRC instructions.  
Analysis of the sequencing data was with the Translate tool on the ExPASY Proteomics Server 
(Swiss Institute of Bioinformatics, http://ca.expasy.org/tools/dna.html).   
   
2.3.11 Antibiotic selection 
 Inclusion of antibiotics in the growth media help to ensure the pGEX-6P-3 vector 
encoding the gene of interest was maintained and minimize contamination by unwanted 
bacteria.  The pGEX-6P-3 vector encodes an ampicillin resistance gene providing use of 
ampicillin in cell media as a selective marker (refer to Fig. 2.1).  E. coli Rosetta 2 cells encode 
an additional plasmid, which provides resistance for the antibiotic chloramphenicol.  The final 
concentration for ampicillin was 100 μg/mL and for chloramphenicol the final concentration 
used was 34 μg/mL.   
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2.4 Bacterial strains and media  
2.4.1 Bacterial strains 
Table 2.3: Bacterial strains used in experiments. 
Bacterial strain Characteristics Source 
E. coli XL-1  Deficient of recA and endA, 
hsdR mutation of EcoK 
endonuclease  
Stratagene® 
E. coli BL-21(DE3)  T7 polymerase upon IPTG 
induction, deficient of lon and 
omp-t proteases 
Novagen® 
E. coli Rosetta
TM
 Derivative of BL-21 cell line, 
F
-
 ompT hsdSB (rB
-
mB
-
) gal 
dcm, pRARE (argU, argW, 
ilex, glyT, leuW, proL)   
Novagen® 
 
 
 
2.4.2 Media type 
 LB broth was prepared in the laboratory by the following procedure.  One litre of LB 
broth contained 10 g of Bacto
TM
 Tryptone (Becton, Dickinson and Company, BD), 5 g of 
Bacto
TM
 Yeast Extract (BD), and 10 g NaCl.  The solution was sterilised at 121 °C for 30 min 
using an autoclave.  For larger preparations, the length of sterilization was extended to 1 hr.  
Antibiotic(s) were added once the solution cooled to approximately 50 °C.  The other growth 
medias were made according to Athena Enzyme Systems
TM
 instructions (Table 2.4).   
 To make 1 L of LB agar, 15 g of Difco
TM
 Granulated Agar was added to 1 L of LB 
broth.  The solution was sterilised at 121 °C for 30 min using an autoclave.  The resulting 
solution was cooled to approximately 50 °C before the addition of desired antibiotic.  Then 15 
mL was poured into sterile petri dishes.  Once LB agar plates were set they could be stored at 4 
°C for 21 days. 
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2.5 Recombinant proteins methods 
2.5.1 Protein expression trials  
 The optimal protein expression conditions for the recombinant GST-fusion proteins 
were determined for each recombinant proteins studied.  To determine optimal expression six 
experimental variables were altered, including: cell type (Rosetta 2 or BL-21), cell media 
(Table 2.4), optical density at 600 nm (OD600) of cells before induction (from 0.4 to 1), 
isopropyl β-D-1-thiogalactopyranoside (IPTG, UltrapureTM IPTG Invitrogen Life 
Technologies) concentration (from 0.05 mM – 0.5 mM), temperature (from 16 – 37 °C), and 
length of induction (4 – 16 hrs).      
 
2.5.2 Expression of GST-fusion proteins and harvesting cells 
 The first step for small-scale and large-scale preparations of recombinant proteins 
was transformation of a competent protein expression cell line with the desired recombinant 
plasmid.  A single colony was then inoculated into a 75 mL LB starter culture, containing 
appropriate antibiotic(s), which was grown at 37 °C for 16 hrs using an Innova 4330 
Refrigerated Incubator Shaker, at 250 rpm (New Brunswick Scientific).  From the starter 
culture, 10 mL of solution was inoculated into 2 L of sterile growth media, in a 6 L Erlenmeyer 
flask used to ensure proper aeration of the culture.   
 
 
Table 2.4: Summary of growth media used in experiments. 
Growth media Source 
Luria Bertani Broth ----- 
Hyper Broth
TM
 Athena Enzyme Systems
TM
 
Power Broth
TM
 Athena Enzyme Systems
TM
 
Superior Broth
TM
 Athena Enzyme Systems
TM
 
Turbo Broth
TM
 Athena Enzyme Systems
TM
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This culture was grown at 37 °C and 215 rpm in the shaker to a desired OD600 (measured with 
a Beckman Coulter DU 640 Spectrophotometer).  At the correct OD600, protein expression was 
induced by the addition of IPTG at the appropriate concentration, and the temperature of the 
shaker was adjusted to the desired expression temperature for the appropriate growth time.  In 
order to harvest the cells and the expressed protein they produced, liquid cultures were 
centrifuged in a Beckman Coulter J2-HS Centrifuge with a JA-20 rotor for 10 min at 3,870 x g 
(rmax 4,000 rpm) and 4 °C.  The subsequent supernatant was decanted and the cell pellets were 
frozen at -80 °C until required.   
 
2.5.3 Lysis of cells 
 The first step in the cell lysis procedure was to resuspend the cell pellet in ice cold 
cleavage buffer (50 mM Tris-HCl [pH 8.0 at 25 °C], 150 mM NaCl, 1 mM EDTA).  A 3X 
volume of lysis buffer was added to the pellet mass and homogenized with an RW16 Basic 
(IKA®-WERKE) cell homogenizer.  For example a 10 g pellet was resuspended into 
approximately 30 mL of 1X cleavage buffer resulting in a homogeneous solution of 
approximately 35 mL.  The following compounds were added to a final concentration of: 5 
mM DTT (Sigma), 1 mg/mL hen egg white lysozyme (10 mg/mL) (Sigma), 0.002 mg/mL 
Pepstatin A (1 mg/mL) (Sigma), 0.05 mg/mL Leupeptin (5 mg/mL) (Sigma), 0.001 M PMSF 
(0.2 M) (Sigma), 250 μL/litre of cells DNaseI (10 mg/mL), and 2 μL (100 U) Benzonase 
(Invitrogen).  The homogenized cell solution was then incubated at 4 °C for 25 min.  DNase I 
was prepared in a reaction buffer (10 mM Tris-HCl [pH 7.5 at 25 °C], 2.5 mM MgCl2, 0.5 mM 
CaCl2, 20 % (v/v) glycerol), to 10 mg/mL and stored at -20 °C.  For small-scale preparations 
the 1 – 1.5 mL cell solution was lysed by sonication using a Fisher Scientific Sonic 
Dismembrator Model 500.  Sonication was carried out at 70 % amplitude for 5 s pulses and 10 
s delays for a total pulse time of 60 s.  The sonicator tip used was a micro 1/8 inch.  For large-
scale preparations the cell solution was lysed by two consecutive passes through a French Press 
at 750 psi, attempting to maintain a consistent flow.  Both a colour change and a decrease in 
the solution’s viscosity were used as indications that lysis was achieved.  The resultant lysate 
was centrifuged at 33,600 x g (rmax 10,000 rpm) for 60 min at 4 °C using a JA – 20 rotor and a 
Beckman Coulter J2-HS Centrifuge.  Centrifugation was done to separate the soluble fraction 
of the lysate from un-lysed cells and cell debris.  The supernatant was decanted and saved for 
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further purification.  Centrifugation was repeated if the resultant supernatant was opaque.  To 
remove any colloids within the supernatant, the solution was passed through glass wool packed 
in a 30 cc syringe.  The resultant solution was next purified by Glutathione-Sepharose (GS) 
affinity purification.  
 
2.6 Protein purification  
2.6.1 Glutathione sepharose affinity purification 
 The first stage of GST-fusion protein purification was Glutathione-Sepharose (GS) 
affinity chromatography using an ÄKTA FPLC and a HR 16/5 column (Amersham 
Biosciences, now GE Life Science) packed with 10 – 15 mL of Glutathione SepharoseTM 4B 
(GE Life Science).   The column was equilibrated with 1X Phosphate Buffered Saline (PBS: 
140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4 [pH 7.3 at 25 °C]).  To 
apply the supernatant of the cell lysate to the column, a 50 mL Superloop
TM
 (GE Life Science) 
was used.  A flow rate of 1 mL/min was used, ensuring a pressure below 0.6 MPa because the 
GS resin is damaged at higher pressures.  To remove unwanted material the column was 
washed with two times the volume loaded with 1X PBS at 1 – 2 mL/min.  Bound GST-fusion 
protein was eluted with an glutathione elution buffer (50 mM Tris [pH 8.0 at 25 °C], 150 mM 
NaCl, and 10 mM reduced L-glutathione).  Detection of the desired GST-fusion protein was 
accomplished by UV absorbance at 280 nm by the UV flow cell monitor within the FPLC.   
Fractions were collected using the FPLC fraction collector with 10 mL glass test tubes.  To 
store the GS column, it was washed with 5 column volumes (CV) of H2O and 3 CV 20 % 
ethanol, and then stored at 4 °C.  After 3 – 5 purifications a more thorough cleaning was done.  
This included 3 CV H2O wash to remove the ethanol, then 1 CV 0.5 – 1 M NaOH, and then 5 
CV of H2O.  The column could then be used for protein purification or washed into 20 % 
ethanol for storage. 
2.6.2 Buffer exchange by dialysis 
Protein solutions were exchanged into the appropriate buffer through dialysis.  Dialysis 
was achieved by using BioDesign Dialysis Tubing
TM
 with a 3,500 molecular weight cut-off 
(MWCO).  Dialysis tubing was cut to an appropriate length and soaked in the dialysis buffer 
for 15 min, after which one end of the dialysis tubing was double knotted.  The protein solution 
was poured into the tubing and the remaining end was sealed with a clip.  The protein solution 
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was dialysed in 1 – 4 L of the appropriate buffer, slowly stirred with a magnetic stir bar, for 12 
– 16 hrs at 4 °C.   
 
2.6.3 PreScission protease cleavage of GST-fusion proteins and removal of the GST tag 
The analyte from the 1
st
 GS affinity column containing the GST-fusion protein solution 
was dialysed into 4 L of PreScission protease cleavage buffer (50 mM Tris [pH 8 at 25 °C] , 
150 mM NaCl, 4 mM DTT, and 1 mM EDTA).  Cleavage of the GST-fusion protein was 
carried out by the addition of 20 μL (80 U) PreScission protease.  The solution was incubated 
for 16 hrs at 4 °C.  For optimal cleavage to occur, it was found that the solution should not be 
stirred or shaken.  Post cleavage, insoluble particles were removed by filtration using a 0.45 
μM Acrodisc® Syringe filter (Pall Corporation).  Purification of the recombinant protein from 
the GST tag was done by repeating GS affinity chromatography.  The recombinant protein, no 
longer containing the GST tag, will not interact with the Glutathione Sepharose
TM
 4B resin 
eluting from the column in the flow-through fractions.  The unwanted GST tag bound to the 
stationary phase was eluted with glutathione elution buffer and then discarded.  The column 
was cleaned and stored as previously described (refer to section 2.6.1).  The eluant was 
dialysed into buffer appropriate for the next stage of purification.   
 
2.6.4 Ammonium sulphate precipitation 
Ammonium sulphate precipitation was used to remove contaminating nucleic acids and 
protein impurities from a partially purified protein solution.  An ammonium sulphate 
precipitation protocol was optimized by determining the minimal percentage of ammonium 
sulphate that resulted in the precipitation of the protein which was to be further purified.  The 
ammonium sulphate concentration was raised from 0 % to 25 % over a 1 hour period at 4 °C 
and incubated for 1 hour at 4 °C.  The resulting precipitate was collected by centrifugation at 
33,600 x g (rmax 10,000 rpm) for 30 minutes at 4 °C in the JA-20 rotor.  The pelleted precipitate 
was gradually re-suspended into 100 mM Tris-HCl [pH 8 at 25 °C, 1 M NaCl, and 5 mM DTT 
buffer by gentle mixing on a Speci-Mix Aliquot Mixer (Barnstead International) for 16 hrs at 4 
°C. 
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2.6.5 Ion exchange chromatography 
Anion exchange chromatography employed a Source
TM
 15 Q ion exchange media (GE 
Life Science) packed in an HR 16/5 column (GE Life Science) with a bed volume of 7.5 mL.  
In anion exchange chromatography, negatively charged proteins interact selectively with the 
positively charged stationary phase while positively charged impurities flow-through the 
column.  Typically, the specific protein was prepared in a buffer at a pH above its isoelectric 
point.  Cation exchange chromatography employed a Source
TM
 15 S ion exchange media (GE 
Life Science) packed in an HR 16/5 column (GE Life Science) with a bed volume of 7.5 mL.  
Cation exchange chromatography utilizes the same principles as anion exchange however 
positively charged proteins selectively interact with the negatively charged stationary phase, 
and usually at a pH below the proteins’ isoelectric point.     
The ionic exchange column was equilibrated by washing with 5 CV of the appropriate 
buffer (Table 2.5), into which the relevant protein to be purified had been equilibrated.  The 
protein solution was then applied to the column using a 50 mL Superloop
TM
 (GE Life Science) 
at a 0.5 – 1 mL/min flow rate, ensuring a column pressure below 0.5 MPa.  To remove 
unwanted material bound by non-specific interactions the column was washed with 5 CV of 
buffer A.  Elution of the proteins bound to the stationary phase was with a 0 % - 100 % 
concentration gradient of 1 M NaCl.  The elution buffer used was the same as buffer A, but 
contained 1 M NaCl.  Source Q and Source S columns were used at a flow rate of 1.0 mL/min.  
At the end of the elution, the column was regenerated by washing the column with 3 CV of 
buffer A, then 5 CV of H2O, followed by 3 CV of 20 % ethanol.  The cleaned column was 
stored at 4 °C. 
 
 
Table 2.5: Ion exchange chromatography strategies employed for Drosophila recombinant  
protein purification.  The isoelectric point (pI), type of ion exchange resin, the running buffer,  
and the pH for the individual recombinant proteins are shown.   
Protein pI Ion Exchange Running Buffer pH 
dMSL1820 – 1039 5.5 Cation Tris-HCl  8.0 
dMSL3185 – 512 5.3 Anion Tris-HCl   8.0 
dMOF370 - 827 8.5 Anion Bis-tris propane 7.0 
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2.6.6 Size exclusion chromatography  
 Size exclusion chromatography utilized either a Superdex
TM
 75 10/300 (GE Life 
Science) or a Superdex
TM
 200 10/300 (GE Life Science) analytical gel filtration column (bed 
volume 24 mL).  The two columns differ in the average size of the pores within the matrix.  
This enabled optimal purification of a desired protein based on its respective size.  For proteins 
or complexes with an approximate size between 70 kDa and 2 kDa the Superdex
TM
 75 10/300 
column was used, and for proteins or complexes between 400 kDa to 7 kDa the Superdex
TM
 
200 10/300 column was used.  Size exclusion columns were pre-equilibrated in 50 mM Tris-
HCl [pH 8.0 at 25 °C], 150 mM NaCl, and 5 mM DTT.  The protein sample was applied to the 
column using either a 500 μL or a 2 mL sample loop (GE Life Science).  The column was run 
at a flow rate of 0.5 mL/min ensuring the column pressure did not exceed 1 MPa.  The column 
was cleaned by 3 CV of H2O and 3 CV of 20 % ethanol, and stored at room temperature. 
  
2.6.7 Concentration of proteins 
 Protein solutions were concentrated by use of either an Ultracel regenerated cellulose 
Amicon® Ultra-15 centrifugal filter device (3,500 MWCO) (Millipore), for large volumes (> 
15 mL), and an Ultracel regenerated cellulose Amicon® Ultra 3.5k Dalton cut-off centrifugal 
filter device (3,500 MWCO) (Millipore), for small volumes (< 15 mL).  Centrifugal filter 
devices were pre-washed with H2O or protein buffer.  Centrifugation was through the use of a 
Sorvall® Biofuge primoR (Mandel) at 2,150 x g (rmax 4,000 rpm) and 4 °C.  Centrifugation was 
carried out for increments of times depending on the desired final volume.    
 
2.7 Protein visualization techniques 
2.7.1 Glycine sodium dodecyl sulphate – polyacrylamide gel electrophoresis 
 Glycine sodium dodecyl sulphate – polyacrylamide gel electrophoresis (SDS-PAGE) 
was utilized for visualization and subsequent analysis of purified recombinant proteins 
through-out over-expression and purification.  SDS-PAGE was performed using the Laemmli 
method (Laemmli, 1970).  All SDS-PAGE gels were cast with a 4 % acrylamide stacking gel 
(25 μL 10 % (w/v) SDS, 0.62 mL 0.5 M Tris-HCl [pH 6.8 at 25 °C], 0.25 mL 40 % 
acrylamide, 50 μL 10 % APS, 10 μL TEMED made up to 2.5 mL with H2O) and a 12.5 % 
acrylamide resolving gel (50 μL 10 % (v/v) SDS, 1.25 mL 1.5 M Tris-HCl [pH 8.8 at 25 °C], 
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1.4 mL 40 % acrylamide, 50 μL 10 % APS, 10 μL TEMED made up to 4.5 mL with H2O) 
using a Hoefer SE245 Mighty Small Dual Gel Caster (GE Life Science), 0.75 mm spacers and 
10 well combs.  A 15 % acrylamide resolving gel was also used, which was made by adjusting 
the amount of 40 % acrylamide and H2O.  Samples were mixed with sample loading buffer 
(62.5 mM Tris-HCl [pH 6.8 at 25 °C], 10 % glycerol, 2 % SDS, 5 % (w/v) β mercaptoethanol, 
and 1 % (w/v) Bromophenol blue), then boiled for 2 min, and then loaded on the gel.  The 
capacity of an individual gel well was approximately 20 μL, but usually 5 – 15 μL samples 
were loaded.  SDS-PAGE was typically done at a 115 V for approximately 1.5 hrs or until the 
dye front had run off the bottom of the gel.  The running buffer utilized consisted of 1X SDS 
buffer (25 mM Tris-HCl [pH 8.2 at 25 °C], 200 mM glycine, 0.1 % (w/v) SDS) diluted from a 
10X stock solution.  Gels were stained with Coomassie staining solution (40 % methanol, 10 % 
v/v glacial acetic acid, 0.1 % w/v Coomassie Brilliant Blue) for 30 mins and destained for 2 to 
4 hrs in 7.5 % v/v glacial acetic acid, and 10 % v/v methanol.  For staining and destaining, gels 
were gently agitated on an IKA® VIBRAX VXR Basic Orbital Shaker.  Photographs of SDS-
PAGE gels were taken with a Gel Logic 200 Scientific Imaging Systems (Eastman Kodak 
Company) and analysed with Kodak Molecular Imaging Software.  
 
2.7.2 Tricine SDS-PAGE 
 Tricine SDS-PAGE was also used for analysing the molecular weight of recombinant 
proteins.  Tricine SDS-PAGE was carried out using the method proposed by Schägger and von 
Jagow (Schagger and von Jagow, 1987).  Tricine SDS-PAGE gels were cast with a 3.8 % 
acrylamide stacking gel (for 6.35 mL: 0.6 mL acrylamide solution [40 % (w/v) acrylamide and 
1.25 % (v/v) N,N’-methylene-bis-acrylamide], 1.55 mL gel buffer [3 M Tris-HCl [pH 8.45 at 
25 °C], 0.3 % (w/v) SDS], 5 μL TEMED, 50 μL 10 % APS, and 4.2 mL H2O)  and a 10 % 
acrylamide resolving gel (for 10.9 mL: 2.7 mL acrylamide solution, 3.3 mL gel buffer, 2.1 mL 
glycerol, 3.3 μL TEMED, 33 μL 10 % APS, and 2.8 mL H2O) using a Hoefer SE245 Mighty 
Small Dual Gel Caster (GE Life Science), 0.75 mm spacers and 10 well combs.  Samples were 
mixed with 2x sample buffer (4 % (w/v) SDS, 20 % (w/v) glycerol, 100 mM Tris-HCl [pH 6.8 
at 25 °C], 4 % (v/v) β-mercaptoenthanol).  The 1X anode buffer (0.2 M Tris-HCl, pH 8.9) and 
the 1X cathode buffer (0.1 M Tris-HCl [pH 8.25], 0.1 M Tricine, 0.1 % (w/v) SDS) were 
diluted from a 10X stock solution.  Gels were stained with Coomassie staining solution for 30 
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mins and destained for 2 to 4 hrs in 10 % v/v glacial acetic acid, and 10 % v/v methanol.  For 
staining and destaining gels were gently agitated on an IKA® VIBRAX VXR Basic Orbital 
Shaker.  Photographs of Tricine SDS-PAGE gels were taken with a Gel Logic 200 Scientific 
Imaging Systems (Eastman Kodak Company) and analysed with Kodak Molecular Imaging 
Software.  
  
2.8 Protein analysis 
2.8.1 Protein concentration determination 
 A Far-UV absorbance spectrum from, 300 nm to 200 nm, was utilized to quantify the 
amount of protein and nucleic acid in a protein solution.  Both a Beckman Coulter DU 640 
Spectrophotometer and a Thermo Scientific Nanodrop Spectrophotometer were used to 
conduct a Far-UV absorbance spectrum.  A quartz cuvette (Bio-Rad quartz spectrophotometer 
cell semi micro 9-Q-10 mm) was used.  A quick and easy method for estimating protein 
concentration was carried out using the absorbance calculated at 278 nm based on the 
percentage of tyrosine, tryptophan, and cysteine in the protein sequence, and the corresponding 
extinction coefficient at 278 nm (http://www.expasy.ch/tools/protparam.html).  The theoretical 
extinction coefficient was determined by the equation:  Extinction coefficient (ε) = (# of Tyr)(ε 
Tyr) + (# of Trp)(ε Trp) + (# of Cys)(ε Cys), where ε Tyr equals 1490 M-1 cm-1, ε Trp equals 
5500 M
-1
 cm
-1, and ε Cys equals 125 M-1 cm-1 at 278 nm measured in water (Gill and von 
Hippel, 1989; Pace, 1990).     
Nucleic acids absorb strongly in the near UV with a maximum at 260 nm whereas the 
aromatic amino acids tyrosine and tryptophan within proteins absorb maximally at 278 nm.  
For a more accurate quantification of the protein concentration it must be remembered that 
nucleic acids posses a strong shoulder extinction in the 280 nm region.  The protein 
concentration in mg/mL was crudely calculated by the equation: Concentration (mg/mL) = 
((1.55 x Abs280) - 0.76 x Abs260), which takes into account the influence of the absorbance at 
280 nm, but does not account for the influence of Tyr, Phe, and Trp at 260 nm (Waddell, 
1956). 
 To calculate a more accurate protein concentration of a homogenous protein solution, 
the Bradford protein assay was carried out.  A standard curve of bovine serum albumin (BSA) 
protein, with concentrations between 0 and 10 mg/mL, was constructed.  Bradford protein 
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assays were carried out using Bradford reagent (Bio-rad), which has a maximum absorbance at 
595 nm.  From the graphed BSA standard curve the protein concentration of a desired protein 
solution could then be extrapolated.   
 
2.8.2 Quaternary structure and molecular weight determination 
 The Superdex 75 and the Superdex 200 size exclusion columns were calibrated 
against a Low Molecular Weight and a High Molecular Weight Gel Calibration kit (GE Life 
Science) respectively (Lane et al., 2006).  The low molecular weight kit contained Albumin 
(67 kDa), Ovalbumin (43 kDa), Chymotrypsinogen A (25 kDa), and Ribonuclease A (13.7 
kDa).  The high molecular weight kit consisted of Blue Dextran (void volume), Thyroglobulin 
(669 kDa), Ferritin (440 kDa), Catalase (232 kDa), and Aldolase (158 kDa).  The calibration 
curves were plotted with Kav versus the log molecular weight, which permitted extrapolation of 
the molecular weight of a recombinant protein.  Kav = [(Ve – Vo) / (Vc – Vo)], where Vo equals 
void volume, Ve equals elution volume, and Vc equals geometric column volume.  Therefore, 
the molecular weight and the quaternary structure could be estimated with the calibrated size 
exclusion columns.  Extrapolated molecular weights are assumed to be reasonable estimates of 
the actual molecular size if the proteins being evaluated have an approximately spherical shape.     
 
2.9 Protein crystallization  
2.9.1 Hanging drop vapour diffusion 
Following size exclusion chromatography, recombinant proteins were buffered in 25 
mM Tris-HCl [pH 8.0 at 25 °C], 150 mM NaCl, and 5 mM DTT, which was exchanged for the 
crystallization buffer (25 mM Tris-HCl [pH 8.0 at 25 °C], 150 mM NaCl, 1 mM TCEP, and 10 
% glycerol).  Protein crystallization experiments were performed using the hanging drop 
vapour diffusion technique (Chayen, 1998).  The protein concentrations used were between 8 – 
10 mg/mL, determined with a Thermo Scientific Nanodrop Spectrophotometer (refer to section 
2.8.1).  Individual hanging drops were equilibrated over a 500 μL reservoir solution containing 
0.5 μL protein solution mixed with 0.5 μL of the unique reservoir solution.  Crystal formation 
is favoured by the droplet containing purified protein, buffer, and precipitants all equilibrating 
with a larger reservoir containing similar buffers and precipitants in higher concentration.  
Hence crystallization was carried out in a closed system at a stable temperature and pH.  
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Variables in crystallizations include initial protein concentration, the effective pH of the 
reservoir/protein droplet, type of precipitant, additives such as salts, and the type of buffer.        
 
2.10 Protein-protein interaction studies 
2.10.1 GST pull-downs  
Protein-protein interactions were tested using GST pull-downs assays (Brymora et al., 
2004).  Experiments consisted of a GST-fusion protein (the bait) mixed with an excess of the 
recombinant protein (the prey).  The prey protein is incubated with the bait protein bound to 
Glutathione Sepharose
TM
 4B resin, and then extensively washed with buffer.  If some prey 
protein remained associated with the bait after washing, it is presumed that the prey and bait 
proteins interact. All GST pull-down experiments were done using 60 - 100 μg of protein for 
the prey, the bait, and the GST control.  The assay had four controls: Glutathione Sepharose
TM
 
4B resin (GS beads) only, purified GST protein plus GS beads, prey protein plus GS beads, and 
bait protein plus GS beads.  All experiments were made with a consistent final volume of 500 
μL.  The pull-down experiment consisted of initial binding of the bait to the GS beads, done by 
adding 60 μg of bait to approximately 15 μL of GS beads (70 % solution), which was incubated 
for 1 hour at 4 °C and gently mixed on a Speci-Mix Aliguot Mixer (Barnstead International).  
GS beads were pelleted by centrifugation using a Microfuge® 18 Centrifuge (Beckman 
Coulter
TM
) at 2,000 rpm for 1 min.  The resulting supernatant was aspirated off the pellet.  
Non-specific interactions and impurities were removed by washing the GS-beads 4X with 1X 
PBS pH 7.3.  Next the prey, 60 μg – 100 μg, was incubated with the bait bound to the GS beads 
for 2 hour at 4 °C on a Speci-Mix Aliguot Mixer (Barnstead International).  Non-specific 
interactions and impurities were removed by washing the GS beads 4 times with 1X PBS pH 
7.3.  The supernatant was removed and the remaining pellet was mixed with 15 μL of sample 
loading buffer (62.5 mM Tris-HCl [pH 6.8 at 25 °C], 10 % glycerol, 2 % SDS, 5 % (w/v) β 
mercaptoethanol, and 1 % (w/v) Bromophenol blue) boiled for 2 min and then analysed by 
SDS-PAGE (refer to section 2.7.1).    
 
2.10.2 Analysis by size exclusion 
 Size exclusion chromatography enabled protein interaction studies based on the 
formation of a stable stoichiometric complex with a characteristic molecular weight.  Protein 
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interaction studies could be assessed with size exclusion chromatography because of the inert 
nature of the stationary phase of the column.  Proteins to be tested were concentrated (refer to 
section 2.6.7) and then mixed together.  The resulting protein solution if needed was 
concentrated and then analysed by size exclusion chromatography (refer to section 2.6.6).  
Protein interactions or the lack there of could be inferred from the elution profile.  Individual 
elution peaks were visualized by SDS-PAGE (refer to section 2.7.1) to ascertain the protein 
make-up.  
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3. Results  
3.1 Cloning the C-terminal domain of Drosophila melanogaster MSL1 
 In a study aimed at defining the protein domains of Drosophila MSL1, it was found 
that a MSL1 C-terminal construct, consisting of amino acid residues 705 – 1039, directly 
interacted with both MOF and MSL3 (Scott et al., 2000).  Moreover, residues 766 – 939 of 
MSL1 were determined to interact with MOF and residues 973 – 1039  of MSL1 the region for 
interaction with MSL3 (Morales et al., 2005; Morales et al., 2004).  Utilization of Protein-
Protein BLAST (BLAST-P) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) enabled identification of 
conserved amino acids within the C-terminus of both Drosophila species and other higher 
eukaryotes.  BLAST-P was used to search the non-redundant protein sequences databank held 
at NCBI.  Amino acid sequence conservation between homologues (e.g. MSL1 sequences from 
different species) is a useful tool in defining domain boundaries in proteins.  Therefore, the 
amino acid residues encompassing a conserved segment of the C-terminus of MSL1 were 
deemed to be part of a protein domain or a linker region enabling gene constructs to be 
designed to encompass a complete C-terminal domain.  Statistical E-values from BLAST-P 
searches less than 0.005, were considered a significant match.  This essentially means that 
aligned sequences yielding scores less than 0.005 are very unlikely to arise simply by chance.  
The E values for Danio rerio, Mus musculus, and Homo sapiens MSL1 were determined to be 
using the BLAST-P algorithm 3x10
-9
, 6x10
-9
, and 5x10
-9
 respectively.  Position-Specific 
Iterated BLAST (PSI-BLAST) did not improve the effectiveness of the search compared to 
BLAST-P as no new homologous sequences were discovered.  The protein sequence of 
Drosophila melanogaster MSL1 was aligned against the best hits from the search based on E-
value criteria and obvious conservation of MSL1 domain structure (Fig. 3.1).  BLAST-P and 
PSI-BLAST consistently identified candidate MSL1 proteins from numerous Drosophila 
species including simulans, sechelia, erecta, and yakuba all of which scored a 98 % or above 
sequence identity, and Drosophila species ananassae, pseudoobscua, willstoni, mojavensis, 
and virulus all were a sequence identity of around 50 %.  Evident from the sequence alignment 
between MSL1 and its higher eukaryotic homologues is the conservation of the PEHE domain, 
suggesting its necessity for proper interaction with both MSL3 and/or MOF (Fig 3.2) (Morales 
et al., 2004; Scott et al., 2000).   
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Figure 3.1: Multiple sequence alignment and cloning strategy for MSL1 proteins.  Hs: Homo 
sapiens, Mm: Mus musculus, Dr: Danio rerio, Dp: Drosophila psuedoobscua, Dm: Drosophila 
melanogaster, Da: Drosophila ananassae.  The blue arrows indicate the primers corresponding 
to the cloned dMSL1 constructs (refer to Table 2.1).  The green arrows indicate the primers 
corresponding to the cloned hMSL1 constructs (refer to Table 2.2).  ClustalW2 and ESPript 2.2 
were used for the multiple sequence alignment (Gouet et al., 1999; Larkin et al., 2007).     
60 
 
 Four unique constructs encompassing the identified PEHE domain were designed 
from the Drosophila melanogaster MSL1 cDNA sequence.  The first construct comprised 657 
base pairs or 219 amino acids in length, termed dMSL1820-1039 (Fig. 3.1 & 3.2).  The second 
construct encoded 855 base pairs or 285 amino acids in length, termed dMSL1754-1039.  The 
third construct was 981 base pairs or 327 in length, termed dMSL1712-1039.  Lastly the fourth 
construct was 1071 base pairs or 357 amino acids, termed dMSL1688-1039.  Increasing the 
overall size of the construct may improve stability by means of affecting the subsequent 
secondary structure of the protein.  The constructs designed are listed below; with the intent of 
future protein interaction studies all contained the PEHE domain (865 – 1004), and regions  
previously determined to be required for interaction with MOF (766 – 939)  and MSL3 (973 – 
1039) (Morales et al., 2004; Scott et al., 2000).      
 All of the amplified Drosophila MSL1 PCR fragments were cleaved with BglII and 
EcoRI generating compatible ends for the pGEX-6P-3 vector also cleaved with BamHI and 
EcoRI.  BglII was used to cleave the amplified gene fragments because the MSL1 PEHE 
domain contains an internal BamHI restriction site (amino acid residues 754 – 755).  Cutting 
the vector and the gene of interest with BamHI and BglII respectively destroyed the BamHI 
restriction site within the MCS of the vector; therefore, analysis of the resulting chimeras were 
carried out using colony PCR and DNA sequencing.  BglII was utilized because it generates 
compatible ends with BamHI.  Proper insertion of the fragment of interest requires verification 
of correct orientation, absence of unwanted mutations, and ablity to express the recombinant 
protein in-frame.  Colony PCR was performed for all four MSL1 constructs and analyzed by 
agarose gel electrophoresis.  The desired gene fragment of interest was verified for all four 
MSL1 constructs because the respective PCR product was the same size as the known 
amplified insert (Fig. 3.3).   
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Figure 3.2:  Schematic drawing of Drosophila melanogaster MSL1 recombinant proteins 
investigated.  The numbers at the beginning and end of the constructs identify the amino acids 
of MSL1 and indicate the fragment of MSL1 expressed.  The C-terminal dMSL1 constructs 
cloned are shown below full length MSL1.  
 
 
 
 
 
 
 
Figure 3.3: Colony PCR of candidate transformants for the four Drosophila MSL1 constructs 
cloned.  (A). Agarose gel of the cloned Drosophila MSL1 gene fragments and verification of 
correct ligation and transformation into XL-1 E. coli cells with colony PCR.  DNA marker 
(Wide Range), PCR amplified dMSL1688-1039, Colony PCR product dMSL1688-1039, PCR 
amplified dMSL1712-1039, Colony PCR product dMSL1712-1039, PCR amplified dMSL1754-1039, 
Colony PCR product dMSL1754-1039.  (B). Agarose gel of the cloned Drosophila MSL1 gene 
fragments and verification of correct ligation and transformation into XL-1 E. coli cells with 
colony PCR.  DNA marker (Wide Range), PCR amplified dMSL1820-1039, Colony PCR 
amplified dMSL1820-1039.   
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3.2 Optimization of protein expression and purification of dMSL1820-1039 
 Expression and purification of the four unique MSL1 C-terminal domain constructs 
were attempted in bacterial cells.  Utilization of E. coli provides a method for fast, inexpensive, 
and easy over-expression of recombinant proteins.  However, various issues in over-expressing 
recombinant proteins in bacteria include: can the protein be reconstituted in bacteria, is it 
expressed as a soluble, stable, and correctly folded protein, can it be purified to homogeneity, 
and will how will the lack of post-translational modification affect the recombinant protein.  
For expression purposes, E. coli BL-21 DE3 (BL-21) cells were freshly transformed with the 
desired plasmid, and plated on LB Agar Amp
100
.  A single colony was inoculated into 75 mL 
of LB Amp
100
 and grown overnight in a shaking incubator at 210 rpm and 37 °C.  For small-
scale preps a pre-warmed 75 mL of LB Amp
100
 was inoculated with 1 mL of overnight culture; 
for large-scale preparations pre-warmed 4 L of  LB Amp
100
 was inoculated with 20 mL of 
overnight culture.  Media containing the appropriate bacterial culture were grown to the desired 
cell density measure by OD at 600nm (OD600) in a shaking incubator at 210 rpm and 37 °C, 
once the OD600 was achieved protein expression was induced by addition of IPTG to a desired 
final concentration.  The incubator was changed to the desired temperature and the culture was 
incubated for an additional 16 hrs at 210 rpm. 
 The initial screening of optimal protein expression conditions were carried out 
through the use of small-scale batch preps; harvested cells were lysed by sonication, and then 
the lysed cells were separated into soluble and insoluble fractions by centrifugation.  Insoluble 
proteins aggregate forming inclusion bodies, typically mis-folded cellular proteins are found in 
inclusion bodies.  In order to compare protein expression and solubility required a consistent 
sonication protocol.  To aid in sonication the solution was incubated with lysozyme; moreover, 
experience with sonication was required to properly assess complete lysis of the cells.  The 
resulting supernatant was subjected to small-scale GST pull-downs.  The soluble fraction 
containing the soluble GST-fusion protein was incubated with approximately 35 μL of GS 
beads (70 %) slurry, which was washed 5 times with 1X PBS, for 2 hrs on a rocker at 4 °C.  
The GS beads were gently pelleted by centrifugation and then washed 5 times with 1X PBS to 
remove non-specific interactions.  The GST pull-downs were analysed by SDS-PAGE.   
 Numerous protein expression conditions were tried with variation in the type of broth, 
optical density (OD600), incubation temperatures, and IPTG concentrations to determine 
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optimal over-expression.  To determine the optimal conditions for recombinant protein 
expression both BL-21 and Rossetta 2 cells were tried.  In both types of cells three OD600 0.4, 
0.6 and 0.8 (or 1.0) were carried out.   The different induction temperatures tested were 16 °C, 
24 °C, and 37 °C and were attempted under different lengths of induction 15 hrs or 4 hrs.  To 
then improve upon protein over-expression expression trails carried out with different designed 
protein expression broths (i.e Hyper or Turbo broth) and various IPTG concentrations (0.05, 
0.1, 0.5, and 1 mM).  Expression trials of the three recombinant proteins dMSL1688-1039, 
dMSL1712-1039, and dMSL1754-1039 failed, as these three recombinant proteins were not expressed 
as soluble protein and found to be in the cell pellet.  
 An example of two small-scale GST-dMSL1820-1039 protein expression trials illustrates 
the difference of soluble protein over-expressed solely due to change of the OD600 (Fig. 3.4).  
Growth of cells containing GST-dMSL1820-1039 resulted in approximately five times more 
soluble recombinant protein when the OD600 of induction was chosen to be 0.6 AU versus 0.4 
AU.   
 
 
Figure 3.4: Analysis of two unique small-scale protein expression trials of dMSL1820-1039.  
SDS-PAGE: protein marker, cell lysate, supernatant (soluble fraction/load GS column), pellet 
(insoluble fraction), GST pull-down, cell lysate, supernatant (soluble fraction/load GS column), 
pellet (insoluble fraction), GST pull-down.  
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Optimal over-expression of recombinant GST-dMSL1820-1039 was empirically 
determined to be at the following conditions: LB broth, OD600 of 0.6 AU, 0.1 mM IPTG, at 16 
°C for 14 hrs (Fig. 3.4).  A large portion of over-expressed dMSL1 GST-fusion protein was 
found to be insoluble under all conditions tested.  This is most likely due to the difficulty in 
expressing a eukaryotic protein in bacteria.  Moreover, over-expression of a heterologous 
protein likely overloads the E. coli protein synthesis machinery, resulting in mis-folded 
proteins which aggregate into inclusion bodies.  However, a significant level of the over-
expressed protein was also found to be soluble enabling further large-scale preparations and 
purification of the dMSL1 C-terminal domain.   
Large-scale purifications were carried out using 4 – 6 litres of LB media under the 
optimal conditions determined for over-expression of GST-dMSL1820-1039.  Large-scale 
preparations consistently resulted in a cell pellet weight of 6 g per L of cell culture.  The cells 
were lysed using a French press, and centrifuged to separate the soluble fraction from the 
insoluble fraction.  The lysate supernatant containing the soluble GST-dMSL1820-1039 protein 
was purified by FPLC GS affinity chromatography.  The molecular weights of recombinant 
GST-dMSL1820-1039 and dMSL1820-1039 were calculated with ExPASy ProPram tool to be 49.5 
kDa and 25.5 kDa respectively.  The correct GST-fusion protein was over-expressed and 
verified by SDS-PAGE, as the protein band migrated at its predicted molecular weight of 
approximately 50 kDa (Fig. 3.4).  The chromatogram of the first GS affinity column verified 
the desired interaction of the GST tagged protein with the stationary phase, which enabled 
purification from the unwanted whole cell extract (Fig. 3.5).  
To remove the GST tag, the purified protein solution of the first GS affinity column 
was dialysed into cleavage buffer: 50 mM Tris-HCl, 150 mM NaCl, and 1 mM EDTA (pH 7.0) 
for 16 hrs.  Proteolytic cleavage of the dialysed GST-dMSL1820-1039 protein was performed by 
the addition of 80 units of PreScission protease.  Prior to proteolytic cleavage the fusion protein 
was diluted by approximately 30 percent to prevent precipitation of the resultant protein once 
the GST tag was removed, as it has been found in the laboratory that the GST-fusion proteins 
are generally more soluble than the proteolytically liberated fragments.   The GST tag was 
purified away by a second passage over the GS affinity column (Fig 3.6 and 3.7).  Cleavage 
and the subsequent removal of the GST tag were conducted carefully because the stability of 
the recombinant protein of interest can be altered.  Therefore, protease inhibitors (Leupeptin, 
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Pepstatin A, and PMSF) were included during the PreScission protease cleavage, and the 
experiment was carried out at 4 °C.  To aid in complete removal of the GST tag, the cleavage 
reaction was empirically found to work best without any shaking, rocking or stirring of the 
solution, likely because oxidation may reduce the effectiveness of cleavage reaction 
(PreScission protease contains an active site sulfhydryl group).  Lastly, in order to enhance 
separation of the GST tag and the recombinant protein, the protein solution was dialysed into 
1X PBS before the second GS affinity column.  Dialysis permitted removal of the free L-
glutathione that was interacting with the GST tag enabling the GST tag to once again strongly 
interact with the stationary phase of the GS affinity column.      
 
 
 
Figure 3.5:  Purification of GST-dMSL1820-1039 by GS affinity chromatography.  The 
chromatogram of the 1
st
 GS affinity column illustrates both the flow-through of the crude 
lysate and the elution of GST-dMSL1820-1039.  Four litres of cell culture had a wet weight of 24 
grams, equalling approximately 50 mL of soluble fraction (cell lysate) applied to the column.  
The single fraction eluted by elution buffer (50 mM Tris [pH 8.0], 150 mM NaCl, and 10 mM 
reduced L-glutathione) was 25 mL.  Absorbance (280 nm) is displayed in maroon and 
percentage of elution buffer in green.     
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Figure 3.6: GST-dMSL1820-1039 PreScission protease experiment and 2
nd
 GS affinity 
chromatography.  SDS-PAGE: protein marker, PreScission protease reaction (purified protein 
solution eluted from 1
st
 GS column dialyzed into 1X cleavage buffer plus PreScission protease, 
load 2
nd
 GS column (after centrifugation of PreScission protease digestion), 2
nd
 GS flow-
through.   
 
Figure 3.7: dMSL1820-1039 purification with a 2
nd
 GS affinity column.  (A). Chromatogram of 
the 2
nd
 GS affinity column of dMSL1820-1039.  The dialyzed protein dMSL1 protein solution 
equalling 35 mL was applied to the column.  The wanted flow-through fraction was 35 mL and 
the unwanted fraction eluted by elution buffer 50 mM Tris [pH 8.0], 150 mM NaCl, and 10 
mM reduced L-glutathione) was 10 mL.  Absorbance (280 nm) is displayed in maroon and 
percentage of elution buffer in green.  (B). Tricine-SDS-PAGE of 2
nd
 GS affinity column. 
Protein markers, 2
nd
 GS flow-through (2
nd
 GS affinity column).   
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The initial two GS affinity columns illustrated excellent and robust purification of 
dMSL1820-1039 (Fig 3.4 & 3.6).  Analysis of the chromatogram of the second GS affinity 
column showed that the GST-fusion tag was correctly cleaved from the recombinant protein 
and two products were successfully purified from one another (Fig. 3.7).  However, the 
dMSL1820-1039 that eluted from the second GS affinity column visualized by SDS-PAGE was 
not at the expected size; the corresponding band indicated its apparent molecular weight to be 
approximately 34 kDa.  Tricine-SDS-PAGE is often used to improve separation of proteins in 
the low mass range, typically less than 100 kDa (Schagger, 2006).  Eluted protein from the 
second GS affinity column was analysed by a tricine gel, which revealed the expected size of 
the predict dMSL1820-1039 band at 26 kDa (Fig. 3.7).     
The eluted protein from the second GS affinity column was analyzed by Far-UV 
absorbance spectroscopy, ranging from 300 nm to 200 nm, which revealed the presence of 
significant nucleic acid impurities based on the ratio of Abs at 280 nm to Abs 260 nm (Table 
3.1).  Therefore, nucleic acids had co-purified with recombinant MSL1 protein.  The addition 
of DNase I and Benzonase® Nuclease was found to be insufficient to remove the nucleic acid 
bound to dMSL1820-1039.  DNaseI is an endonuclease, which cleaves non-specifically dsDNA 
and ssDNA, while Benzonase® Nuclease is a non-specific endonuclease, which degrades all 
forms of DNA and RNA.  Co-purification of nucleic acid is likely because it forms a complex 
with dMSL1820-1039, which effectively protects the nucleic acid from digestion.  The high level 
of absorbance at 260 nm required the removal of the nucleic acid co-purifying with dMSL1820-
1039 for further purification of the recombinant protein.  Hydroxyapatite chromatography was 
first attempted as it is often used in the purification of both nucleic acids and DNA binding 
proteins (Broadhurst, 2001; Schroder et al., 2003).  The column used was a Bio-Scale
TM
 Mini 
ceramic hydroxyapatite type I (BIO-RAD). The end result of the hydroxyapatite 
chromatography was a protein solution which remained unchanged relative to to the sample 
loaded.  Nucleic acid impurities may be removed by their differential affinity for the stationary 
phase as compared to the protein; however, this did not occur.  The ratio of Abs280 nm 
compared to Abs260 nm was not increased, indicating that the interaction between the nucleic 
acids and MSL1 was not disrupted by the column matrix (data not shown).   
Ammonium sulphate precipitation was used in an attempt to remove the unwanted 
nucleic acids.  Initial findings showed that increasing the ammonium sulphate from 0 % to 40 
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% resulted in the complete precipitation of dMSL1820-1039 (Fig. 3.8).  Furthermore, increasing 
the percent of ammonium sulphate from 40 % to 70 % and then 70 % to 100 % resulted in 
precipitation of various impurities, one being GST.  The Abs280 to Abs260 ratio was found to 
increase by the 40 % ammonium sulphate precipitation, indicating the removal of unwanted 
nucleic acids (Table 3.1).  Therefore, ammonium sulphate precipitation effectively worked as a 
purification step and acted as a concentration step (Fig. 3.8).  Likely due to the increase in 
concentration ammonium sulphate precipitation also revealed other significant protein 
impurities with dMSL1820-1039.  Both optimal purification of dMSL1820-1039 and the capability 
for resuspension of the resulting precipitant was determined to be at 25 % ammonium sulphate.  
The resulting precipitant was readily resuspended into 100 mM Tris-HCl (pH 8.0), 1 M NaCl, 
and 5 mM DTT.  Furthermore, comparison of precipitation by 25 % to 40 % ammonium 
sulphate revealed an improvement in removal of the nucleic acid contaminant (Table 3.1).  
 
 
Figure 3.8: Ammonium sulphate precipitation of partially purified dMSL1820-1039. (A). SDS-
PAGE of the precipitants from an ammonium sulphate gradient from 0 – 40 %, 40 – 70 %, 70 – 
100 %, and the final supernatant.  Protein marker, Elute 2
nd
 GST analyte, 0 – 40 % (NH4)2SO4 
precipitation, 0 – 40 % (NH4)2SO4 precipitation, 40 - 70 % (NH4)2SO4 precipitation, 40 - 70 % 
(NH4)2SO4 precipitation, 70 – 100 % (NH4)2SO4 precipitation, 70 – 100 % (NH4)2SO4 
precipitation, supernatant (final solution).  (B). SDS-PAGE of optimized ammonium sulphate 
precipitation of dMSL1820-1039 protein solution.  Protein markers, elute 2
nd
 GS affinity column, 
0 – 25 % (NH4)2SO4 precipitation, supernatant (final solution).  Note (NH4)2SO4 ppt stands for 
the precipitant resulting from ammonium sulphate precipitation. 
69 
 
Table 3.1: dMSL1820-1039 ammonium sulphate precipitation.   
 Original 
solution  
40 % 
(NH4)2SO4 ppt 
(resuspended) 
40 %  
(NH4)2SO4 
supernatant 
Original 
solution 
25 %  
(NH4)2SO4 ppt 
(resuspended) 
25 %  
(NH4)2SO4 
supernatant 
Abs280 nm 7.0 1.4 5.2 6.0 1.4 4.6 
Abs260 nm 8.0 0.68 7.0 9.0 0.38 8.8 
Abs280 nm 
/ Abs260 
nm ratio 
1:1 2:1 0.8:1 0.7:1 4:1 0.5:1 
Note (NH4)2SO4 ppt stands for the precipitant resulting from ammonium sulphate precipitation.  
Samples were diluted tenfold to obtain accurate measurements. 
 
 
The theoretical pI for dMSL1820-1039 is predicted to be 5.5; consequently, anion 
exchange chromatography (Source Q) should be the preferred type of purification.  Numerous 
experiments on a Source Q anion exchange column were attempted, varying the type of buffer, 
the pH, and the amount of NaCl in buffer A (equilibrating / loading buffer).  In each case, both 
the protein and the Source Q column were equilibrated in identical buffers.  It was determined 
that dMSL820-1039 could not be further purified by anion exchange chromatography as it did not 
strongly interact with the stationary phase.  Moreover, the analyte from Source Q columns 
typically produced a dilute unstable protein solution (data not shown).  For these reasons cation 
exchange chromatography (Source S) was attempted.  Source S equilibrated with 25 mM Tris-
HCl (pH 8.0), 25 mM NaCl, and 5 mM DTT was found to further purify dMSL1820-1029.  Tris-
HCl buffer (pH 8.0), is not an ideal buffer for Source S or a typical pH because the ammonium 
group of Tris might interact with the negative charge of the stationary phase.  The 
chromatogram of the cation exchange chromatography showed that dMSL1820-1039 interacted 
with the stationary phase and eluted as a single fraction at a unique elution buffer percentage, 
20 % - 25 % of 1.0 M NaCl or 27.6 mS/cm – 32 mS/cm (Fig. 3.9).  The results indicated that 
the dMSL1 C-terminal domain had been purified to homogeneity as shown by SDS-PAGE. 
Furthermore, the Abs280 to Abs260 ratio was found to improve from 1.4:1 to 4:1 (Table 3.2).   
Size exclusion chromatography (Superdex 75) was utilized for a final cleaning of 
dMSL1820-1039 and determination of the quaternary structure.  Following cation exchange 
chromatography, dMSL1820-1039 protein solution was dialysed into 20 mM Tris-HCl (pH 8.0), 
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100 mM NaCl, and 5 mM DTT and then concentrated to 8 mg/mL.  dMSL1820-1039 was 
determined to have an elution volume  (Ve) of 12.0 mL, which corresponds to the expected size 
of a dMSL1820-1039 monomer, approximately 25 kDa (Fig. 3.10).  SDS-PAGE verified that 
dMSL1820-1039 was purified to homogeneity, enabling protein crystallization trials (Fig. 3.10).  
Overall the purification of dMSL1820-1039 led to an improvement of the Abs280 to Abs260 ratio, 
which was mirrored with the step-wise removal of protein impurities and the resultant 
homogenous dMSL1820-1039 protein solution (Table 3.2 and Fig. 3.11).  The In addition to SDS-
PAGE, a UV spectrum enables a means to determine the quality of the protein purification.   
 
   
 
Figure 3.9: dMSL1820-1039 purification by Source S cation exchange. (A). Source S cation 
exchange chromatogram of dMSL1820-1039.  Dialyzed dMSL1820-1039  protein solution (25 mM 
Tris-HCl [pH 8.0], 25 mM NaCl, and 5 mM DTT) applied to the ion exchange column 
equalled 20 mL.  The collected fraction was 6 mL eluting at 20 % - 25 % of 1.0 M NaCl. 
Elution conditions were a concentration gradient, 0 % to 50 %, of 25 mM Tris (pH 8.0), 1 M 
NaCl, and 5 mM DTT Absorbance (280 nm) is displayed in maroon and the elution buffer 
percent in blue.  (B). SDS-PAGE of dMSL1820-1039 purification by Source S.  Protein marker, 
peak #1 eluted Source S (volume 70 – 78 mL). 
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Figure 3.10: dMSL1820-1039 purification by Superdex 75 size exclusion chromatography.  (A). 
Superdex 75 Size Exclusion chromatogram of dMSL1820-1039.  The loaded protein solution was 
1 mL (4 mg/mL).  The collected fraction was 3.0 mL.  Absorbance (280 nm) is displayed in 
maroon.  The void volume (Vo) was 7.84 mL, with the total column volume (Vt) being 24 mL.  
(B). SDS-PAGE of dMSL1820-1039 purification by Superdex 75.  Protein marker, load Superdex 
75 (4 mg/mL), elute Superdex 75 (Ve of 11.0 – 11.5), elute Superdex 75 (Ve 11.5 – 14.0 mL). 
 
 
Table 3.2: Spectroscopic measurements through-out the purification of dMSL1820-1039 from a 
single 4 litre recombinant protein preparation.   
Identification Abs280nm Abs260nm 280 / 260 ratio 
Elute from 1
st
 GS affinity column 3.1 2.5 1.2:1 
Elute from 2
nd
 GS affinity column 1.8 0.9 2:1 
Eluted GST from 2
nd
 GS column 1.8 2.1 0.9:1 
25 % AmSO4 ppt (resuspended) 0.7 0.5 1.4:1 
25 % AmSO4 supernatant 2.3 2.5 1:1 
Load Source S 0.7 0.5 1.4:1 
Concentrated elute of Source S 1.5 0.4 4:1 
Elute of Superdex 75 0.7 0.3 2.2:1 
Note samples were diluted tenfold to obtain accurate measurements. 
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Figure 3.11: Far-UV spectrum of dMSL1820-1039.  Superdex 75 size exclusion column analyte 
was 1.5 mg/mL.  The Far-UV spectrum was from 210 – 300 nm.  
 
  
The Far-UV spectrum for dMSL1820-1039 illustrated it was a homogenous protein solution, 
because a single peak at 280 nm which lacked a significant shoulder at 260 nm was observed.  
From a 4 litre large-scale protein preparation 20 mg of purified soluble dMSL1820-1039 protein 
was produced.  
Numerous crystallization conditions were tried; several commercially available sparse 
matrix crystallization kits were tried they included Wizard I and II, JCSG+ Suite, HR2-110 
Suite, and the PACT Suite.  The protein concentration used for crystallization was 
approximately 8 mg/mL.  The crystallization buffer used was 20 mM Tris-HCl (pH 8.0), 150 
mM NaCl, 1 mM TCEP, and 10 % glycerol.  Glycerol was added to help maintain protein 
stability (Sousa, 1995).  So far no protein crystals have been obtained, with the major problem 
being related to the instability of the dMSL1820-1039 protein.  Storage of purified dMSL1820-1039 
at 4 °C for longer than 48 hrs consistently resulted in almost complete degradation of the 
original protein band as seen with SDS-PAGE (data not shown).  Moreover, preliminary tests 
of secondary structure and stability, by circular dichroism and limited proteolysis (trypsin 
digestion) indicted an unstable protein as both tests failed (data not shown).  However, 
promising precipitants and phase separations have been found indicating the possibility of 
obtaining a protein crystal.  The most promising precipitant found was 2-methyl-2,4-
pentanediol commonly known as MPD.    
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3.3 Cloning C-terminal construct of Homo sapiens MSL1 
Four unique constructs were designed for the C-terminal domain of Homo sapiens 
MSL1 (hMSL1) based on the MSL1 sequence alignment (Fig 3.1).  The first construct encoded 
149 amino acids and was termed hMSL1465-614 (Fig 3.1 & Fig 3.12).  The second construct was 
210 amino acids in length, termed hMSL1404-614.  The third construct encoded 250 amino acids 
in length, termed hMSL1364-614.  The last was 352 amino acids in length, termed hMSL1262-614.  
Individual constructs were generated through the use of unique synthetic primers.  All 
of the PCR products were designed to have a BamHI restriction site and a SalI restriction site.  
Cleavage of the PCR products and the pGEX-6P-3 vector with BamHI and SalI generated 
compatible ends, facilitates insertion of the inserts of interest and correct orientation.  Clean 
double digestion with BamHI and SalI was difficult to achieve, but this was overcome by first 
digesting with SalI for 4 hrs and then BamHI for 16 hrs.  The subsequent ligation experiments 
were also difficult, as single colonies bearing the recombinant plasmid were rarely observed.  
Ligation reaction mixtures were incubated with XL-1 competent cells, previously determined 
to possess a transformation efficiency of 4.7 x 10
5
 colonies per μg of DNA, at 4 °C for 45 min.  
Transformation was found not to be the problem, which was determined using positive and 
negative controls.  The positive controls used were transformation of XL-1 competent cells 
with uncut pGEX-6P-3 vector, and the negative control was XL-1 competent cells alone.   
 
 
 
Figure 3.12: Schematic drawing of Homo sapiens MSL1 recombinant protein constructs that 
were studied.  The full length hMSL1 protein is illustrated at the top. The numbers at the 
beginning and end of the constructs identify the amino acids of hMSL1 and indicate the 
hMSL1 fragment that was over-expressed and purified.   
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Figure 3.13: Colony PCR on the four Homo sapiens MSL1 constructs cloned.  (A). Agarose 
gel of the cloned Homo sapiens MSL1 gene fragments and verification of correct ligation and 
transformation into XL-1 E. coli cells with colony PCR.  DNA marker (Wide Range), PCR 
amplified hMSL1465-614, Colony PCR product hMSL1465-614, PCR amplified hMSL1404-614, 
Colony PCR product hMSL1404-614, PCR amplified hMSL1364-614, Colony PCR product 
hMSL1364-614.  (B). Agarose gel of the cloned Homo sapiens MSL1 gene fragments and 
verification of correct ligation and transformation into XL-1 E. coli cells with colony PCR. 
DNA marker (Wide Range), PCR amplified hMSL1262-614, Colony PCR product hMSL1262-614.  
 
 
Eventually, however, successful ligation/transformation was achieved for each of the four 
constructs.  Verification of the presence of the desired gene fragment in each of the plasmids 
cloned was carried out by colony PCR (Fig. 3.13).  All four constructs were subsequently 
verified by DNA sequencing.       
Small-scale protein expression trials were attempted for each of the hMSL1 constructs 
cloned.  All of the protein expression trials failed; none of the trials resulted in a soluble 
recombinant protein that would bind to GS beads.  The most promising result was found for the 
construct hMSL1465-614, which was found to be expressed, however, only as an insoluble 
protein (data not shown).   
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3.4 Optimization of protein expression and purification of dMSL3186-512 
 The Drosophila MSL3 (dMSL3) construct was designed to contain the entire MRG 
domain, and encompass a stable C-terminal domain (Fig. 3.15) (Morales et al., 2005; Zhang et 
al., 2006a).  The dMSL3 construct was 981 base pairs or 327 amino acids, termed dMSL3186-
512 (Fig 3.14 & 3.15).  Drosophila melanogaster MSL3 homologues were identified by 
BLAST-P (3.19).   The Homo sapiens homologue had a sequence identity of 25 % to 
dMSL3186-512 and an E value of 1x10
-11
, and the Mus musculus homologue had a sequence 
identity of 24 % to dMSL3186-512 and an E value of 2x10
-9
.  Various Drosophila species 
reported 90 % and above in sequence identity including simulans and yakuba; however, the 
majority of the Drosophila species including ananassae and pseudoobscura had a sequence 
identity between 60 – 70 %.  The paralogue of dMSL3 MRG15 was determined to have a 
sequence identity of 30 % and an E value of 1x10
-4
.  Alignment of the protein sequences of 
Drosophila MSL3 homologues, paralogues, and orthologues revealed conservation of the 
MRG domain (Fig. 3.15).  Moreover, the secondary structure of the solved Homo sapiens 
MRG15 structure was overlaid with the aligned proteins’ sequences, which showed the 
conservation of the reported secondary structure of the MRG domain (refer to section 1.5.1).  
The gene fragment of dMSL3186-512 was successful cloned into the pGEX-6P-3 vector; both the 
PCR amplified gene fragment and the expression vector were double digested with BamHI and 
EcoRI, generating compatible ends between the vector and the insert.  Colony PCR verified the 
correct presence of the desired insert (Fig. 3.16).  DNA sequencing further confirmed the 
correct orientation of the insert and that the recombinant protein to be over-expressed was in-
frame, and no unwanted mutations occurred.  
 
 
 
Figure 3.14: Schematic drawing of Drosophila melanogaster MSL3 domain structure.  The 
recombinant protein construct that was studied is shown below the illustration of the wild-type 
protein.  The numbers at the beginning and end of the constructs identify the amino acids of 
dMSL3 and indicate the dMSL3 fragment that was over-expressed and purified.   
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Figure 3.15: Multiple sequence alignment of Drosophila MSL3.  Da: Drosophila ananassae, 
Dm: Drosophila melanogaster, Dp: Drosophila psuedoobscura, Hs: Homo sapiens, Mm: Mus 
musculus, Sc: Saccharomyces cerevisiae, Sp: Schizosaccharomyces pombe.  The blue arrows 
indicate the primers corresponding to the cloned MSL3 constructs (Table 2.1).  ClustalW2 was 
used for the multiple sequence alignment (Larkin et al., 2007).  The PDB accession 
identification of Homo sapiens MRG15 is 2AQL.  ESPript 2.2 was used for the alignment of 
the secondary protein structure against the sequence alignment (Gouet et al., 1999).  
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Figure 3.16: Colony PCR of Drosophila MSL3 constructs cloned.  Agarose gel of the cloned 
Drosophila MSL3 gene fragment and verification of its correct ligation and transformation into 
XL-1 E. coli cells with colony PCR.  DNA marker (Wide Range), PCR amplified dMSL3186-512 
gene fragment, Colony PCR product of transformed XL-1 cells possessing plasmid encoding 
the dMSL3186-512 gene fragment. 
 
 
 
 Small-scale GST pull-downs were performed to identify optimal recombinant protein 
over-expression conditions.  Recombinant dMSL3186-512 protein possessing an N-terminal GST 
tag was successfully over-expressed as a soluble protein (Fig. 3.17).  Optimal protein 
expression of recombinant GST-dMSL3186-512 was determined to be under the following 
conditions: E. coli BL-21 cells, LB broth, OD600 of 0.8 AU, 0.1 mM IPTG, at 14 °C.  Even at 
the optimized conditions over half of the expressed protein was found to be insoluble, 
indicating the difficulties of expressing a eukaryotic protein in E. coli.  Subsequent large-scale 
purifications were carried out using 4 litres of LB media; the cell culture consistently resulted 
in a cell pellet weight of 3 g per 1 L of cell culture.  The predicted molecular weight of the 
dMSL3186-512 was determined to be 37.6 kDa, and the GST-dMSL3186-512 fusion protein to be 
64 kDa.   
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Figure 3.17: Expression and crude purification dMSL3186-512 by affinity chromatography.  
SDS-PAGE of dMSL3186-512 protein expression and purification with GS affinity 
chromatography.  Protein was expression under the following conditions: BL21 (D3) cells 
grown in LB Broth, OD600nm = 0.8, 0.1 mM IPTG, grown at 16 °C for 14 hrs: protein marker, 
cell lysate, supernatant (soluble fraction), pellet (insoluble fraction), load 1
st
 GS column, elute 
1
st
 GS column, PreScission digestion (load 2
nd
 GS column), flow-through 2
nd
 GS column, elute 
2
nd
 GS column.  
 
 
Utilization of batch cultures enabled large-scale purification of dMSL3186-512.  GS affinity 
chromatography was used to capture the GST-fusion protein and thereby facilitate purification.  
Hence, the GST-dMSL3186-512 protein and the cleaved dMSL3186-512 protein were effectively 
purified by GS affinity chromatography (Fig. 3.17). 
The theoretical pI for dMSL3186-512 was determined to be 5.3; therefore, anion exchange 
chromatography with a equilibrating / loading buffer of 25 mM Tris (pH 8.0), 25 mM NaCl, 
and 5 mM DTT was utilized.  dMSL3186-512 protein was found to strongly interact with the 
stationary phase of the Source Q anion exchange column eluting as a single peak between 24 % 
– 27 % of 1.0 M NaCl or 23 mS/cm – 25.8 mS/cm (Fig. 3.18)   
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Figure 3.18: dMSL3186-512 purification by Source Q anion exchange.  (A). Source Q anion 
exchange chromatography of dMSL3186-512.  Dialyzed dMSL3186-512  protein solution (25 mM 
Tris-HCl [pH 8.0], 25 mM NaCl, and 5 mM DTT) applied to the ion exchange column 
equalled 10 mL.  The collected fraction was 4 mL eluting at 24 % - 27 % of 1.0 M NaCl. 
Elution conditions were a concentration gradient, 0 % to 50 %, of 25 mM Tris (pH 8.0), 1 M 
NaCl, and 5 mM DTT.  (B). SDS-PAGE of dMSL3186-512 anion exchange chromatography.  
Protein markers, load Source Q, elute 1
st
 peak (volume 102 – 104 mL), elute 2nd peak (volume 
106 – 110 mL). 
 
 
 
The dMSL3186-512 protein solution was concentrated to 2 mg/mL for size exclusion 
chromatography (Superdex 200).  Size exclusion chromatography verified that MSL3186-512 has 
a monomeric quaternary structure, a Ve of 16.0 mL, which correlated to a MW of 40 kDa (Fig. 
3.19).  However, the protein partially precipitated during concentration therefore crystallization 
trials could not be attempted.  
A Far-UV spectrum revealed that the protein solution did not contain significant 
amounts of unwanted nucleic acid (Fig. 3.20).  Therefore, the recombinant dMSL3186-512 
protein was determined to be soluble, purified to homology, a prerequisite for subsequent 
studies.  Moreover, recombinant dMSL3186-512 was found to be stable, as the protein could be 
stored at 4 °C for over 120 hrs without degradation (data not shown).  In summary, the 4 litre 
large-scale protein prep produced 16 mg of purified soluble dMSL3186-512 protein.   
 
 
80 
 
 
Figure 3.19: dMSL3186-512 purification by Superdex 200 size exclusion.  (A). Chromatogram of 
size exclusion chromatography of dMSL3186-512 (Superdex 200 10/300).  The loaded protein 
solution was 1 mL (2 mg/mL).  The collected fraction was 1.5 mL.  Absorbance (280 nm) is 
displayed in maroon.  The void volume (Vo) was 8.04 mL, with the total column volume (Vt) 
being 24 mL. (B). SDS-PAGE of dMSL3186-512 size exclusion chromatography.  Protein 
marker, load Superdex 200, elute Superdex 200 (Ve of 15.5 – 17.0 mL). 
 
 
 
 
Figure 3.20: Far-UV spectrum of dMSL3186-512.  The spectrum was of the dMSL3186-512 protein 
solution purified by anion exchange chromatography, and was determined to be 1.8 mg/mL. 
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3.5 Optimization of protein expression and purification of MOF371-827 
 The cloning of the construct Drosophila MOF371-827 was previously completed by 
Ewa Kerc (University of Saskatchewan) prior to the start of my masters’ degree.  The 
recombinant dMOF371-827 construct contained the chromodomain, the CCHC zinger finger 
domain, and the MYST family HAT domain (Fig. 3.21).  The CCHC zinc finger segment of 
MOF is thought to be involved in the protein interaction with MSL1 (Akhtar and Becker, 
2000).  The construct also was designed to contain the known domains necessary for 
acetyltransferase activity, which permitted activity assays to ascertain where or not a 
catalytically active C-terminal domain was generated.  The amino acid sequence of dMOF371-
827 was aligned against the reported MYST HAT family members from both Homo sapiens and 
Saccharomyces cerevisiae (Fig. 3.22).  PSI-BLAST revealed Homo sapiens MOF had a 
sequence identity of 54 % and an E value of 1x10
-135
 compared to the dMOF371-827 construct.  
Homo sapiens MOZ had a sequence identity of 51 % and an E value of 1x10
-81
, Homo sapiens 
Tip60 had a sequence identity of 43 % and an E value of 5x10
-81
, and S. cerevisiae Esa1 had a 
sequence identity of 45 % and an E value of 2x10
-73
.   
 
 
 
 
Figure 3.21: Schematic drawing of Drosophila melanogaster MOF domain structure.  The 
recombinant protein construct that was studied is shown below the wild-type protein.  The 
numbers at the beginning and end of the constructs identify the amino acids of dMOF and 
indicate the dMOF fragment that was over-expressed and purified.   
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Figure 3.22: Multiple sequence alignment of Drosophila MOF homologues.  Hs: Homo 
sapiens, Sc: Saccharomyces cerevisiae, Da: Drosophila ananassae, Dm: Drosophila 
melanogaster, Dmoj: Drosophila mojavensis, and Dp: Drosophila pseudoobscura.  The blue 
arrows indicate the primers corresponding to the cloned MSL3 constructs (Table 2.1).  
ClustalW2 was used for the multiple sequence alignment (Larkin et al., 2007).  The PDB 
accession identification of Homo sapiens MOF is 2PQ8.  ESPript 2.2 was used for the 
alignment of the secondary protein structure against the sequence alignment (Gouet et al., 
1999). 
 
 
 Recombinant GST-dMOF371-827 was successfully over-expressed when BL-21 cells 
were used and the cell culture was grown in Hyper Broth with protein expression conditions of 
OD600 of 0.6 AU, 0.1 mM IPTG, 16 °C for 14 hrs.  Protein expression with the Hyper Broth 
growth media was determined to be enhanced compared to LB broth, Power Broth, Superior 
Broth, and Turbo Broth.  Large-scale purifications were done using 4 – 6 litres of LB cell 
culture, which consistently resulted in a cell pellet weight of 15 g per litre of cell culture.  The 
predicted molecular weight of GST-dMOF371-827 was determined to be 79.4 kDa and the 
cleaved product dMOF371-827 was calculated to be 53 kDa.  Crude purification of GST-
dMOF371-827 was effectively achieved with GS affinity chromatography (Fig. 3.23).  Analysis 
of the fractions from first GS affinity column verified the capture and purification of GST-
dMOF371-827.  Moreover, SDS-PAGE of the eluate from the GS affinity column revealed that 
the protein solution contained a significant portion of both GST-dMOF371-827 and dMOF371-827 
(Fig. 3.23).  Cleavage of the GST tag by means of PreScission protease combined with a 
second GS affinity column resulted in successful purification of dMOF371-827 and effective 
removal of the GST tag (Fig. 3.23).   
dMOF371-827 was determined to have a theoretical pI of 8.5; further purification, 
however, was determined to be by means of anion exchange chromatography and not cation 
exchange chromatography.  Anion exchange chromatography (Source Q) with a loading / 
equilibrating buffer consisting of 25 mM bis-Tris propane (pH 7.0), 25 mM NaCl, and 5 mM 
DTT resulted in dMOF371-827 to effectively bind to the stationary phase and elute as a single 
peak at 40 – 46.5 % 1.0 M NaCl (Fig. 3.24).  SDS-PAGE analysis of the anion exchange 
chromatography revealed removal of numerous impurities (Fig. 3.24).  Interestingly, 
spectrophotometric analysis of the different purification stages illustrated a significant amount 
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of nucleic acid present all through purification (Table 3.3 & Fig. 3.25).  Furthermore, none of 
the different purification techniques removed the nucleic acids.  
 Histone acetyltransferase assays were carried out on GST-dMOF371-827 after the first 
GS affinity column, on dMOF371-827 protein solution eluted from the second GS affinity 
column, and MOF371-827 purified by Source Q anion exchange column (Fig. 3.26).  The HAT 
assays were all completed by Dr. Vikki Weake (Stowers Research Institute, University of 
Kansas).  The results demonstrated that the purified recombinant GST-MOF371-827 and 
dMOF371-827 possessed high acetyltransferase activity in the presence of HeLa core histones 
21,104 and 14,655 cpm respectively.  The recombinant dMOF371-827 further purified with ion 
exchange (Source Q) was found to have lost its HAT activity, 859 cpm.  The two negative 
controls GST alone and core histone proteins alone were both determined to low activity 1785 
and 530 cpm respectively.  The level of auto-acetylation was found to be negligible as the HAT 
activity was never above the measured level for core histone proteins alone.        
 
 
Figure 3.23: dMOF371-827 protein expression and purification by affinity chromatography.   (A). 
SDS-PAGE of dMOF371-827 protein expression and purification with the 1
st
 GS affinity column.  
Protein was expression under the following conditions: BL21 (D3) cells grown in Hyper 
Broth
TM
, OD600nm = 0.6, 0.1 mM IPTG, grown at 16 °C for 14 hrs. Protein marker, cell lysate, 
pellet (insoluble fraction), supernatant (soluble fraction/load GS column), elute 1
st
 GS column, 
elute 1
st
 GS column, PreScission protease digestion.  (B). SDS-PAGE of 2
nd
 GS affinity 
column.  Protein marker, load 2
nd
 GS column, flow-through (2
nd
 GS column), elute (2
nd
 GS 
column). 
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Figure 3.24: dMOF371-827 purification by Source Q anion exchange chromatography. (A). 
Chromatogram of MOF371-827 purification by Source Q.  Dialyzed dMOF371-827 protein solution 
(25 mM bis-Tris [pH 7.0], 25 mM NaCl, and 5 mM DTT) applied to the ion exchange column 
equalled 15 mL.  The collected fraction was 4 mL eluting at 40 % - 46.5 % of 1.0 M NaCl. 
Elution conditions were a concentration gradient, 0 % to 100 %, of 25 mM bis-Tris (pH 8.0), 1 
M NaCl, and 5 mM DTT.  (B). SDS-PAGE of dMOF371-827 purification by Source Q. Protein 
markers, load Source Q, flow-through (8 – 50 mL), 1st peak (80 – 84 mL), 3rd peak (100 – 112 
mL), 2
nd
 peak (90 – 94 mL).    
 
 
 
Table 3.3: Spectroscopic measurements through-out the purification of dMOF371-827 from a 
single 4 litre recombinant protein preparation.  
Identification Abs260 nm Abs280 nm 
Elute from 1
st
 GS affinity 
column 
2.1 2.2 
Elute from 2
nd
 GS affinity 
column 
0.4 0.3 
Eluted GST sepharose from 
2
nd
 GS column 
0.7 0.8 
Elute Source Q 0.3 0.2 
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Figure 3.25: Far-UV spectrum of dMOF371-827.  The spectrum was of the dMOF371-827 protein 
solution purified by anion exchange chromatography, and was determined to be 1.5 mg/mL. 
 
 
Moreover, in the absence of core histones minimal acetyltransferase activity was measured 
indicating very low levels of auto-acetylation.  Therefore, the majority of the measured 
acetyltransferase activity in the presence of core histones was directed towards the histone 
proteins and not dMOF371-827.  GST alone and core histones alone were the negative controls 
verifying acetyltransferase activity was via dMOF371-827.  Surprisingly, dMOF371-827 purified by 
anion exchange chromatography no longer possessed acetyltransferase activity, indicating an 
unwanted disruption of dMOF371-827 occurred. 
The dMOF371-827 protein solution was typically concentrated to 2.0 mg/mL for size 
exclusion chromatography (Superdex 200).  The majority of dMOF371-827 eluted at a Ve of 10.5 
mL, which corresponds to approximately 230 kDa.  This suggested that the recombinant 
dMOF371-827 protein had a tetrameric quaternary structure (Table 3.4).  Numerous trials to 
attempt to remove the quaternary structure by means of detergents and other additives failed to 
result in a change in the state of the protein.  The two main additives tried were zinc (for the 
CCHC zinc finger) and acetyl-CoA (for the MYST HAT domain).  Moreover, purification by 
size exclusion chromatography drastically reduced the overall protein concentration and 
subsequently the total amount of the purified protein (Fig. 3.27).   
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Figure 3.26:  Recombinant dMOF371-827 specifically acetylates histones.  (A). Histone 
acetyltransferase assays were carried out with HeLa core histones and various purified 
recombinant dMOF371-827 proteins.  GST-MOF indicates the concentrated protein analyte from 
the 1
st
 GS affinity column (6 mg/mL).  GST demarks the concentrated protein analyte from the 
2
nd
 GS affinity column (4 mg/mL).  MOF is the concentrated protein analyte of the flow-
through from the 2
nd
 GS affinity column (4 mg/mL).  SQ MOF corresponds to the concentrated 
protein analyte of anion exchange chromatography (2 mg/mL).  CH demarks the presence of 
core histone extracted from HeLa cells.  The enzyme activity assays were completed by Dr. 
Vikki Weake (Stowers Research Institute, University of Kansas).  (B). Major bands of a SDS-
PAGE of the recombinant proteins tested for acetylation activity. GST-MOF (6 mg/mL), GST 
(4 mg/mL), MOF (4 mg/mL), SQ-MOF (2 mg/mL). 
 
 
The reduction of the overall protein amount permitted only protein-protein interaction studies, 
but not crystallization trials.  In summary, the 4 litre large-scale protein prep produced 24 mg 
of purified soluble dMOF371-827 protein.  
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Table 3.4: Summary of the analysis of the quaternary structure of dMOF371-827. 
Running Buffer pH Additives to the Running 
Buffer 
Additional Info Results 
20 mM Tris, 
150 mM NaCl 
5 mM DTT 
8 ----- ----- Elution at 10.5 mL 
indicating a tetramer 
20 mM sodium 
citrate 
100 mM NaCl 
5 mM DTT 
5.5 ----- ----- Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris 
150 mM NaCl 
5 mM DTT 
8 0.5 mM zinc chloride, and 0.3 
mM Acetyl-CoA 
----- Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris  
150 mM NaCl 
5 mM DTT 
7 0.5 μM zinc chloride ----- Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris 
150 mM NaCl 
5 mM DTT 
8 0.5 mM zinc chloride, and 0.3 
mM Acetyl-CoA 
Zinc chloride was 
present post 
PreScission 
protease 
Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris 
150 mM NaCl 
5 mM DTT 
8 0.5% (w/v) CHAPS detergent Incubated with 2% 
(w/v)  CHAPS 
detergent prior to 
column 
Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris 
150 mM NaCl 
5 mM DTT 
8 0.5% (w/v) CHAPS detergent Incubated with 1.2 
% (w/v)  CHAPS 
detergent prior to 
column 
Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris 
150 mM NaCl 
5 mM DTT 
8 0.5% (w/v) CHAPS detergent Incubated with 0.5 
% (w/v) Octyl β-D 
glucopyranoside 
detergent prior to 
column 
Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris 
150 mM NaCl 
5 mM DTT 
8 0.5% (w/v) CHAPS detergent Incubated with 0.5 
% (w/v) N-
Dodecyl-β-D 
maltoside detergent 
prior to column 
Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris 
150 mM NaCl 
5 mM DTT 
8 1 M Urea Incubated with 1 M 
Urea prior to 
column 
Elution at 10.5 mL 
indicating a tetramer 
20 mM Tris 
150 mM NaCl 
5 mM DTT 
8 2 M Urea Incubated with 2 M 
Urea prior to 
column 
Elution at 10.5 mL 
indicating a tetramer 
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Figure 3.27: Representative purification of dMOF371-827 by Superdex 200 size exclusion 
column. SDS-PAGE: protein marker, load (2 mg/mL), elute (Ve of 9.5 – 10.5 mL).  
 
 
3.6 Protein interaction studies: dMSL1820-1039 and dMOF371-827 
The initial GST pull-down assays to test the interaction between the recombinant 
proteins dMSL1820-1039 and dMOF371-827 revealed that the interaction was not above background 
levels as the amount of dMOF371-827 in lanes 2 – 4 (GST-dMSL1 + dMOF371-827 + GS beads) 
was the same as in the control, lane 7 (dMOF371-827 + GS beads) (Fig. 3.28).  In an attempt to 
reduce the background level of dMOF interacting with GS beads the non-ionic detergent 
TWEEN®20 was added; the results from the addition of detergent indicated a reduced level of 
background but also the complete removal of dMOF-dMSL1 interaction. 
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Figure 3.28:  dMSL1820-1039 and dMOF371-827 GST pull-down assay. 12.5 % SDS-PAGE, Lane 
1: protein markers, Lane 2: 60 μg GST-dMSL1820-1039 and 60 μg dMOF371-827, Lane 3: 60 μg 
GST-dMSL1820-1039 and 60 μg dMOF371-827, Lane 4: 60 μg GST-dMSL1820-1039  and 60 μg 
dMOF371-827, Lane 5: 60 μg GST-dMSL1820-1039 incubated with GS beads, Lane 6: 8 μg GST-
dMSL1820-1039 incubated with GS beads, Lane 7: 10 μg dMOF371-827 incubated with GS beads, 
Lane 8: 60 μg purified GST incubated with GS beads, Lane 9: 10 μg dMOF371-827, Lane 10: 8 
μg dMSL1820-1039.  
 
 
Additional interaction studies were performed using size exclusion chromatography; where the 
respective proteins were incubated together at unique stages in their purification, and with a 
variety of additives.  Size exclusion chromatography permits studying protein-protein 
interactions by means of separating proteins based on their size in an inert environment. The 
first of the interaction studies combined purified dMSL1820-1039 and purified dMOF371-827 (Table 
3.5).  Zinc and acetyl-CoA were added to promote the secondary protein structure of dMOF371-
827.   
 
 
 
Table 3.5: Experimental setup for the dMSL1820-1039 and dMOF371-827 protein-protein 
interaction study. 
Proteins Additives 
Approx. 0.3 mg/mL dMSL1820-1039 and  
Approx. 0.25 mg/mL dMOF371-827 
 
0.002 mg/mL Pepstatin A, 0.05 mg/mL 
0.001 M PMSF, 0.5 mM DTT, and 0.5 μM 
ZnCl2 
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Analysis of the size exclusion chromatography by SDS-PAGE revealed that the dMSL1820-1039 
and dMOF371-827 co-eluted with an elution volume (Ve) of 13 mL. The calibrated size exclusion 
column revealed that a Ve of 13 mL equates to a molecular weight of approximately 100 kDa, 
indicating that the both dMSL1820-1039 and dMOF371-827 are in a monomeric state.  The 
recombined molecular weight of two respective monomers of dMSL1820-1039 and dMOF371-827 
would be 80 kDa. The discrepancy between the 100 kDa and 80 kDa may be explained by the 
impurities present.  However, the overall protein levels were diminished greatly, to the extent 
that the results may not be significant. 
Additional experiments directed towards establishing the dMSL1820-1039 and dMOF371-
827 protein-protein interaction were performed by incubating the recombinant proteins: GST-
dMSL1820-1039 and GST-dMOF371-827, where the GST-fusion tag remained on both proteins 
(Table 3.6). The GST fusion tag would aid in maintaining stability and provide additional 
secondary structure, in an effort to promote protein-protein interaction.  The combined protein 
solution was incubated for 12 hours at 4 °C, after which PreScission protease was added to 
cleave the fusion tag, and the protein solution was incubated for an additional 16 hours. To 
identify the protein-protein interaction, the protein solution was first purified with GS affinity 
chromatography to remove the cleaved GST tag and then subsequent examination by means of 
size exclusion chromatography.   
 
 
Table 3.6: Experimental setup for the GST-dMSL1820-1039 and GST-dMOF371-827 protein- 
protein interaction study 
Proteins Additives 
Approx. 0.5 mg/mL GST-dMSL1820-1039 and  
Approx. 0.5 mg/mL GST-dMOF371-827 
 
0.002 mg/mL Pepstatin A, 0.001 M 
PMSF, 5 mM DTT, and 0.5 μM ZnCl2 
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The chromatogram of the size exclusion column indicated that dMOF371-827 and 
dMSL1820-1039 eluted as two distinct peaks (data not shown). The Ve of dMOF371-827 ranged 
from 11.5 to 12.5 mL, identifying the MW as a 185 kDa to 155 kDa or a trimer quaternary 
structure.  The Ve of dMSL1820-1039 was 16 mL, which extrapolates to a MW of 30 kDa a 
monomer.  Again, the interaction between MSL1 and MOF was observed to be very weak, 
where only a portion of dMOF371-827 co-eluted with dMSL1820-1039.  In an effort to further aid in 
protein stability, the protein interaction between GST-dMSL1820-1039 and GST-dMOF371-827 was 
tried in the presence of 10% glycerol. The end result was a protein solution that failed to be 
properly cleaved by PreScission protease (data not shown).   
Lastly, protein interaction between dMOF371-827 and dMSL1820-1039 was tested by means 
of anion exchange chromatography.  Anion exchange chromatography was tried because the 
resin may mimic the overall positive charge of histone proteins. The positive charge of histones 
extends from the high percentage of basic amino acids.  The chromatogram of the Source Q 
column combined with SDS-PAGE verified that both dMOF371-827 and dMSL1820-1039 
recombinant proteins were loaded onto the column; however, only dMSL1820-1039 eluted from 
the column (data not shown).  Therefore, the in vitro protein interaction studies between 
dMOF371-827 and dMSL1820-1039 by means of GST-pulldowns, size exclusion chromatography, 
and ion exchange chromatography failed to demonstrate a strong stable interaction.    
 
3.7 Protein interaction studies between dMSL3186-512 and dMOF371-827 
Protein interaction studies between dMSL3186-512 and dMOF371-827 did not result in a 
stably bound complex. Both recombinant proteins were determined to be 0.5 mg/mL (Fig. 
3.29B).  Protease inhibitors (Leupeptin, PMSF, and Pepstatin A), reducing agent DTT, and 
zinc chloride were added to the incubation mixture.  The size exclusion chromatogram 
indicates two distinct peaks.  However, due to the proteins becoming too dilute SDS-PAGE can 
not verify the results (Fig. 3.29).  Furthermore, it seems that the complex quaternary structure 
of dMOF371-827 remained. 
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Figure 3.29: dMOF371-827 and dMSL3186-512 protein interaction study. (A). Chromatogram of 
size exclusion chromatography (Superdex 200) of dMSL3186-512 and dMOF371-827.  Absorbance 
(280 nm) is displayed in maroon.  The void volume (Vo) was 7.84 mL, with the total column 
volume (Vt) being 24 mL.   (B). SDS-PAGE of dMOF371-827 and dMSL3186-512 protein 
interaction studies.  Protein marker, dMSL3186-512, dMOF371-827, load Superdex 200 (dMSL3186-
512 and dMOF371-827 protein solution combined), elute 1
st
 peak (Ve 9.0 – 9.5 mL), elute 2
nd
 peak 
(Ve 15.0 – 15.5 mL).  
 
 
3.8 Protein interaction study: dMSL1820-1039, dMSL3186-512, and dMOF371-827 
 In an effort to see if the three recombinant proteins when present together would form a 
stable complex all three recombinant proteins: dMSL1820-1039, dMSL3186-512, and dMOF371-827 
were individually purified and then incubated.  The experimental design consisted of 
incubating purified dMSL3186-512, GST-dMSL1820-1039, and GST-dMOF371-827.  The volumes of 
the individual proteins were adjusted to attempt a 1 to 1 to 1 ratio.  All three proteins had a 
final protein concentration of 0.25 mg/mL.  Protease inhibitors (PMSF and Pepstatin A), 
reducing agent DTT, and zinc chloride were added to the incubation mixture.  The interaction 
studies between dMSL1820-1039, dMSL3186-512, and dMOF371-827 resulted in a protein solution 
loaded onto the size exclusion column which was too unstable and too dilute (Fig. 3.30).  
Therefore, the presence of all three proteins did not lead to a more stable protein complex. 
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Figure 3.30: dMSL1820-1039, dMSL3186-512, and dMOF371-827 protein interaction study. SDS-
PAGE, Lane 1: protein markers, Lane 2: GST-dMSL1820-1039, Lane 3: GST-dMOF371-827, Lane 
4: dMSL3186-512, Lane 5: protein solution of all three recombinant proteins (pre-cleavage), Lane 
6: load 2
nd
 GS column (post PreScission protease cleavage), Lane 7:  elute 2
nd
 GS affinity 
column, Lane 8: elute GST only, Lane 9: load Superdex 200 10/300.  
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4. Discussion 
Co-immunoprecipitation experiments on Drosophila larval cell extracts revealed that  
MSL1, MSL2, and MSL3 all interact with one another (Copps et al., 1998).  Yeast two-hybrid 
experiments demonstrated that the interaction between MSL1 and MSL3 was strong.  From co-
immunoprecipitation experiments in the presence of RNase from Drosophila cell extracts it 
was demonstrated that MSL1, MSL2, MSL3, and MOF remained as a stable complex, which 
suggested that the interactions were due to protein-protein interactions and were not RNA 
mediated (Akhtar et al., 2000).  It was further shown that FLAG-tagged MSL1 could co-purify 
MSL2, MSL3, and MOF from adult Drosophila cell extracts (Scott et al., 2000).  Moreover, a 
C-terminal construct of MSL1 comprised of amino acid residues 705 – 1039 (MSL1705-1039) 
was able to specifically pull-down both MSL3 and MOF from Drosophila cell extracts (Scott 
et al., 2000).  To confirm the protein interactions between MSL1705-1039 plus HA-tagged MSL3 
and MSL1705-1039 plus HA-MOF recombinant proteins were made with in vitro translation 
(expression of protein in a cell free system); it was found that MSL1705-1039 co-purified with 
HA-MSL3 but not with HA-MOF (Smith et al., 2000).  This indicated that the C-terminal 
domain of MSL1 directly interacted with MSL3 but the interaction with MOF requires an 
additional factor (post-translational modification).  MOF was determined to strongly interact 
with MSL1 when in the presence of MSL3 (Morales et al., 2004; Smith et al., 2000).  It was 
also found that the in vitro  translated MSL1, residues 973 – 1039, interacted with HA-MOF 
from Drosophila cell extracts (Morales et al., 2004).  Furthermore, it was determined that the 
complete MRG domain, residues 185 – 490, of MSL3 was required for interaction with MSL1 
as shown with Drosophila larvae expressing FLAG-tagged MSL3 constructs co-purified with 
MSL1 (Morales et al., 2005).  In order to conclusively establish the interactions between 
MSL1, MSL3, and MOF, and confirm the precise protein domains required for protein-protein 
interaction, all three proteins were over-expressed in an E. coli bacteria system.  Conversion 
from studies in insect cells or Drosophila to bacteria enables over-expression of a select protein 
to levels required for structure determination by X-ray crystallography and also rules out the 
possibility of protein post-translational modifications contributing to the interactions being 
studied.   
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4.1 Cloning and recombinant protein expression 
To date, the only reported domain within the C-terminus of Drosophila MSL1 is the 
PEHE domain, consisting of amino acids 865 – 1004 (Marin et al., 2003).  However, BLAST 
searches do not reveal any annotated protein domains within the C-terminal region.  A 
Drosophila MSL1 C-terminal construct, consisting of amino acid residues 705 – 1039, directly 
interacted with both MOF and MSL3, suggesting a functional C-terminal domain exists (Scott 
et al., 2000).  Consequently, this project attempted to clone a complete C-terminal domain; a 
complete domain is defined as a protein domain which could properly fold, akin to its native 
conformation.  Moreover, protein constructs were designed to remove linker sequences, amino 
acids that connect two functional protein domains, as they are typically highly susceptible to 
proteolytic cleavage.  In an effort to do so, an analysis of amino acid sequence conservation 
between Drosophila MSL1 and higher eukaryotes was completed.  Sequence conservation did 
not confidently identify a clearly delineated MSL1 C-terminal domain.  To improve the odds of 
over-expressing a stable C-terminal domain, four unique Drosophila MSL1 constructs --
dMSL1688-1039, dMSL1712-1039, dMSL1754-1039, and dMSL1820-1039 -- were cloned and protein 
expression trials were conducted.  In conjunction with these studies on the C-terminus of 
Drosophila MSL1, four unique Homo sapiens MSL1 C-terminal constructs were cloned: 
hMSL1262-614, hMSL1364-614, hMSL1404-614, and hMSL1465-614.  Minimal results have been 
reported on the protein domains of Homo sapiens MSL1; therefore, this study was directed also 
towards characterizing the Homo sapiens MSL1 C-terminal domain.  Furthermore, to confirm 
the interaction between dMSL1 and dMSL3 a Drosophila MSL3186-512 construct was cloned 
containing the MRG domain.  The MRG domain is the reported domain for protein interaction 
with MSL1 (Morales et al., 2005; Zhang et al., 2006a).  The structure of the MRG domain 
from dMSL3 remains unknown; therefore, another objective of this study was to generate a 
stable and soluble protein permitting structural studies.   
In order to clone a eukaryotic gene permitting recombinant protein expression in 
bacteria, MSL cDNAs were utilized.  cDNA was generated from mature mRNA from a 
eukaryotic cell., in this case either Drosophila melanogaster or Homo sapiens, that was 
comprised solely of exons as the introns were previously spliced.   
As outlined in sections 3.1, 3.3, and 3.4, cloning was completed for four unique dMSL1 
gene fragments, four unique hMSL1 gene fragments, and one dMSL3 gene fragment.  Cloning 
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of the desired gene fragments was completed within the multiple cloning site (MCS) of the 
pGEX-6P-3 vector.  Notably, the pGEX-6P-3 vector enables antibiotic selection because it 
possesses an Ampicillin resistance gene.  As such, in the presence of Ampicillin E. coli that is 
transformed with a vector is pressured to keep the plasmid in order to survive.  Ligation of the 
double digested gene fragment into the MCS of the vector proved to be the most difficult stage 
in cloning, particularly with the hMSL1 constructs.  Experimentation with different ratios of 
vector to insert eventually produced single colonies, but even then not many colonies were 
typically recovered.  Consequently, this indicates that E coli XL-1 cells had difficultly up-
taking or maintaining the hMSL1 chimeras.  E. coli XL-1 cells were used as they have been 
genetically engineered for cloning and plasmid purification, by improving their competency.  
Moreover, XL-1 cells are deficient of recombination (recA), and the endonuclease (endA), 
thereby improving insert stability and improving the quality of plasmid preparation, 
respectfully.  Confirmation of cloning was determined by three means: firstly, by streaking 
single colonies produced from the transformation of ligated vector into XL-1 cells, onto LB 
agar plates possessing Ampicillin; secondly, using colony PCR, in which a single colony is 
used as a template as opposed to a purified DNA template; and thirdly, by DNA sequencing 
which aids in assessing the quality of cloning as well the accuracy of recombinant protein 
expression.   It is important to note, that while colony PCR uses similar principles to that of 
PCR, the initial denaturing step causes the cells to burst exposing the plasmid encoding the 
insert. 
To aid in expression of recombinant proteins all of the constructs were individually 
cloned into a pGEX-6P-3 vector.  The pGEX-6P-3 vector enables expression of recombinant 
protein with an N-terminal GST tag.  Through double digestion of both the vector and insert 
complementary restriction ends were generated and correct alignment of the gene fragment into 
the MCS was completed; therefore, the in-frame GST fusion protein was expressed.  Over-
expression of a GST-fusion protein can be achieved through the pGEX-6P-3 vector’s 
chemically inducible Ptac promoter.  By means of IPTG, chemical induction results in 
expression of T7 RNA polymerase, release of the lac operon repressor from the Ptac promoter 
enabling expression of the recombinant promoter.  The strength of Ptac promoter directs the 
cell’s attention towards expression of the recombinant protein slowing cell division.   
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Additionally, the lac I gene within the pGEX-6P-3 vector creates basal expression of the 
recombinant GST fusion protein continuously.   
As opposed to yeast, insect, mammalian or other bacterial cell lines, E. coli was used as 
it allows the recombinant protein to be over-expressed to levels of 50 % of the total cellular 
protein.  Unfortunately, however, recombinant eukaryotic protein expression in E. coli often 
results in insoluble protein and can be toxic to the bacteria.  Moreover, E. coli often have 
difficulty translating and properly folding nascent protein, and incorporating post-translational 
modifications.  To facilitate increased expression levels and protein assembly in E. coli, unique 
growth temperatures, ODs, type of media, and IPTG concentrations were tried in combination.  
Varying induction temperatures, ranging from 16 °C to 37 °C, were used to further retard cell 
division thereby enhancing the ability of bacteria to express recombinant protein. Notably, 
most eukaryotic protein post-translational modifications do not occur in bacteria.   
To decipher which C-terminal dMSL1, hMSL1, or dMSL3 construct encoded a stable 
and soluble protein small-scale GST pull-downs were conducted.  GST pull-downs are a fast 
and simple technique.  As outlined in section 3.2, the soluble fraction is separated from the 
insoluble fraction by centrifugation; the GST of the GST-fusion binds to its substrate, the tri-
peptide glutathione immobilized onto agarose beads, and captures the fusion protein.  These 
glutathione-agarose beads are washed to remove any contaminating bacterial proteins and the 
desired GST-fusion protein are visualized with SDS-PAGE.  Complete solubility of a protein 
often cannot be achieved since bacteria have problems with expressing eukaryotic proteins.  
Therefore, the goal is to maximize the amount of soluble protein.  Notably, protein expressions 
of all four dMSL1 constructs were tried in both BL21 and Rosetta 2 cells (data not shown).  
BL21 cells are E. coli cells genetically designed for protein expression as they are deficient in 
both Lon and ompT proteases and thus able to aid in recombinant protein stability.  Rosetta 2 
cells, derived from BL21 cells, are designed to enhance eukaryotic protein expression by 
possessing seven rare tRNAs which are required for efficient translation of many eukaryotic 
genes.   
As shown in section 3.1, the dMSL1820-1039 construct transformed into BL21 cells 
resulted in a soluble GST-fusion protein.  While dMSL1688-1039, dMSL1712-1039, and dMSL1754-
1039 were cloned, they were not successfully over-expressed as soluble protein (data not 
shown).  Consequently, it can be concluded that a minimal C-terminal region consists of 
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residues 820 – 1039, which is largely comprised of the PEHE domain -- the region of highest 
conservation of amino acids between other eukaryotes --.   
As determined by colony PCR (Fig. 3.13) and DNA sequencing (data not shown), the 
four Homo sapiens MSL1 constructs were all successfully cloned but the subsequent 
recombinant proteins failed to be expressed (Fig. 3.13).  One possibility is that the pGEX-6P-3 
vector used was altered during cloning and as the entire vector was not sequence the disruption 
was not detected.  This possibility was strengthened from the lack of GST protein found in 
expression trials, typically over-expressed even when the recombinant protein was not.  
Another possibility is that the protein sequences did not accurately encompass a complete 
domain and thus did not encode stable, soluble proteins.  While the difficulty of bacteria to 
express eukaryotic proteins cannot be ruled out, BL21 (DE3) cells and Rosetta 2 cells were 
utilized in protein expression. 
Recombinant dMSL3186-512 was successfully cloned as determined by colony PCR (Fig. 
3.16) and DNA sequencing (data not shown).  Over-expression of soluble protein to levels 
permitting further studies was observed by small-scale GST pull-downs (Fig. 3.17).  The 
dMSL3186-512 construct slightly differed from the two dMSL3 proteins, MSL3141-512 and 
MSL3181-512, found to interact with MSL1 (Morales et al., 2005);  our lab altered the MRG 
domain, since residues eliminated were not well conserved with Drosophila MRG15 and 
MSL3 from other eukaryotes.        
As outlined in section 3.5, dMOF371-827 was cloned prior to the start of this project.  
Small-scale GST pulldowns were tried to assess both expression of a soluble protein and 
capture of the GST-fusion protein (Fig. 3.23).  dMOF371-827 was found to be expressed as a 
soluble protein to levels that allowed large scale preparations.   
In an effort to study each individual protein and possible protein complexes, the 
recombinant proteins needed to be over-expressed, harvested, and purified to homogeneity.  
While consistent small-scale over-expression and harvesting of the recombinant proteins 
dMSL1, dMSL3, and dMOF allowed large-scale protein preparations and purifications to be 
examined, a future goal of this project is to verify each protein through crystallization as well 
as plausible protein interactions via co-crystallization.  As such, purity and yield of the 
recombinant proteins were used to assess the quality of the purification protocol.  Large-scale 
protein preparations and subsequent purification protocols for dMSL1820-1039, dMSL3186-512, 
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and dMOF371-827 were tried with an ultimate goal of purifying each protein to a concentrated, 
homogeneous protein solution.  The final stage of protein purification entails achieving 95 % 
homogeneity.  This is reached when the desired protein is the only observable band identified 
with SDS-PAGE.  The difficulty in purifying a protein of interest is separating it from the other 
components in the cell, particularly unwanted contaminating proteins, while simultaneously 
yielding large amounts of pure protein.  Utilization of the pGEX-6P-3 vector allowed use of a 
GST tag, which aided in both solubility and stability of the recombinant protien.  Moreover, the 
GST tag enables affinity chromatography to be used as the initial step in the purification of a 
recombinant GST-fusion protein thereby permitting a robust purification step to quickly and 
easiliy remove the majority of unwanted cellular proteins.  
 With the aim of maintaining protein structure and solubility temperature, pH, and ionic 
strength of a buffered solution must routinly be adjusted for each individual protein.  Hydrogen 
bonds, hydrophobic interactions, and ionic interactions are important to protein stability and 
are also directly affected by the buffered protein solution.  The unique properties required to 
purify a recombinant protein have to be carefully considered in an empirical manner as the 
protein sequence only provides limited estimates of the protein’s isoelectic charge, molecular 
weight, and extinction coefficient.  Protein purifaction is completed by exploiting the 
differences in properties between the protein of interest and the unwanted proteins within the 
mixture.  Reducing the number of steps yeilds quicker preperation, lower protein losses, and 
lower costs.  
Protein purification was performed using fast protein liquid chromatography (FPLC).  
FPLC is a form of column chromatography that enables protein purification using a variety of 
different stationary phases, including affinity, ionic, and hydrophobic chromatography.  The 
flow-rate is commanded by an adjustable pump that drives the mobile phase containing the 
analyte through a select column.  FPLC permits purification under constant pressure, whereby 
each protein can be purified from the column in a fast and efficient manner in an effort to 
decrease protein degradation.  Purification under higher pressure also permits increased 
resolution when compared to gravity flow.  A detector attached to the FPLC provides a way to 
characterize the retention time for the analyte and enables UV spectroscopic data on the 
analyte, allowing measurement of the yield, concentration, and purity of the recombinant 
protein. 
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To further prevent protein degradation, protease inhibitors were included in the 
buffered protein solutions.  In doing so, protein integrity was maintained during the course of 
purification.  Pepstatin A, PMSF, and Leupeptin were used to provide a broad inhibition of 
potential proteases.  Pepstatin A inhibits aspartyl proteases along with a majority of other acid 
proteases, PMSF inhibits serine proteases and Leupeptin inhibits both serine and cysteine 
proteases.    
To characterize the C-terminus of dMSL1 the recombinant dMSL1820-1039 protein was 
successfully over-expressed and purified to homogeneity (Fig. 3.3 and 3.10).  The conditions 
for over-expression were determined to be at an OD of 0.6, 0.1 mM IPTG, and an induction 
temperature of 16 °C.  Analysis of the cell pellet weight was found consistently to be 6 g/L.  
Cell pellet weight is a quick assessment of the recombinant protein yield; however, its quality 
is limited as both the solubility and the final OD of the culture can greatly vary.  The best 
assessment of quality is consistency among individual preparations and the efficacy of cellular 
growth to the desired OD.   
Through utilization of two GS affinity columns, a progressive and robust purification of 
dMSL1820-1039 was observed (Fig. 3.7 and 3.8). The pGEX-6P-3 vector provides a GST-fusion 
protein with a PreScission protease site between GST and the recombinant protein; this site 
allows for quick cleavage and removal of the unwanted GST fusion tag under very mild 
conditions.  While the GST-fusion tag greatly facilitates purification, solubility, and stability, it 
can inadvertently interfere with crystallization; and was therefore removed by the second GS 
affinity column (refer to section 3.2). Notably, to prevent unwanted disulphide bonds between 
the two cysteine residues within dMSL1820-1039 the reducing agent, DTT, was added to all 
buffered protein solutions after the initial GST affinity column.   
As shown in section 3.2, further purification of dMSL1820-1039 was attempted through 
both cation exchange (Source S) and anion exchange (Source Q) chromatography. Anion 
exchange (Source Q) did not aid in purification as the pI (isoelectric point) of the dMSL1 
fragment was 5.5 and it consistently eluted in the flow-through (data not shown).  Conversely, 
cation exchange (Source S) was successful in further purifying dMSL1.  To maximize the 
purification by Source S, minimal levels of salt were used in the loading/equilibration buffer; 
specifically 25 mM NaCl and 25 mM Tris-HCl (pH 8.0) (Fig. 3.9).  At pH 8.0 dMSL1820-1039 is 
above its pI and should be negatively charged; the charge of the stationary phase in Source S at 
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pH 8.0 is also negative.  Therefore, purification by Source S may be attributed to a positively 
charged region on the surface of dMSL1, as the pI is an estimate of the entire protein.  The 
electrostatic potential on the surface of a protein can be different from other surface regions, 
and the interior of a protein, as proteins in solution are a globular structure and not uniform in 
shape and charge.  Ion exchange permits fast and mild elution by a 25 mM – 1 M NaCl 
concentration gradient, as proteins elute based on the strength of their interaction with the 
stationary phase.  Gel filtration (Superdex 200) enabled both assessment of the protein’s 
quaternary structure as well as the purification of remaining contaminants based on size.  
Figure 3.10 illustrates that dMSL1820-1039 is a monomer and that further purification was 
achieved as smaller protein bands were not observed by SDS-PAGE.  Through the various 
stages of purification aggregates, minor contaminants, and degradation products were removed 
and the desired recombinant protein was transferred into a suitable buffer for structural studies.     
Similar to dMSL1, recombinant dMSL3186-512 protein was purified to homogeneity, 
establishing both over-expression and a purification protocol (Section 3.5).  The conditions for 
over-expression were found to be at an OD of 0.8, 0.1 mM IPTG, and induction temperature of 
16 °C.  Compared to that of dMSL1820-1039 the pelleted cell weight was consistently 5 g/L.   
As with dMSL1820-1039, dMSL3186-512 was purified by the combination of two GS 
affinity columns, which resulted in the removal of the GST tag, capture of the fusion protein, 
and rapid removal of impurities (Fig. 3.17).  Again DTT aided in stabilizing the recombinant 
protein by ensuring the buffered solution was kept in reduced state.  Contrary to dMSL1820-1039 
purification, Source Q facilitated as the intermediate step in the purification of dMSL3186-512. 
After screening different salt concentrations and buffer types (data not shown) purification was 
achieved under the following conditions: 25 mM Tris-HCl (pH 8), 25 mM NaCl, and 5 mM 
DTT (Fig. 3.18).  To further purify the dMSL3186-512 and determine its quaternary structure gel 
filtration (Superdex 200) was again performed and dMSL3186-512 was determined to be a 
monomer (Fig. 3.19).  Majority of the dMSL3186-512 protein precipitated while concentrating 
the eluted protein solution.  Further experiments need to be directed towards improving the 
stability of dMSL3186-512 at high concentrations; it was determined that concentrating of 
dMSL3186-512 to levels above 2 mg/mL resulted in protein precipitation (Fig. 3.19).  
Interestingly, the stability of dMSL3186-512 estimated by the absence of degradation products 
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during purification and storage indicates that it is stable.  To aid in further stability, different 
buffers with varying pH or the addition of 5 – 20 % glycerol may be tried.   
As shown in section 3.6, recombinant dMOF371-827 was successfully over-expressed and 
purified to homogeneity (Fig. 3.27).  It was previously illustrated that full-length dMOF could 
be coupled with a GST tag and purified from E. coli (Akhtar et al., 2000).  This project further 
demonstrated that higher yields and purity could be achieved permitting dMOF structure 
determination.  Over-expression was found to be improved with the use of Hyper Broth under 
the following conditions: 0.1 mM IPTG, OD 0.6, and an induction temperature of 16 °C.  The 
pellet cell weight was determined to be 15 g/L; the difference in weight compared to dMSL1 
and dMSL3 is likely attributed to the Hyper Broth.  Protein inactivation was a key 
consideration during the purification of dMOF371-827, as the directive of this study was to 
characterize how the complex of MSL1, MSL3, and MOF mediates MOF enzyme activity.  
Recombinant GST-fusion protein was again captured by using GS affinity chromatography, 
and after PreScission protease digestion a second GS affinity chromatography enabled a fast 
recovery of recombinant dMOF371-827 (Fig. 3.23).  Given that dMOF371-827 contained 10 
cysteine residues, the risk of disulphide bonds was high and DTT was used as an additive to all 
solutions.  After screening Source Q ion exchange chromatography with various buffers and 
pH the following conditions were used: 25 mM Bis-tris propane (pH 7), 25 mM NaCl, and 5 
mM DTT; this resulted in high resolution purification (Fig. 3.24).  dMOF371-827 eluted from 
Source Q was concentrated and polished by gel filtration (Superdex 200).  Many difficulties 
were encountered upon gel filtration.  Specifically, dMOF371-827 did not elute efficiently from 
the column, as the fractions were too dilute to continue with crystallization or protein 
interaction studies.  Furthermore, the eluted dilute dMOF371-827 appeared to be a tetramer (Fig. 
3.25 and Table 3.4).  Often dMOF371-827 eluted in the void volume, indicating that it is an 
aggregate with a weight above the maximum molecular weight that can be resolved by the 
column.  High activity of dMOF371-827 and GST tagged dMOF371-827 indicates a correctly folded 
protein (Fig.3.26); however, the loss of activity of dMOF after ion exchange chromatography 
indicates a detriment to either overall protein structure or a possible removal of the zinc atom 
bound by the zinc finger.  The possible removal of zinc atom in the CCHC zinc fingers is 
unlikely as dMOF was shown to possess acetylation activity in the presence of EDTA (Akhtar 
and Becker, 2000).  Moreover, the inclusion of DTT in the purification of dMOF after the 
104 
 
second GS affinity column may result in the removal of the zinc atom of the zinc finger or an 
alteration of the zinc finger provoking the aggregation of MOF371-827.  If either occurs, an 
alteration of the protein structure may result.  Another possibility was oxidation of the protein, 
which may cause aggregation as the half-life of DTT is short.  PMSF a strong nucleophile may 
also be affecting the zinc finger through disruption of the interaction between the zinc atom 
and the sulphurs of the three cysteine residues.  Understanding the activity assays of dMOF371-
827 remained problematic and due to time restrictions this problem was not fully explored.  
Interestingly, the Abs280 to Abs260 nm ratio, which measures the protein to nucleic acid 
quantity, was used and did not change throughout purification indicating that there was no 
detectable change in the protein structure.  Furthermore, the limited elution of dMOF371-827 
during size exclusion chromatography and the analyte that does elute was measured to be a 
tetramer, supporting the idea that purification by anion exchange chromatography was 
problematic.  Moreover, SDS-PAGE of soluble fraction of dMOF371-827’s over-expression 
consistently revealed two protein bands at approximately 80 kDa and at 55 kDa respectively.  
Further purification of dMOF371-827 by preScission protease and a GS affinity column SDS-
PAGE indicated an accumulation of the protein band at 55 kDa; indicating that the protein 
band observed in the SDS-PAGE of the soluble fraction is the over-expressed dMOF371-827 
lacking the N-terminal GST tag (prior to cleavage of the tag).  Interestingly the SDS-PAGE of 
ion exchange column revealed a protein band at approximately 45 kDa, which may be 
dMOF371-827 without its chromodomain.          
Ascertaining properly folded recombinant proteins can be done with enzyme activity 
assays, limited trypsin proteolysis, circular dichroism, and 
1
H, 
15
N HSQC 2D NMR.  Given 
that dMSL1820-1039 is not an enzyme; the secondary structure was determined by limited trypsin 
proteolysis and circular dichroism.  Due to the possibility that the protein was susceptible to 
trypsin, a negative result was difficult to understand and thus the results of limited trypsin 
proteolysis were not shown.  Similarly, the results of circular dichroism were also not shown as 
additional trials need to be done to ensure the results.  As such, an assessment of whether 
MSL1 was folded correctly was inconclusive.  Ultimately 
1
H, 
15
N HSQC 2D NMR should be 
utilized to confirm the state of folding of dMSL1820-1039 (Dyson and Wright, 1998).  However, 
due to time restrictions an assessment of dMSL3186-512 and dMOF371-827 was not attempted.  
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Activity assays on dMOF371-827 were attempted, which provided insight that the recombinant 
protein was properly folded.   
All three recombinant proteins dMSL1, dMSL3, and dMOF have been reported to 
interact with nucleic acid.  dMOF has been shown to interact with RNA, DNA, and 
nucleosomes (Akhtar et al., 2000), dMSL3 was reported to interact with DNA and RNA and 
dMSL1 is known to interact with nucleosomes, suggesting it also associates with DNA and 
RNA (Morales et al., 2004).  However, the C-terminal domains of MSL1, MSL3, and MOF not 
thought to be important for interacting with roX RNA or the chromosome.  Therefore, in 
accordance to protein purification strategies all unwanted cellular particles should be removed; 
therefore, all purification protocols included the addition of DNase I and benzonase (RNase 
and DNase).  During purification Far-UV spectra were also measured to observe the Abs280 to 
Abs260 ratio.  Assessment of purification was tested by the Far-UV spectrum as a peak at 280 
nm and a lack of a visible shoulder at 260 nm indicates homogeneity.  It is important to note 
that through-out purification of the recombinant proteins the Abs280 to Abs260 ratio was 
attempted to be improved not the specific 280 nm and 260 nm measurements as the 
inconsistency between different protein batches.     
The purification protocol for dMSL1820-1039 resulted in a protein solution lacking 
appreciable amount of nucleic acid (Fig. 3.11).  Evaluation of ammonium sulphate 
precipitation strongly indicated that contaminating the nucleic acids were largely removed 
(Table 3.1).  Moreover, ethanol precipitation of the flow-through fractions of Source S cation 
exchange revealed material was purified away from dMSL1820-1039 (Fig. 3.9). Interestingly, this 
material could not be visualized by ethidium bromide staining of native PAGE or agarose gels 
of the material (data not shown).  It was also determined that dMSL3186-512 was purified to 
eliminate contaminating nucleic acids (Fig. 3.20).  The presence of nucleic acid as evidence by 
absorbance at 260 nm for dMOF371-827 remains inconclusive due to the potential absorbance 
and interference by the CCHC zinc finger at 260 nm (Fig. 3.25).  A summary of the 280 nm to 
260 nm ratio from for the unique stages of dMSL1820-1039’s protein purification protocol was 
provided in Table 3.2.  Whereas shown in Table 3.1 is the 280 nm to 260 nm ratio from the 
initial ammonium sulphate precipitations.               
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4.2 Protein interaction studies 
 Quantification of interaction strength and propensity for the above proteins is difficult 
to ascertain from the literature as previous studies fail to include protein quantity within their 
reported data.  Furthermore, in vitro interaction studies of recombinant protein expressed in 
bacterial systems are susceptible to problems due to mis-folded proteins and lack of post-
translational modifications.  This study used GST pull-down assays for testing direct 
interaction between a GST tagged bait protein and a prey protein, both of which have been 
purified to a desired homogeneity.  The bait and prey protein can be interchangeable depending 
on which protein is the GST-tagged protein.  Complexes recovered from GS beads are readily 
resolved by SDS-PAGE (Brymora et al., 2004).  Size exclusion chromatography can be 
utilized to assess protein-protein interactions because it provides an inert environment which 
will not disrupt a pre-formed protein complex (Copps et al., 1998).  Moreover, ion exchange 
chromatography can be employed to test protein-protein interactions.     
Using GST pull-down assays (Fig 3.28) interaction between dMSL1820-1039 and 
dMOF371-827 did not exceed background levels.  Furthermore, the adjustment of incubation 
periods, protein concentration, and the addition of non-ionic detergents did not improve 
interaction between dMSL1820-1039 and dMOF371-827.  The problem with dMOF371-827 found after 
ion exchange chromatography should not have been observed in the GST pull-down assays 
with GST-tagged dMOF371-827.  In addition, interaction studies by size exclusion 
chromatography and anion exchange chromatography established that the interaction between 
dMSL1820-1039 and dMOF371-827 is weak to non-existent as the proteins failed to elute together.  
These results are in accordance with previous studies with in vitro translated MSL1 (705 – 
1039) and MOF (Smith et al., 2000).  However, these results are contrary to studies with in 
vitro translated MSL1 (residues 973 – 1039) and HA-MOF from Drosophila cell extract 
(Morales et al., 2004).  Interaction studies between dMSL3186-512 and dMOF371-827 showed no 
interaction, which coincides with the literature that MSL3 and MOF cannot directly interact 
(Fig. 3.29) (Morales et al., 2005; Morales et al., 2004).  However, in Homo sapiens MSL3 and 
MOF were found to directly interact (Taipale et al., 2005).  Contrary, to previous studies 
finding the interaction with MSL1 and MOF was strengthen in the presence of MSL3 the 
interaction studies with all three recombinant proteins dMSL1820-1039, dMSL3186-512, and 
dMOF371-827 demonstrated no interaction (Fig. 3.30) (Morales et al., 2004; Smith et al., 2000).  
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In summary, all of the interaction studies proved to be inconclusive as no strong stable 
interactions were observed.    The possibility that post-translation modifications are needed 
may be a problem, specifically MOF.  Also, this study tested the interaction with a MSL1 
construct ranging from 820 – 1039, previous studies tested the interaction with MSL3 and 
MOF with longer MSL1 constructs (705 – 1039 and 766 – 1039).  Therefore, the removal of 
the amino acid residues 766 – 819 may be important for the protein interaction.  Moreover, the 
difficulties may be due to the difficulties in dMOF371-827 purification, inclusion of DTT, PMSF, 
and dMOF tetrameric quaternary.             
 
4.3 Crystallization 
As shown in section 3.2, crystallization trials were attempted on dMSL1820-1039, with no 
crystals obtained.  Commercial sparse matrix screens were used to scan conditions likely to 
form dMSL1820-1039 crystals.  If promising conditions were obtained, then conditions were 
explored in the vicinity of the promising hits.  Various promising precipitants were observed, 
indicating the protein concentration, the precipitants, the salt concentration, and the type of 
buffer are having a positive effect on provoking dMSL1820-1039 to crystallize.  The stability of 
dMSL1820-1039 remains to be problem for crystallization as after 48 hrs in storage significant 
degradation products are consistently observed (data not shown). Crystallization trials could 
not be performed with dMSL3186-512 because its stability at concentrations above 2 mg/mL must 
be first improved.  The crystal structure of the MRG domain of MRG15 from Homo sapiens 
has been solved, indicating that the MRG domain folds properly in vitro, and can be 
crystallized (Bowman et al., 2006).  The structure of the chromodomain of Drosophila MOF 
was solved (Nielsen et al., 2005).  Also, the structure of the Homo sapiens MOF MYST HAT 
domain has been published, which supports the value of determining dMOF371-827, because the 
construct also includes the chromodomain.  Crystallization trials could not be performed with 
dMOF371-827 due to the heterogeneity in quaternary structure and the difficulty in purification 
by size exclusion chromatography.   
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5. Future Directions 
 The research presented summarizes cloning, expression, and purification to 
homogeneity of a Drosophila MSL1 C-terminal construct and a Drosophila MSL3 C-terminal 
construct consisting of the MRG domain.  Moreover, the study has shown expression and 
purification of an enzymatically active Drosophila MOF construct comprised of the 
chromodomain, MYST HAT domain, and the CCHC zinc finger.  Initial protein-protein 
interaction studies were attempted between the recombinant MSL1, MSL3, and MOF 
Drosophila proteins.  Lastly, cloning of the Homo sapiens MSL1 C-terminus was described.   
Additional experiments are required to improve the stability of Drosophila MSL1820-
1039, and to obtain proof of its secondary structure.  In an effort to do so, dMSL1820-1039 could be 
bound to either dMOF or dMSL3.  In doing so, the complex would stabilize the individual 
proteins by both altering the conformation of the proteins and by protecting susceptible regions 
from proteases.  Another practical approach could be to carefully remove or add 3 - 5 amino 
acids to the C-terminal construct.  In this way, the folding (secondary structure) of the 
recombinant protein could be improved by the inclusion or removal of amino acids.  
Interestingly, the use of Tris buffer did not affect the interaction of recombinant dMSL1820-1039 
with the stationary phase, even though the recommended buffer for Source S is HEPES buffer.  
Both buffers optimally work at pH 8.0; however, Tris buffer is zwitterionic its positive charge 
may interact with the negative stationary phase, effectively inhibiting desired interaction 
because of a loss of binding sites.   
Also, Drosophila MSL3186-512 protein needs to be stabilized at a higher concentration in 
order for protein crystallization trials and interaction studies to be completed.  Typically 
crystallization trials require a protein concentration between 8 – 20 mg/mL.  The most direct 
method would be to try obtaining more soluble protein by varying the expression conditions.  
Also, the stability of protein can be greatly affected by the choice of buffer or the addition of 
additives such as 5 – 20 % glycerol.  Furthermore, different growth media should be attempted 
in order to aid in the production of soluble protein.   
Future studies may also benefit from addressing what exactly occurred to dMOF371-827 
because of, or during, anion exchange chromatography.  Moreover, activity assays could be 
done in the presence and absence of zinc to quantify whether or not zinc effects activity at all 
stages of dMOF purification.  Near-UV spectroscopy could be used to quantify the level of 
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zinc in dMOF protein during purification as zinc absorbs maximally at 500 nm (Futaki et al., 
2004).  Size exclusion chromatography must be done more conclusively in order for 
crystallization trials.  Size exclusion chromatography could also be done prior to ion exchange 
to determine whether the problem created during ion exchange is also problematic to size 
exclusion.  MOF371-827 possessing 13 cysteine residues requires the constant presence of a 
reducing agent; reduced L-glutathione could be substituted for DTT due to the possibility of 
problems arising because of DTT.  Successful activity assays with recombinant MOF now 
permit mutation studies coupled with activity assays to provide insight into the mechanism of 
acetylation.   
Successful expression and purification of recombinant dMSL1, dMSL3, and dMOF 
permits an assessment of the strength of their unique protein interactions.  These unique protein 
interactions experiments would include: dMSL1 and dMSL3, dMSL1 and dMOF, dMSL3 and 
dMOF, and all three dMSL1, dMSL3, and dMOF.  The dissociation constant (Kd) enables the 
measurement of affinity between two proteins.  In order to measure the Kd of the unique 
protein interactions several techniques may be employed including: surface plasmon 
resonance, fluorescence spectroscopy (tryptophan fluorescence), isothermal titration 
calorimetry, and/or a Myc-tag permitting use of antibodies.  Over-expression and purification 
of the recombinant proteins also permits future structure determination studies with either x-ray 
crystallography and or nuclear magnetic resonance.  The possibility of co-crystallization trials 
requires further experiments directed towards establishing stable protein complexes. 
Over-expression of recombinant dMOF371-827 and establishment of its HAT activity on 
core histone proteins now grants further studies into its catalytic mechanism.  The mechanism 
proposed for Esa1, MOF homologue and member of the MYST HAT family, can be tested 
(refer to section 1.4.2) (Yan et al., 2002).  The two Esa1 mutations C304A and E338Q may be 
carried out MOF C680A and E714Q respectively.  Additionally the affect on the previously 
reported MOF G691E mutation may be assessed (Akhtar and Becker, 2000).   
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